













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
















A thesis submitted for the degree of Doctor of Philosophy 
 










I hereby declare that this thesis has been composed by me for the degree of PhD at 
the University of Edinburgh. As far as I am aware, this work has not been presented 
in any previous application for a degree. All work was performed by myself, unless 
otherwise stated in the text, and all sources of information have been acknowledged 

























     Sonic hedgehog (Shh) is an important signalling protein expressed extensively in 
development, throughout tissues of the central nervous system, gut and the posterior 
of the limb bud. The complicated expression pattern of Shh is regulated by a series of 
long-range enhancers located flanking and dispersed throughout a 1 Mb genomic 
desert. Disruption of SHH as a result of mutations within the gene or its enhancers 
has been implicated in two developmental conditions. These are Holoproencephaly 
(HPE3) a common developmental defect of the forebrain and frequently the mid-face 
in humans, and preaxial polydactyly (PPD), a congenital limb abnormality 
encompassing a varied phenotype affecting the digits on the anterior side of the 
hands and feet that has been attributed to misexpression of Shh.  
 
       In order to investigate the Shh regulatory landscape and survey regulatory 
activity, a transposon-based chromosomal engineering strategy known as the local 
hopping enhancer detection (LHED) system was employed. Using this method a 
targeting vector containing a LacZ reporter gene as well as LoxP sites was inserted 
within the Shh region. The ‘hopping’ nature of the transposable element was then 
exploited to scatter it throughout the region. Tetraploid complementation embryos 
derived entirely from ES cells were generated and examined in order to gain an 
insight into enhancer activity. The region was found to be in an open conformation 
over its length and is generally susceptible to all Shh enhancers.  Genes within the 
regulatory domain, such as the widely expressed Rnf32 gene, were found to resist 
Shh enhancer activities by a process of regulatory evasion by the promoter, a 
mechanism that may be common in large regulatory domains.  Finally, at the 
boundaries of the region Shh activity was found to be lost incrementally at a number 




     Mouse lines were also generated to look at both enhancer activity and loss of 
function effects and three deletions of increasing size were generated between Shh 
and the furthest enhancer, the Zrs. These in turn, delete firstly a gut and pharyngeal 
epithelial enhancer, secondly the gut, pharyngeal enhancers as well an oral epithelial 
enhancer and finally all three epithelial enhancers as well as three forebrain 
enhancers. Reporter gene expression was found to be lost incrementally from those 
enhancers deleted without disrupting the rest of the region. Previously unidentified 
notochord enhancer(s) were found to lie within the region 100-530 kb upstream of 
Shh.  Examination of the resultant phenotypes showed that gut and craniofacial 
defects were found to occur as a result of the loss of enhancers which drive 
expression within these tissues. Variable phenotypes were found to occur potentially 
as a result of temporal changes to Shh expression or as a result of threshold levels of 
HH being required for normal development. Other enhancers within the Shh region 
and outwith the deletions were not found to be disrupted by these modifications 
suggesting the enhancers within the region act independently of each other. The 
largest deletion resulted in bringing the Zrs (which drives Shh limb expression) 
within 170 kb of the gene, however limb development; was not, found to be affected 
suggesting distance is not required for Zrs function.  
     Overall, the LHED transposon system has been utilised in order to examine the 
Shh region in more detail, allowing mapping of enhancer function by reporter gene 
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2.1 The Hedgehog genes 
The hedgehog gene (Hh) was first discovered by (Nusslein-Volhard and 
Wieschaus 1980) within a mutation screen of Drosophila embryos.  Hh has been 
shown to encode a secreted protein which is involved in patterning the Drosophila 
embryo. It is confined to engrailed-expressing cells and serves to pattern the 
posterior compartment of each segment primordium (Lee et al. 1992). Loss of 
function mutations result in a phenotype whereby the denticles found on the larval 
cuticle resembled the spines of a hedgehog, thus giving the gene responsible its name 
(Nusslein-Volhard and Wieschaus 1980).  
 
Vertebrate hedgehog genes were first identified in mice, fish and chickens via 
a cross-species screen (Echelard et al. 1993; Krauss et al. 1993; Riddle et al. 1993). 
Unlike the fly where only a single Hh gene was identified, Within the mouse three 
Hh genes are known- Desert Hedgehog (Dhh) which is most closely related to the 
Drosophila Hh gene; Indian hedgehog (Ihh) and Sonic Hedgehog (Shh) (Echelard et 
al. 1993).  
 
In mice, Shh has been shown to be essential for patterning the early embryo. 
Shh is expressed at Hensen’s node, throughout the notochord, the floor plate of the 
neural tube, and the early gut endoderm, and in the posterior of the limb buds. It thus 
plays a key role in patterning of the ventral neural tube (Echelard et al. 1993), the 
anterior posterior limb axis (Riddle et al. 1993), the epithelial morphogenesis of the 
oral cavity to hindgut (Chuong et al. 2000) and the ventral somites (Johnson et al. 
1994).  
Ihh is expressed at two main sites within the embryo; the endoderm of the 
mid-gut and lung and the cartilage of the developing long bones in the limb. Within 
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the limb, Ihh is normally expressed within the growth plate where it is responsible 
for regulation of chondrocyte proliferation and differentiation. Ihh is not found to be 
expressed early in development when Shh is expressed in the posterior mesenchyme, 
suggesting that Ihh has a distinct role from Shh. Despite this, Ihh has biological 
properties similar to that of Shh, including the ability to regulate the conserved 
targets Patch1 (Ptc1) and Gli (Vortkamp et al. 1996). 
In mice, Dhh has been found to play a role in male sexual development and in 
the formation of the perineurium, which protects the nerve fibres of the peripheral 
nervous system.  Dhh has been found to be expressed within foetal testes at E11.5, 
with no transcripts being detected in foetal ovaries (Bitgood et al. 1996). 
 
2.2 The Hh signalling pathway 
The hedgehog signal transduction pathway is an evolutionary conserved 
signalling cascade essential for the proper patterning and development of tissues in 
metazoan organisms.  
The Hh protein is initially synthesised as a 45 KDa precursor protein, which 
undergoes an autoproteolytic cleavage via an intein-like mechanism. The C-terminal 
domain of Hh, which resembles a self-splicing intein domain, catalyses both its own 
removal and replacement by cholesterol (Hall et al. 1995). Two fragments are 
generated; a 25 KDa non-functional C-terminal fragment and a 19 KDa N-terminal 
fragment, which is covalently linked with cholesterol. The N-terminal domain is 
further modified within the endoplasmic reticulum by a protein known as skinny 
hedgehog which palymitoylates a Cys residue near its N-terminus. Once both lipid 
modifications are performed the protein is packaged and released in lipid-associated 
particles (Hall et al. 1995).  
The Hh ligand functions as a morphogen that has been implicated in both 
short and long range signalling. Within the vertebrate, Shh is expressed within the 
notochord where it acts locally at high concentrations to induce floor plate 
specification (Roelink et al. 1995). Whereas, at larger distances over ~200 µm, and 
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lower concentrations it is found to contribute to the specification of motor neurons 
and the induction of Ptc1 (Ericson et al. 1996; Marigo and Tabin 1996; Ericson et al. 
1997). Within the Drosophila embryo Hh acts locally to regulate Wingless (Wg) 
within cells adjacent to those expressing the Hh protein (Ingham 1993). A 
concentration dependent gradient of Hh protein is necessary for patterning the adult 
fly abdomen (Struhl et al. 1997). Hh has also been shown to act at long-range to 
pattern the anterior posterior axis of the Drosophila wing where is acts over distances 
of 8-10 cell diameters to induced expression of both Dpp and Ptc (Mullor et al. 
1997).  
It was originally believed that the molecular mechanism of Hh transduction in 
responding cells differs significantly between Drosophila and mammals (Huangfu 
and Anderson 2006; Varjosalo et al. 2006). However, more recent evidence suggests 
these pathways, although somewhat different, have many similarities.  
In responding cells, the Hh protein binds to Patched (Ptc) a 12 pass 
transmembrane protein which functions as its core receptor and works in 
combination with co-receptors such as Ihog/Cdo (Marigo, Davey, et al. 1996; Stone 
et al. 1996; Tenzen et al. 2006; Zhang et al. 2006). In the absence of Hh, Ptc 
represses the activity of the 7-pass transmembrane protein Smoothened (Smo), a 
member of the G-protein coupled receptor superfamily (GPCRS), which has been 
shown to strongly resemble the Frizzled (Fz) family of proteins (Nusse 2003). Both 
Smo and Fz have an N-terminal extracellular cysteine-rich domain (CRD). The 
mechanism by which Ptc represses Smo activity still remains unclear. Early reports 
suggested that Ptc represses Smo by directly binding to it via the CRD domain much 
like Fz and Wnt family ligands, however this was later shown to be an artefact of the 
over-expression experiments used and that actually Smo inhibition is achieved by 
sub-stoichiometic amounts of Ptc  (Stone et al. 1996). The Ptc protein has similar 
structure to cholesterol trafficking regulator Niemann-Pick C1 (Npc1) protein. Like 
Npc1, Ptc contains a sterol-sensing domain suggesting it could play a role in 
transporting hydrophobic molecules that regulate Smo activity (Huangfu and 
Anderson 2005). Smo signalling activity has been shown to be modified by sterol 
derivatives (Eaton 2008). A more recent study suggests that Smo activation involves 
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a conformational rearrangement modulated by lipidic molecules acting at multiple 
distinct sites within its extracellular and heptahelical domains suggesting Smo 
activity is determined by multiple physiological inputs (Myers et al. 2013). Ptc might 
therefore function by regulating the availability of such molecules, with its similarity 
to Npc1 suggesting it could promote transport of small lipophilic molecules (Eaton 
2008).  
Once Smo inhibition is released it forms an active conformation. In 
Drosophila this is communicated to the cytosol through a signalling complex 
comprising the Costal 2 (Cos2), Fused (Fu) and Suppressor of Fused proteins (SuFu). 
In the absence of Hh signalling, Cos2 forms a complex with Fu, SuFu and the Ci 
zinc-finger transcription factor that both promotes cleavage of the full-length Ci to its 
repressor form and prevents entry of Ci to the nucleus (Ruel et al. 2003). In the 
presence of Hh a complex is formed between Smo and Cos2, which prevents 
inhibition of Ci by Cos2 complex generating the activator form of Ci (CiA) which 
can then move to the nucleus with the help of Fu to activate target genes (Ruel et al. 
2003) (Figure 2.1A).  
Two mammalian Cos2-like proteins exist, Kif7 and Kif27 which share ~23% 
and ~38% sequence homology respectively (Katoh and Katoh 2004, 2004).  Three 
homologs of Ci are found within vertebrates; Gli1, Gli2 and Gli3 (Jia et al. 2002; Jia 
et al. 2005; Bhatia et al. 2006).  
Phosphorylation plays an important role in regulating the Hh pathway.  When 
Smo is phosphorylated by PKA, Cos2 is released and a recognition signal for Slimb 
is established leading to the degradation of the Ci protein by the proteasome into Ci-
R. In vertebrates phosphorylation of Gli3 allows its recognition by β-Trcp, resulting 
in the formation of the repressor molecule (Gli3-R). Activation by Shh relieves the 
inhibition of Smo by Ptc. Smo becomes phosphorylated by Grk2, binds to β-Arrestin 
and Kif3a, and is trafficked to the cilium. This relieves the inhibitory effect of Sufu 
and allows the full-length Gli3 (Gli3-A) to translocate to the nucleus and activate 
target genes (Jia et al. 2002; Jia et al. 2005; Bhatia et al. 2006).  
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Hh signal transduction in mammals utilises the primary cilium, an 
evolutionarily conserved microtubule-based organelle analogous to the flagella, 
comprising a central microtubule structure known as the axoneme which protrudes 
from the surface of the cell. This is the major difference between mammals and 
Drosophila with regards the Hh signalling pathway. In Drosophila only a few cell 
types are ciliated and thus they do not appear to require cilia for Hh signalling (Han 
et al. 2003; Sarpal et al. 2003).  
The assembly and disassembly of the cilium is mediated by intraflagellar 
transport (IFT) proteins and their associated Kinesin II (Kif 3 family), mice mutated 
in genes associated with these proteins such as Kif3a and Ift88  have been shown to 
lose Gli repressor and activator function (Rosenbaum and Witman 2002; Huangfu 
and Anderson 2005). Smo, Ptc1, Gli1, Gli2, Gli3 and Sufu are all found to localise to 
the primary cilium (Chen et al. 2009). Binding of Hh to Ptc causes removal of Ptc1 
from the cilium and translocation of Smo in a Kif3a and β-arrestin dependent 
manner. In the absence of the Hh ligand Ptc1 inhibits Smo resulting in it being held 
within intracellular vesicles within the cell, with Gli3 being kept in the primary 
cilium in a complex with Kif7 and Sufu (Corbit et al. 2005; Rohatgi et al. 2007) 





Figure 2.1: The Hedgehog signalling pathway 
A. The Drosophila Hh signalling pathway in the absence (left) or presence (right) of Hh. In the 
absence of ligand, Patched (Ptc) inhibits Smoothened (Smo), which is held in intracellular 
vesicles. A complex of proteins, including cubitus interruptus (Ci), Costal2 (Cos2) and 
several kinases, is established. Phosphorylation of CI establishes recognition signals for 
Slimb leading to partial degradation of Ci by the proteasome and formation of the repressor 
form (Ci-R). Ci-R then translocates to the nucleus, where it represses transcription of HH 
targets. Binding of secreted Hh to Ptc, blocks Ptc activity and releases Smo from inhibition. 
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Smo moves to the plasma membrane, where phosphorylation allows interaction with Cos2. 
Subsequent phosphorylation of Cos2 by Fu leads to release of unphosphorylated, full-length 
Ci, which can translocate to the nucleus where it promotes transcriptional activation.  
B. The vertebrate Hh signalling pathway. In the absence of Shh ligand, Ptc1 inhibits Smo, 
which is held in intracellular vesicles. Gli3 is kept in the primary cilium in a complex with 
Kif7 and Sufu. Phosphorylation of Gli3 by kinases allows its recognition by b-TRCP and 
leads to partial degradation by the proteasome, resulting in the formation of the repressor 
molecule. Activation by Shh relieves the inhibition of Smo by Ptc1. Smo becomes 
phosphorylated by Grk2, binds to β-Arrestin and Kif3A, and is trafficked to the cilium. This 
relieves the inhibitory effect of Sufu and allows the full-length Gli3 to translocate to the 
nucleus and activate target genes.  
 
2.3 Shh signalling within the central nervous system 
Shh acts as a morphogen during development of the early vertebrate ventral 
neural tube. Later in the dorsal brain it acts as a mitogen on the progenitors of the 
cerebellum, tectum, neocortex and hippocampus (Ruiz i Altaba et al. 2002).  
Dorosoventral specification of the neural tube is hypothesised to occur via 
two methods. The general consensus suggests Shh is secreted from the notochord (a 
mesodermal rod which underlies the neural tube) inducing differentiation of the 
floorplate (a group of specialised cells located at the ventral midline of the vertebrate 
neural tube). The floorplate expresses Shh in response to the notochord signal 
(Echelard et al. 1993). This is founded in studies within chick which suggests that the 
floorplate is unable to develop after removal of the notochord (Placzek et al. 2000). 
Alternatively, it has been suggested that the floorplate, notochord and dorsal 
endoderm share a common origin in the Henson’s node, thus all represent sources of 
Shh (Teillet et al. 1998).  
Shh gradient signalling establishes distinct progenitor domains via the 
regulation of a group of homeodomain proteins including members of the Pax, NKX, 
Dbx and Irx families. These proteins are divided into two classes; class I which are 
synthesised in the presence of Shh and class II which are repressed by Shh. By either 
repression or activation of these targets Shh expression leads to the definition of five 
neural progenitor domains within the ventral neural tube. Subsequently, mutual 
repressive interactions among these factors result in the formation of boundaries 
(Jessell 2000). Gli1, Gli2 and Gli3 are expressed in gradients within the floor plate 
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predominantly within ventral, intermediate and dorsal regions, respectively and act 
as targets of Shh signalling (Ruiz i Altaba, Palma, and Dahmane 2002). Shh null 
mice do not develop floorplate or most ventral cell types suggesting Shh is both 
necessary and sufficient for inducing ventral-neural cell types (Ruiz i Altaba, Palma, 
and Dahmane 2002). Loss-of-function Smo mutations lead to a more dorsally 
extended failure in the specification of ventral cell types (Wijgerde et al. 2002). This 
difference is attributed to the contribution of Ihh from the underlying gut endoderm.  
The notochord source of Shh also extends into the brain where it is required 
for ventrally patterning a number of cell types within the hindbrain and midbrain. 
Whereas, Shh emanating from the prechordal plate is required for ventral forebrain 
induction (Fuccillo et al. 2004). Shh is also a target of its own expression, as its 
activation in the ventral midline of the CNS is dependent on high levels of Shh 
signalling from the underlying axial mesoderm (Echelard et al. 1993).  
As well as having a role as a morphogen, Shh has also been implicated as 
having a mitotic and antiapoptotic role within the CNS. Experiments during the 
1950s showed that in the embryonic chick the brain collapses if the notochord and 
anterior hindbrain are separated from the neuroepithelium. This is attributed to the 
notochord secreting a trophic factor important for the expansion of the brain vesicles 
(Kaellen 1965). More recently, it has been shown that when the notochord is 
transiently displaced from the midbrain floor plate during development, the brain 
vesicles exhibit abnormal folding and collapse, as a result of decreased proliferation 
and increased apoptosis within the midbrain. This has been attributed to decreased 
SHH levels, as a similar effect can also be induced via the addition of cyclopamine 
(an inhibitor of Shh) or rescued by implanting Shh secreting cells (Britto et al. 2002).  
The brain develops from the anterior region of the neural tube and is divided 
into three primary vesicles; the hindbrain vesicle, midbrain vesicle and forebrain 
vesicle. The forebrain becomes divided into the diencephalon caudally and the 
telencephalon rostrally. The telencephalon subsequently differentiates into the 
olfactory bulbs anteriorly, the cerebral cortex dorsally and the basal ganglia 
ventrally. From E11 onwards, distinct telencephalic progenitor zones become 
morphologically apparent. Two structures are formed in the ventral telencephalon; 
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the lateral ganglionic eminence (LGE) a precursor to the striatum and the medial 
ganglionic eminence (MGE) (Zaki et al. 2003).  
In Shh null mice, forebrain development is severely affected. The 
telencephalon is hypoplastic, uninvaginated and the ganglionic eminences are not 
morphologically identifiable. Expression of ventral telencephalon genes such as Nkx 
2.1, Ihx6 and Gsh1 is absent (Pabst et al. 2000; Corbin et al. 2001; Rallu et al. 2002) 
However, in less severely affected Shh
 
null embryos, a small ventral telencephalic 
domain continues to express genes such as Gsh2, Mash1 and Dlx2 (Rallu et al. 2002; 
Corbin et al. 2003). It is possible that other Hh homologues can pattern the 
telencephalon or can partially compensate for the absence of Shh. In support of this 
possibility, mice mutant for both Shh and Ihh appear to lack all ventral character 
throughout the CNS (Zhang et al. 2001).   
Sources outside the telencephalon also influence its patterning. SHH from the 
Hensen’s node is crucial for specification of the MGE (Echelard et al. 1993; Epstein 
et al. 1999; Gunhaga et al. 2000). Whereas SHH signalling from the prechordal plate 
could also be required for specification of the ventral telencephalon (Kiecker and 
Niehrs 2001).  
Conditional gene ablation of Smo or Shh reveal different telencephalic 
phenotypes depending of the timing of gene ablation ranging from normal 
telencephalon development although with reduced olfactory bulb size, to no ventral 
telencephalon. Early HH signalling between E7.5 and E10.5 is therefore believed to 
be critical for setting up ventral telencephalic progenitor domains. However, it is not 
required after E12.5 (Machold et al. 2003; Fuccillo et al. 2004).  
The forebrain and epithelia of the facial primordial originate from the same 
ectoderm. Neural cell fate is thought to be a result of the presence of Bmp 
antagonists and Fgf signalling (Schuurmans and Guillemot 2002; Meulemans and 
Bronner-Fraser 2004; Wilson and Houart 2004). The ventral forebrain is also in 
contact with the mesenchyme of the fronto-nasal process allowing communication 
between tissues. Cranial neural crest cells which give rise to the facial mesenchyme 
originate from specific axial positions along the dorsal neural tube (Le Douarin et al. 
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2004). Chick embryos exposed to cyclopamine at various developmental time points 
produce a variety of facial malformations the severity of which correlate with the 
temporal and spatial inhibition of Shh. If Shh signalling is disturbed during 
gastrulation severe malformations of the forebrain and face occur whereas at later 
time points a grossly morphologically normal telencephalon results however with 
facial dysmorphologies (Chiang et al. 1996; Cordero et al. 2004; Marcucio et al. 
2005). 
 
2.4 Shh signalling within the Gut 
      The gut begins to develop within the mouse embryo from E8.0 when the anterior 
and posterior endoderm invaginates forming foregut and hindgut pockets, which then 
extend and fuse to form the gut tube. From this tube the digestive system comprising 
the oesophagus, stomach, small intestine and colon and respiratory systems arise 
during development (Ramalho-Santos et al. 2000). 
Within the developing gut Hh proteins are secreted from within the epithelia 
and then function within the endoderm on targets such as Ptc1, Smo and Gli 
(Ramalho-Santos, Melton, and McMahon 2000).  
Expression is firstly detected within the hindgut and foregut pockets and then 
extends towards the mid-gut during gut closure. Broad expression is found within the 
gut tube until E10.5 and then by stages E11.5-14.5 Shh is down-regulated within the 
hind stomach, jejunum and ileum. Ihh, in contrast is found to be expressed within the 
hind stomach to anus (Bitgood and McMahon 1995). At later stages (E18.5) both 
Shh and Ihh were found to be expressed within the stomach epithelium, the small 
intestine and the colon. Targets of Hh such as Ptc1, Gli1 and Bmp4 are found to be 
expressed in the mesenchyme throughout the gastrointestinal tract. Shh, Ptc1 and 
Ptc2 transcripts have also been detected within the adult stomach (Ramalho-Santos, 
Melton, and McMahon 2000). 
Both Shh and Ihh mutants have gastrointestinal defects including a smaller 
gastrointestinal tract, malrotation of the gut as a result of reduction in smooth muscle 
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thickness and annular pancreas. Histologically, Shh mutants have been shown to 
have an overgrown stomach epithelium, overgrown villi within the duodenum, 
imperforate anus and intestinal transformation of the stomach (Ramalho-Santos, 
Melton, and McMahon 2000). 
The embryonic mouse lung begins developing at E9.5, following the 
invagination of the ventral foregut into a pair of endothelial buds. These buds extend 
and undergo dichotomous branching between stages E9.5-16.5 in order to form the 
conducting airways and terminal acini. By E17.0 the terminal buds have dilated in 
order to form sac-like structures which then go on to form the future alveoli (Ten 
Have-Opbroek 1991). Shh is required for functional lung formation, with transcripts 
being detected throughout the lung epithelium from E11.5 and this expression 
continues until birth and peaks just before parturition. Targets of Shh including Ptc1 
and Smo are found within the mesenchyme of the developing buds adjacent to Shh 
expressing epithelial cells (Miller et al. 2001). Shh null mice lose lung symmetry as a 
result of branching defects resulting in a dramatic lung phenotype. The resulting lung 
lobes fail to develop a network of air sacs, and the oesophagus and trachea fail to 
divide. Mesenchymal proliferation is severely reduced and various Shh targets are 
found to be down-regulated (Pepicelli et al. 1998).  
During embryonic development, the heart and lung develop in parallel to 
form the cardiopulmonary circulation system when the lung endoderm protrudes into 
the cardiac mesoderm. Multi-potent cardiopulmonary mesoderm progenitors (CPPs) 
are a population of cells that have been identified within the posterior pole of the 
heart and are marked by expression of genes such as Wnt2, Gli1 and Isl1. This 
population of cells has been shown to arise from cardiac progenitors before lung 
development begins. CPPs go on to generate the mesodermal lineages within the 
cardiac inflow tract smooth muscles, proximal and vascular endothelium and pericyte 
like cells. The regulation of these cells is controlled by expression of Shh from the 
foregut endoderm which is required for connection of the pulmonary vasculature to 
the heart (Peng et al. 2013).  
Shh expression is observed in the pharyngeal epithelial lining and in the 
anterior ectoderm-derived epithelial lining from around E11.5-12.5 and is implicated 
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in the development of the oral cavity, the tooth and the tongue (Cobourne et al. 
2004). Shh has been recently shown to be involved in patterning of the fungiform 
papilla, a complex set of tissues and cell types which sit within the epithelium of the 
tongue and includes the taste buds. Shh signalling centres have been found to be 
located within the fungiform placode and are required for taste bud development and 
maintenance, most likely via stage-specific autocrine and/or paracrine mechanisms 
and by engaging epithelia-mesenchymal or connective tissue interactions (Liu et al. 
2013). 
 
2.5 Shh signalling within the limb 
          The zone of polarizing activity (ZPA) is a small region of sub apical 
mesenchyme cells found located at the posterior margin of the early limb bud. A 
series of experiments in which the ZPA was grafted onto different positions along the 
anterior-posterior axis of the limb bud led to the belief that the identity of a digit is 
dependent on the distance from the polarizing region (Wolpert 1969; Tickle et al. 
1975). A model was therefore proposed in which the ZPA produces a diffusible 
morphogen that sets up a concentration gradient across the limb bud and provides 
cells with positional information. 
 
Shh was shown to be expressed in the ZPA of the chick wing bud, and grafts 
of transfected chicken embryo fibroblasts expressing Shh were shown to have 
polarizing activity and were capable of inducing digit formation at the anterior of the 
limb (Riddle et al. 1993). Shh RNA  has been detected ectopically at the anterior as 
well as at the posterior of the limb bud in mouse mutants with additional pre-axial 
digits as found in the Sasquatch (Ssq) mouse mutant (Sharpe et al. 1999). 
     Shh was originally believed to pattern the limb bud by forming a gradient across 
the posterior half of the limb (Gritli-Linde et al. 2001). In many cases the expression 
domains of Shh and Ptc1 are observed in adjacent embryonic tissues while in other 
cases they are transiently co-expressed in the same regions which include the neural 
tube (Echelard et al. 1993), the sclerotome (Fan and Tessier-Lavigne 1994; Johnson 
et al. 1994), the visceral mesoderm (Roberts et al. 1995), as well as the limb bud 
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where Ptc is found to be expressed in cells in the posterior 2/3 of the limb bud in 
response to Shh signalling  (Riddle et al. 1993). The timing of Ptc1 induction in these 
tissues correlated with the timing of Shh signalling. In addition, Ptc1 is ectopically 
induced in response to Shh misexpression (Marigo, Scott, et al. 1996). Binding of 
Shh to Ptc is believed to limit the spread of the Shh protein. Hedgehog interacting 
protein (Hhip1) is up-regulated in response to Shh, and also binds to Shh to limit its 
range. Both targets of Shh therefore are believed to help create a gradient of Shh 
expression (Chuang and McMahon 1999). Cdo, Boc and Gas1 are negatively 
regulated by Shh and are believed to enhance Shh signalling. They are expressed in 
overlapping patterns in the anterior of the limb bud with Boc1 and Gas1 playing 
roles in facilitating long range Shh signalling (Allen et al. 2007; Allen et al. 2011).  
 
Shh signalling is also mediated through the mutual antagonism of Hand2, a 
member of the basic helix-loop-helix family of DNA binding proteins and Gli3, a 
zinc finger containing DNA-binding protein. Just after limb budding, Hand2 is 
expressed within the posterior of the limb bud.  Hand2 then pre-disposes the 
expression of Shh either directly or through activation of the 5’ HoxD complex 
within the ZPA, leading to determination of the A-P axis (te Welscher et al. 2002). A 
conditional limb mutation for Hand2 results in the loss of Shh expression and a 
phenotype resembling the Shh null limb (Galli et al. 2010).   Once SHH is activated 
it maintains Hand2 and HoxD expression while regulating members of the Gli family 
of proteins by proteolytic processing. The function of Shh signalling in digit 
patterning is to relieve Gli3 repression in cells in the posterior half of the limb bud 
(Figure 2.2 A). In addition graded Shh signalling in the region is translated into a 
gradient in the ratio of Gli3A/Gli3R protein present, which results in cells responding 
in a dose-dependent manner to specify digit identity (Litingtung et al. 2002; te 
Welscher et al. 2002; Wang et al. 2007). In mammals Gli processing takes place in 
primary cilia (as discussed above), polydactyly is therefore often found in human 
patients exhibiting ciliopathies (Quinlan et al. 2008).  
 
Shh is inactive, but primed for expression in the anterior margin of the limb 
(Amano et al. 2009) and under certain genetic circumstances can be ectopically 
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expressed resulting in the generation of limb defects such as preaxial polydactyly 
(Anderson et al. 2012).  Several genes have been identified by genetic analysis as 
being responsible for repressing the expression in the anterior domain.  Alx4 is 
specifically expressed in the anterior margin of the limb and when deleted results in 
disrupted anterioposterior polarity meaning Shh is induced within the anterior of the 
limb bud (Panman et al. 2005).  At the distal edge of the developing limb bud ETS 
transcription factor genes, Etv4 and Etv5 are expressed maintained by Fgf expression 
in the apical ectodermal ridge (Lettice et al. 2012). Limb buds that are deficient in 
both Etv4 and Etv5 ectopically express Shh in a mesenchyme domain at the anterior 
margin of the limb, indicating that their normal role is to restrict Shh expression to 
the posterior region of the limb (Mao et al., 2009; Zhang et al., 2009). Although 
Etv4/5 bind to two sites within the Zrs, the binding at one of these sites is sufficient 
to regulate Shh negatively in the anterior domain (Mao et al. 2009; Zhang et al. 2009; 
Lettice et al. 2012) (Figure 2.2 B).   
 
Members of the ETS transcription factors have been shown to play distinct 
roles in the spatial pattern of Shh. Occupancy at multiple ETS sites, which bind the 
factors Gabpα and Ets1, regulates the position of the Shh expression boundary in the 
limb, thus defining the ZPA. Multiple binding of Etv4 and Etv5 at the Zrs, in 
contrast, represses ectopic Shh expression outside the ZPA. It has been shown that 
the Zrs is open and fully capable of binding to activating factors such as Ets1 in the 
anterior domain of the limb bud. As a result, new mutant sites are capable of binding 
ETS factors in both normal and ectopic domains and overriding Etv4/Etv5 repression 




Figure 2.2: Patterning of the developing limb bud 
A.  Patterning of the early limb bud is defined early in development by the antagonist activity of 
Gli3 in the anterior and by Hand2 (which down regulates Gli3) in the posterior of the limb 
bud.  Initiation of Shh expression is dependent on Hand2 expression and the HoxA/D genes 
(Hox10-13).   
B.   Shh expression is repressed in the anterior margin and thus restricted to the posterior margin 
of the limb.  Alx4, Etv4 and Etv5 are involved in this repression. Twist1 expression in the 
limb up regulates Alx4, Etv4 and Etv5 and in the posterior limb bud the Fgf signalling 
pathway.   
C. The expression boundary of Shh is determined by ETS transcription factor binding sites. 
Within the limb, ETS1/Gabpα is expressed across the limb bud (left). In the wild-type 
embryo this leads to Shh production within the ZPA (right depicted in yellow). Deletion of 
one of the ETS1 sites causes a reduction in area of Shh expression (right depicted in dark 
blue) whereas the addition of an Ets1 site results in an increased Shh expression area (right 
depicted in orange).  
 
The two most posterior digits within the mouse limb are completely derived 
from the polarizing region. These digits (4 and 5) are both exposed to the same high 
concentration of Shh in the ZPA but the cells that form digit 4 spend a shorter time 
within the region before being displaced by growth. This function of Shh is not 
consistent with a classic morphogen gradient model. It is therefore suggested that 
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specification of anterior and posterior digits involve different mechanisms; a 
concentration gradient of Shh which specifies digit 2 and possibly digit 1 and late 
expansion based differences in duration of Shh signalling which specifies the two 
posterior digits with digit 4 being specified by a shorter time than digit 5. Finally 
digit 3 is specified by a combination of Shh concentration and time (Ahn and Joyner 
2004; Harfe et al. 2004). However, when Shh expression is reduced at early time 
points within the limb bud thus reducing cellular expansion, the digits are lost in the 
order D3, D5, D2, D4 which reflects the reverse order from normal digit primoridia 
form. Whereas, when Shh is lost at late stages the digits which still form remain 
morphologically normal despite cell number reduction (Zhu et al 2008). This led to 
the proposal of a biphasic model in which digit specification takes place very early in 
mouse limb bud development due to a concentration gradient of Shh expression, and 
later Shh is required for the proliferation of the specified digit precursors. Shh is 
therefore hypothesised to act firstly as a morphogen, within the early stages of 
development, at later stages it then exerts mitogenic activity in order to produce 
sufficient cell numbers for digit development. These two activities combine to 
specify digit identity, and as the limb bud expands the position in which these digits 
form (Zhu et al. 2008). The processing of the Shh protein is believed to be important 
in determining the range of signalling, this has been demonstrated in mice in which 
the cholesterol modification of Shh no longer takes place, resulting in middle digit 
loss (Lewis et al. 2001).  
 
2.6 Loss of Shh in development 
 
Shh null mice have been generated by inserting a PGK-Neo cassette within 
exon 2 of the gene leading to the loss of 97 of the 198 residues and truncation of the 
protein (Chiang et al. 1996). In contrast to humans where haploinsuffiency at the Shh 
locus occurs, mice heterozygous for the aforementioned mutation were found to be 
viable and phenotypically normal. However, the disrupted Shh gene was lethal when 
homozygous. Pups are stillborn and expected to have died at or just before birth 




The earliest defect exhibited within Shh -/- mice is found within the forebrain 
at E8.5 which corresponds to when Shh is beginning to be expressed within the 
embryo. At this stage the midline is found to be indistinct and the cephalic folds of 
the neural tube fused. Additionally, the optic vesicles which are normally separate 
appear within a single continuous vesicle which protrudes at the midline (Chiang et 
al. 1996). At the stage of neural tube closure (E9.5) an overall reduction in the size of 
the brain and neural tube is exhibited. By E11.5 embryos exhibit small size and 
defects within the presumptive midbrain and forebrain and the externally visible 
lateral eye structures are absent. By E15.5 embryos exhibit some growth retardation 
throughout most of the embryo and lack distinct hind limb and forelimbs. Extreme 
forebrain and craniofacial defects are observed with facial structures such as the 
eyes, nose and oral structures being mostly unidentifiable (Chiang et al. 1996). By 
E18.5 histological analysis suggests abnormalities of the heart, lung, kidney and 
foregut. The limbs are also shown to be completely truncated with the hind limb 
missing both the tibia and fibula, whereas the forelimb exhibits only a bony 
extension of the humerus which could represent either a fused ulna/radius or an 
extended bent humerus. Defects are also found within the ribs with usually only five 
or six rib cartilages remaining (Chiang et al. 1996).  
 
Within Shh-/- embryos defects of the foregut are also exhibited from early 
stages. At E8.5 within wild type mice outgrowth of the lung, liver and pancreas from 
the foregut is apparent. However within the mutant, although hepatic buds are 
formed, development of the lungs is delayed at least half a day. At E9.5 the trachea-
oesophageal septum is not established meaning that by E10.5 the trachea and 
oesophagus are not found as two separate tubes as expected but instead a single 
trachea-oesophageal tube that connects to the stomach (Litingtung et al. 1998). 
 
By E16.5 the trachea and oesophagus are in close contact, with the mutant 
trachea surrounded by a cartilaginous structure, a reduction in size of the oesophagus 
lumen is also found at the level of the heart. Whereas at the level of the lungs the 
oesophagus is absent and instead a region of thick mucosa resembling the stomach 
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lining showing continuity with the lung epithelium is found suggesting the 
oesophagus and lung epithelium have merged (Litingtung et al. 1998).  
 
The lungs are also affected within the mutant; at E9.5 the developing lung is 
hypoplastic indicating epithelial branching is affected (Litingtung et al., 1998). By 
E13.5, the asymmetry of the left and right lung lobes is completely absent and the 
lung appears as a single lobe, which is reduced to a simple sac by E18.5 as a result of 
enhanced cell death and decreased cell proliferation (Litingtung et al. 1998). 
 
Gastrointestinal defects including gut malrotation, reduced smooth muscle, 
intestinal transformation of stomach, annular pancreas, duodenal stenosis, and 
imperforate anus are also observed (Ramalho-Santos, Melton, and McMahon 2000). 
 
In humans the SHH gene was identified as a causative locus of HPE, a 
common developmental defect of the forebrain and frequently the mid-face in 
humans (Belloni et al. 1996). The condition involves incomplete development and 
septation of midline structures in the CNS. In its most severe form it results in failure 
of division of the forebrain into right and left hemisphere, cyclopia, a primitive nasal 
structure and/or midfacial clefting usually leading to death. Whereas in its mild form 
signs can include microcephaly, hypertelorism and the presence of a single maxillary 
incisor as a result of premature fusion of the epithelial dental lamina (Roessler et al. 
1996). The condition is highly variable even within families (Roessler et al. 1996).  
 
Shh was chosen as a potential candidate locus for HPE3 as a result of its 
expression pattern and the phenotype of the Shh -/- mouse. Genetic mapping also 
suggested the Shh locus could be involved in the disease and mutations of the gene 
including missense and nonsense mutations were identified in a number of HPE3 
families (Roessler et al. 1996). 
 
In humans, the ventral forebrain is particularly sensitive to the level of SHH 
expression, given that a 50% reduction in its normal levels causes HPE (Roessler et 
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al. 1996). In mice, loss of both Shh alleles is required to generate a similar HPE 
phenotype (Chiang et al. 1996).  
 
      Teratogenic agents such as ethanol and retinoic acid have also been shown to 
affect SHH. Both these agents have long been recognised to cause central nervous 
system and craniofacial malformations in humans which are believed to be mediated 
through the SHH pathway (Schneider et al. 2001). In sheep, deformities of the head 
consisting of distortion or absence of facial bones, cyclopia of the eyes, 
micropthalmia and anopthalmia with fusion of the cerebral hemispheres and absence 
or displacement of the pituitary and hydrocephalus as well as, on occasion, limb 
defects have been shown to be linked to ingestion of Veratrum californicum (wild 
corn lily) by pregnant ewes (Binns et al. 1959). The teratogenic steroidal alkaloid, 
cyclopamine, was purified from the plant and has been shown to act by inhibiting the 
cellular response to the Shh signal (Cooper et al. 1998; Incardona et al. 1998). 
Cyclopamine has also been shown to have a similar effect when administered to 
chick embryos (Incardona et al. 1998).  
 
2.7 Misexpression of Shh in development 
 
Misexpression of SHH is also a major cause of the human congenital limb 
abnormality PPD (OMIM: 174500); a condition encompassing a varied phenotype 
affecting the digits on the anterior side of the hands and feet. Patients with preaxial 
polydactyly exhibit phenotypes ranging from mild triphalangeal thumb to severe 
duplications of the digits and tibial aplasia (Lettice and Hill 2005). These mutations 
are dominantly inherited and highly penetrant, and were originally found to map to 
the 7q36 region within humans (Heus et al. 1999). In mice the dominant mouse 
mutations Hemimelic extra toes (Hx) and Hammertoe (Hm) exhibit limb defects 
which are analogous to the PPD defects, with the former exhibiting PPD and radial 
and tibial hemimelia and the latter webbing between the digits (Clark et al 2000). 
These mutations were shown to map to a homologous region to PPD within humans 
(Heus et al. 1999; Clark et al. 2000).  Originally the PPD phenotype was attributed to 
mutations within the Lmbr1 gene as it was present within the mapped locus and was 
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expressed within the developing limbs at the stage that Hx and Hm mutations arise 
(Clark, Marker, and Kingsley 2000; Clark et al. 2001), however comprehensive 
analysis of the LMBR1 coding region from cell lines of PPD mutations found no 
pathogenic mutations of LMBR1 (Heus et al. 1999; Clark et al. 2001). Mice in which 
one copy of Lmbr1 has been deleted exhibited wrist defects in 25% of instances 
(Clark et al. 2001). However human patients in which one copy of LMBR1 was 
lacking were shown to have no limb defects. A mouse was therefore generated in 
which exon 1 including the translational start site and potentially the transcriptional 
start site was deleted (Clark et al. 2001). Within these mice around 7% of Lmbr1 
transcripts were still found to be produced (Clark et al. 2001). Histological samples 
from mice suggested no defects were present within the organs of the liver, kidney, 
spleen, testes, epididymis or seminal vesicle. There was a low incidence of limb 
defects; however, in contrast to the Hx mutant digit loss rather than digit gain was 
exhibited (Clark et al. 2001). It was therefore postulated that a gain of function rather 
than deletion mutation within Lmbr1 was responsible for the PPD phenotype (Clark 
et al. 2001).  
The Shh gene was also found to be physically linked to the PPD phenotype; it 
was therefore proposed that PPD was in fact occurring as a result of mutations to a 
long-range regulator of Shh (Chang et al. 1994; Sharpe et al. 1999). This hypothesis 
was made more plausible by data from Holoproencephaly patients who had a 
translocation breakpoint distal to Shh thus suggesting that cis-regulatory control 
elements were required for normal expression of Shh during craniofacial 
development (Roessler et al. 1997).  
 
Ssq is a mouse mutation which arose through a random transgenic insertion, 
and presents with a semi-dominant phenotype in which extra digits are present on the 
hind limbs in heterozygotes and the fore and hind limb of homozygotes. The 
mutation mapped to intron 5 of the Lmbr1 gene and was found to be as a result of 20 
kb duplication (Lettice et al. 2002). A genetic cis/trans test was performed in which a 
mouse cross was devised whereby the Ssq allele was located in cis to a 
distinguishable Shh null allele and was used to verify that the Ssq phenotype was 
abrogated when the Ssq allele was placed in a cis position relative to the Shh null 
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allele (Lettice et al. 2003). A similar test was later performed in Hx mice which again 
showed that the phenotype was abrogated in the presence of the Shh null allele 
(Sagai et al. 2004). This suggested that both mouse mutants were exhibiting 
phenotypes directly as a result of misexpression of Shh. Molecular studies were then 
performed to confirm that an 800 bp highly conserved long-range regulatory element 
was present within this region. This regulator was designated the ZPA regulatory 
sequence (Zrs) (Lettice et al. 2003; Sagai et al. 2004). The Hx mice as well as four 
unrelated human PPD families were found to have base substitutions within this 
conserved sequence, with the conserved region also being capable of driving 
expression of the LacZ reporter gene within the posterior of the developing limb bud 
in a pattern similar to endogenous Shh (Lettice et al. 2003). The ZRS therefore 
comprises a cis-regulatory element which is both necessary and sufficient for driving 
spatial and temporal expression of Shh, functioning as a long-range regulator, 
operating over a large distance of approximately 1 Mb to regulate Shh expression 














Figure 2.3: Regulation of Shh expression in development 
Schematic illustration of the multiple sites of Shh expression in the E11.5 embryo (top); the colours 
used match the relevant enhancers (coloured bars) which are shown in their genomic context 
alongside other genes within the region (Bottom).  
  
2.8 The Shh gene desert 
 
The region between the ZRS and Shh comprises a large gene desert within 
which a number of other potential cis-regulators of Shh reside or flank (Jeong et al. ; 
Jeong et al. 2006; Sagai et al. 2009) (Figure 2.3). By utilising a transgenic reporter 
assay in mice two intronic enhancers, SBE1 and SFPE2, and a further enhancer 7 kb 
upstream of Shh, SFPE1, were identified (Epstein, McMahon, and Joyner 1999). 
SFPE1 and SFPE2 were found to function redundantly to direct LacZ expression 
within the floor plate of the spinal cord and hindbrain (Jeong et al. 2006). 
 
SBE1 is capable of driving expression within the ventral midbrain and caudal 
region of the telencephalon (Epstein, McMahon, and Joyner 1999).  A mouse line 
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has been generated to carry a deletion of the 525 bp intronic sequence mediating 
SBE1. Embryos lacking SBE1 were found to initiate Shh transcription but are unable 
to maintain it within the ventral midline of the rostral midbrain and caudal 
diencephalon from E10.0 onwards, however reporter gene expression within the 
forebrain tissue zona limitans intrathalamica (Zli) of Shh 
ΔSBE1/ΔSBE1 
was unaffected 
Together this data suggests SBE1 is important for maintenance of expression in the 
ventral midbrain (but not the Zli) at E11.5  therefore suggesting that SBE1 could be 
functioning redundantly with an unidentified enhancer to control Shh transcription at 
earlier time points (Jeong et al. 2011).  
 
A comparative sequence analysis approach was also utilised to examine the 
region of DNA upstream of Shh. Three enhancers were identified 300-450 kb 
upstream of Shh, SBE2, SBE3 and SBE4 which were found to direct LacZ expression 
within the rostral diencephalon, telencephalon and ventral diencephalon, respectively 
(Jeong et al. 2006).  
 
A point mutation within SBE2 which results in a cytosine to thymine base 
change has been identified within an individual with HPE3 (Jeong et al. 2006). This 
individual exhibited microcephaly, midfacial hypoplasia, cleft lip and palate, 
diabetes insipidus and moderate fusion of the hypothalamus and basal ganglia. This 
base change was shown to result in an inability to drive expression within structures 
from the optical vesicles to the rostral diencephalon, a phenomenon which was found 
to be similar to embryos carrying a version of SBE2 which had 10 bp deleted within 
the region of the base pair change (Jeong et al. 2006). This 10 bp region was 
therefore hypothesised to be an important binding site for a transcriptional regulator 
which was later identified as the homeodomain protein Six3. Six3 is therefore 
believed to function as a context dependent activator or repressor of target gene 
expression in the developing eye and forebrain, and has also been identified as a 
mutated locus within some HPE patients (Jeong et al. 2008).  
 
A further cluster of cis-regulatory elements have also been found located 600-
900 kb upstream of Shh, these elements have been found to reside within and close to 
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the Rnf32 gene (see Figure 2.3) (Sagai et al. 2009). Mammal amphibian conserved 
sequence (MACS1) which is located within intron 8 of the Rnf32 gene was found to 
drive expression within the respiratory and gut endoderm and caudal regions and also 
the urogenital tract. Whereas Mammal Fish conserved sequence (MFCS4) located 
just downstream of Rnf32 was found to direct reporter expression within the oral 
epithelium, epiglottis, soft palate and arytenoids swelling. Both MACS1 and MRCS1 
were found to drive expression within an overlapping border in the pharyngeal 
structures.  Finally, Mammal Reptile Conserved sequence 1 (MRCS1) was found to 
act as an enhancer for promoting expression within derivatives of the oral epithelium 
including the epithelia of the  hair and whisker buds, dental placode, rugae of the  
hard palate and fungiform papillae of the anterior tongue. These elements were 
therefore shown to drive reporter gene expression in a co-linear pattern along the 
anterior-posterior body axis within the epithelial linings of the oral cavity and gut 
(Sagai et al. 2009). 
 
Deletion of MFCS4 has been undertaken, with homozygote offspring found 
to be viable at birth, however dying after a few days. These offspring were found to 
have bloated bellies and have stomachs devoid of any milk, suggesting an inability to 
swallow. The soft palate within the neonates was found to be truncated, the epiglottis 
was found to be lost or reduced in size and hypotrophy of the aryteroid and tongue 
deformation was also exhibited; thus, suggesting that this enhancer is essential for 
morphogenesis of the pharyngeal structures necessary for respiration and 
swallowing. Shh expression was also found to be lost within associated regions 
within mutants as compared to wild-type controls (Sagai et al. 2009).  
 
Recently, an additional enhancer has been located approximately 100kb from 
Shh (See Figure 2.3). This enhancer designated the SLGE (Shh lung gut enhancer) 
has been shown to drive expression similarly to the MACS1 enhancer. Expression is 
found within the intestine, oesophagus and whole stomach as well as the alveoli of 
the lungs. However, unlike MACS1 it is not capable of driving expression within the 
laryngotracheal tract. This enhancer is believed to contribute to SHH gut expression 
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at later stages of development (E12.5) when MACS1 is not thought to function 
(Tsukiji et al. 2013) (Figure 2.3).  
 
2.9 Conservation of Shh enhancers  
 
         The Zrs is conserved in a number of vertebrate species including fish 
and Chondrichthyes. Like mammals, the genomic location of the Zrs within the 
Lmbr1 gene is also found to be conserved within fish and sharks. This conservation 
over nearly 400 myr suggests that not only is the sequence of the Zrs essential for 
correct function but also its location in the genomic landscape (Lang et al.).  
 
The oral epithelium-specific enhancer MRCS1 is conserved in birds and reptiles at 
the almost same level as between mammals; whereas, its homolog has not been 
identified in amphibians and teleost fishes. MFCS4 is conserved between mammals 
and teleost fishes, although with lower sequence similarity, a homolog has also been 
identified within Fugu (Woolfe et al. 2005). The lung-gut epithelium-specific 
enhancer MACS1 is conserved in amphibians, but not in teleost fishes (Sagai et al. 
2009).  
SBE2 sequences have been identified in a number of species, with those sequences 
identified in humans, chicken and amphibians capable of driving expression within 
the correct tissues in mice. In contrast the Fugu SBE2 sequence was not capable of 
this.  While SBE3 sequences were only found in closely related organisms, including 
chimp and rat. SBE4 sequences have also been identified in a number of species; 
however the degree of conservation is reduced in comparison with SBE2, with 
conserved reporter activity from the chick but not the frog or Fugu (Jeong et al. 
2006).  
It is likely that the Shh enhancers have evolved as species diverged with their 
appearance relative with the presence of the tissues they are expressed in. For 
example, the MACS1 enhancer is not present within fish where lungs are also not 
present. The forebrain enhancers appear to be conserved only functionally within 
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mammals and birds suggesting they may have arisen relatively recently in accord 
with more complex brain function. Alternatively, it could be that more diverged 
species have evolved different enhancers for driving Shh expression which have so 
far not been identified. SLGE appears to have very low evolutionary conservation 
between species, with it, in general, only being present within rodent species, with 
even rabbit sequences unable to drive expression within the mouse (Tsukiji, Amano, 
and Shiroishi 2013). It is speculated that this is as a result of the SLGE enhancer 
being of redundant function with MACS1 and therefore under less evolutionary 
constraint (Tsukiji, Amano, and Shiroishi 2013). 
 
 
2.10 Mutations affecting Shh regulation 
 
Homozygous deletions of the Zrs result in a complete loss of Shh expression 
in the limb resulting in ulnar aplasia and oligodactyly (Sagai et al. 2005).  
Heterozygous point mutations within the ZRS in both humans and mice have been 
shown to result in mis-expression of SHH leading to PPD as previously discussed 
(Lettice and Hill 2005). So far, fifteen different ZRS single-point mutations have 
been identified within humans which are associated with limb abnormalities with the 
most prevalent being gain of function mutations. Point mutations have also been 
identified in other species including mice, cats and chickens, where again they are 
associated with extra toes (Anderson et al. 2012). Point-mutations within the Zrs 
have been shown to result in ectopic anterior Shh expression, which is expected to 
effectively generate an additional ZPA. This affects the Gli3A:Gli3R ratio leading to 
the respecification of extra-digits or the transformation of thumb to finger (Anderson 
et al. 2012). The autosomal dominant disorder Werner mesomelic syndrome has also 
been shown to be caused by several point mutations within the ZRS. This condition 
presents with a severe phenotype consisting of preaxial polydactyly of the hands and 
feet, as well as dwarfism as a result of tibial hypoplasia (Wieczorek et al. 2010).  
 
Duplications which include the ZRS have been described as causing 
Triphalangeal thumb polysyndactyly syndrome (TPTPS). Families with Haas Type 
40 
 
polysyndactyly (complete syndactyly with polydactyly), Laurin-Sandrow syndrome 
(mirror image duplication of all digits) and Syndactyly type IV (SD4) (complete 
syndactyly affecting fingers of both hands) have also have also been found to occur 
as a result of duplications of the ZRS (Sun et al. 2008). A correlation between smaller 
duplications and more severe phenotype has been identified; whereby small micro 
duplications within the ZRS region (<80 kb) have been shown to be the underlying 
genetic cause of Laurin-Sandrow syndrome whereas larger duplications result in less 
severe phenotypes (Lohan et al. 2014). It is suggested that it is possible that the 
different sizes of duplications affect the efficiency with which the ZRS region 
interacts with Shh. With the sizes of the aberrations affecting the locus dynamics and 
thereby influencing Shh expression negatively, potentially resulting from a similar 
pathogenic mechanism as ZRS point mutations (Lohan et al. 2014).  
 
Chromosomal inversions with breakpoints between Shh and the ZRS have 
also been identified both in mice and in humans. Within Dsh (short digits) mice, Shh 
has been shown to be ectopically activated in the cartilage of early digit primordia 
(Niedermaier et al. 2005). It has been suggested that the misexpression of Shh in 
these mice is the result of the removal of a repressor that enabled additional 
expression to occur in the early developing digits. Within humans, a TPTPS patient 
was identified who had an intrachromosomal inversion within the SHH region. This 
led to a phenotype whereby fusions of all fingers and toes along the entire length of 
each digit had occurred.  ‘Enhancer adoption’ was the term used to describe this 
phenomenon, as one breakpoint was found to have occurred upstream of the SHH 
gene meaning that it ended up under the influence of a different enhancer at the other 
end of the breakpoint, freeing it from the influence of the ZRS and other regulators 
(Lettice et al. 2011). Chromosomal rearrangements within the gene desert flanking 
SHH have also been identified. These have been identified as disturbing the SHH 
CNS enhancers resulting in a variable HPE phenotype, similar to that exhibited 






2.11 Neighbouring genes to Shh 
 
A number of other potential regulatory targets are present within the Shh/Zrs 
genomic region (See Figure 2.3). The Rnf32 gene lies between the Zrs and Shh gene, 
originally suggested to be testes specific is actually found to be ubiquitously 
expressed during embryo development (van Baren et al. 2002). As previously 
mentioned (Section 2.8), within its introns enhancers of Shh gut and pharynx 
expression are found (Sagai et al. 2009). The actual function of Rnf32 however 
remains unclear and no mouse mutants have been reported to date. 
  
The Zrs is located within intron 5 of Lmbr1(Figure 2.3), a gene which is 
expressed ubiquitously within the developing embryo but is not expected to play a 
role in limb development (Hill 2007). Lmbr1 deletion mice are found to be viable 
with a low incidence of limb malformations (Clark et al. 2001).  
 
          Upstream of Lmbr1 (and Shh) lie two genes Nom1 and Mnx1 (Figure 2.3), very 
little is known with regards to the former, Mnx1 however has been shown to play 
pivotal roles in both pancreatic development (Thaler et al. 1999) and the 
establishment of motor neuron identity (Thaler et al. 1999). Smaller sized mice 
which have a ‘curled appearance’ have been found to result when homozygous Mnx1 
deletions are generated. These mice die at birth as a result of respiratory failure due 
to improper motor neuron specification (Thaler et al. 1999).  
 
       Downstream of Shh lie three genes, Rbm33, Cnpy1 and En2, Rbm33 is 
postulated to be an RNA binding protein. Cnpy1 is a homolog of a zebrafish gene 
Canopy1. Canopy1 is expressed in the midbrain-hindbrain boundary in zebrafish, 
binds Fgfr1, and plays a role in Fgf signalling (Hirate and Okamoto 2006). En2 is a 
homeobox containing gene which is implicated in CNS development in humans and 
mice. Both Cnpy1 and En2 have been shown to be expressed within the mid-
hindbrain boundary region within the mouse with En2 playing a role in restricting the 
fate of progenitor cells to a midbrain or hindbrain lineage (Davis et al. 1988; Paek et 
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al. 2012). Whether Cnpy1 also plays a functional role within this region or whether 
some kind of bystander effect is at play is unknown. 
       In early stages of limb development, neither Lmbr1 nor Rnf32 are up regulated in 
the ZPA, implying that the Zrs is specifically acting on Shh (Amano et al. 2009). 
However, at later stages, Lmbr1 expression is detected, at least in chicken, in the 
posterior limb together with Shh (Maas and Fallon 2004). This could suggest a 
relaxation of any mechanisms that ensure a preferential interaction between the Zrs 
and the Shh gene during early limb development. In mouse limbs despite the number 
of more proximal targets of Rnf32, Lmbr1, Nom1 and Mnx1, the Zrs has been found 
to act specifically on Shh, with deletion of the enhancer having no effect on the 
expression of the other genes (Amano et al. 2009).  
 
 
2.12 Long range Regulation 
 
The utilization of a number of discrete regulatory regions distributed over 
large genomic distances is becoming increasingly recognised as a method of 
organizing temporal and spatial transcriptional gene control. Whole genome 
comparison and large screens for sequences with regulatory potential has identified 
enrichment for conserved non-coding elements and enhancers in ‘gene deserts’ 




2.13 Conservation of Gene deserts  
 
The vertebrate genome has been shown to have an uneven distribution of 
genes, with some regions of the genome found to be gene dense whereas others are 
found to reflect ‘gene deserts’. Some gene deserts such as that associated with Shh 
contain regulatory sequences that act at large distances to control the expression of 
neighbouring genes. In contrast other gene deserts are non-essential and can be 
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deleted without any major phenotypic effects (Nobrega et al. 2004). Comparative 
sequence analysis of human gene deserts and orthologous regions within the chick 
genome has divided these two types of gene desert into stable and variable categories 
(Ovcharenko et al. 2005). Stable gene deserts display high levels of sequence 
similarity in humans and chickens, whereas variable deserts appear to be specific to 
mammalian lineages. Stable deserts were found to display lower repeat density and 
an amount of human/mouse sequence conservation comparable to that of gene rich 
regions within the human genome (Ovcharenko et al. 2005). They were also found to 
be depleted of breakpoints disrupting conserved synteny suggesting that a 
considerable degree of purifying selection has been acting on stable gene deserts. 
The majority of genes flanking stable gene deserts were found to be those involved 
in processes such as regulation of transcription, skeletal and muscle development, 
DNA binding and regulation of metabolism (Ovcharenko et al. 2005).  
 
      The function of variable gene deserts is more ambiguous however, it is suggested 
that these gene deserts could possibly represent recently evolved regions that have 
not been fixed, or they may lack important function and represent genomic 
‘junkyards’ (Ovcharenko et al. 2005).  
 
 
2.14 Long range regulation in Development 
 
Like Shh, many developmentally important genes are involved in multiple 
processes during embryo development. The role of long-range regulatory elements 
appears to be of great importance in regulating developmental genes and several 
developmental genes have been found to have highly-conserved cis-regulatory 
elements and complex regulatory genomic landscapes associated with them, the 
importance of which is reflected in their role in common human disorders. In general 
the regulatory architecture of a single gene may consist of multiple elements that 
reside within introns and extend for large distances at either end occupying positions 







Similar to Shh other genomic loci have been shown to be composed of regulatory 
domains comprising multiple enhancer elements responsible for driving expression 
within separate tissues. SOX9 is an evolutionary conserved transcription factor that 
is expressed in a variety of tissues. Mutations in the human gene have been shown to 
result in cause the skeletal malformation syndrome campomelic dysplasia (CD) with 
associated XY sex reversal (Foster et al. 1994; Wagner et al. 1994). Sox9 has been 
shown to be a regulator of chondrogenesis and testogenesis in the mouse (Bi et al. 
1999; Akiyama et al. 2002; Chaboissier et al. 2004). CD patients also show defects in 
other organ systems where SOX9 is expressed (Ng et al. 1997) such as the inner ear, 
brain, pancreas and heart (Houston et al. 1983; Mansour et al. 1995; Mansour et al. 
2002). Among the symptoms seen in CD are deafness, Pierre Robin sequence 
(micrognathia, cleft palate and glossoptosis) and scoliosis. Translocation breakpoint 
analysis within CD patients suggested the presence of multiple cis-regulatory 
elements residing within a 600 kb interval extending 350 kb 5′ and 250 kb 3′ to Sox9 
(Wunderle et al. 1998). Five highly conserved sequence elements were later 
identified by sequence analysis  which lie up to 290 kb 5′ to the gene, with three 
more, E6–E8 lying up to 450 kb 3′ to human Sox9  (Bagheri-Fam et al. 2001). These 
elements were tested within mice with the lacZ expression patterns shown to be 
mediated by the Sox9 promoter (neural tube and hindbrain), enhancer E1 (node, 
notochord, gut, bronchial epithelium and pancreas), enhancer E3 (Cranial neural 
crest cells and inner ear) and enhancer E7 (forebrain and midbrain) shown to 
recapitulate the many aspects of the complex endogenous Sox9 expression pattern. 
All four cis-regulatory sequences initiated lacZ expression at stages very similar to 
endogenous Sox9. However, while fragments E5–E3 and enhancer E1 were able to 
recapitulate Sox9 expression also at later stages, both neural enhancers could 
reproduce only the early aspect of Sox9 expression. Elements E2, E4 and E6 did not 
show independent enhancer activity suggesting these elements could be general 
enhancers that up-regulate an already specified expression (Bagheri-Fam et al. 2006). 
More recent evidence suggests a large genomic landscape surrounds Sox9, 
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translocation breakpoints in families with Pierre Robin have been identified both 1.5 
Mb telomeric and centromeric to Sox9. These have been investigated using a LacZ 
reporter assay which identified the presence of a potential craniofacial enhancer; 
HCNE-F2 located within a micro deletion region centromeric to the gene (Benko et 
al. 2009).  
 
2.14.2 Pax6 
Pax6 is a transcription factor which plays an important function during 
development and maintenance of the eye, pancreas and the central nervous system. 
Haploinsufficiency for PAX6 function has been shown to result in eye defects both 
the mouse (Small eye) and human (aniridia) (Jordan et al. 1992; Glaser et al. 1994). 
The Pax6 gene is surrounded by a large number of evolutionary conserved regions 
(ECR) and a number of cis-regulatory elements have been identified both upstream 
and downstream of the gene, including within introns of the ubiquitously expressed 
Elp4 gene. These regulatory elements have been shown to carry out independent and 
overlapping functions to drive Pax6 expression (Kleinjan et al. 2006).  
Recently, a number of further elements were identified using comparative 
genomics analysis of the elephant shark genome, including eagBNe6 which was 
responsible for driving hindbrain and spinal cord activity. The enhancer agCNE1-11 
was shown to drive novel olfactory system, pineal gland and nervous system 
expression. Several of the agCNEs were shown to drive overlapping expression 
patterns with each other and with previously characterised Pax6 enhancers including 
two trigeminal nerve cis-elements that both drive highly similar expression patterns, 
suggesting that in their case the enhancers simply add to the robustness of the 
regulatory architecture, similar to the role fulfilled by shadow enhancers in 
Drosophila. The full number of Pax6 enhancer elements are believed to function as 




Like Ssq which played a role in identifying the Zrs, the recessive mouse 
mutation, limb deformity (ld) which results in disruption of the distal limb skeleton 
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has also played a role in identifying a cis-regulatory landscape involved in limb 
development. The Ld phenotype results in synostosis of the zeugopod in combination 
with oligodactyly and syndactyly of the metacarpal bones and digits. Five separate ld 
alleles were identified, with the Ld locus found to consist of a large ~450 kb 
chromosomal landscape which encompasses two functionally unrelated genes 
Formin1 (Fmn1) and Gremlin 1 (Grem1). The former is a gene which plays a role in 
remodelling of the actin cytoskeleton while the latter has been shown to inhibit  
BMP-2, -4, and -7 serving to regulate the expression of FGFs 4 and 8 and SHH and 
thus necessary for proper limb development (Gazzerro et al. 2005). Three out of five 
of the ld alleles were found to disrupt the C-terminus of Fmn1. However, it was not 
possible to recapitulate the ld phenotype via targeted inactivation of the Fmn1 gene. 
Instead deletions of exons 10-24 of Fmn1 or loss of function mutations of Grem1 
were found to reproduce the associated limb phenotype.   It was therefore postulated 
that a cis-regulatory element associated with Grem1 regulation was present within 
the C-terminal of Fmn1. The position of this element was later mapped to exons 19-
23 of Fmn1, located at a distance of 41 kb from Grem1 (Zuniga et al. 2004; Zeller 
and Zuniga 2007).  
 
2.14.4 The HoxD cluster  
 
Like Shh, the Hox genes, which consist of thirty-nine genes organised into 
four clusters, play a key role in limb development. The HoxD cluster is necessary for 
limb development of both the proximal and distal limb segments (Zakany and 
Duboule 2007). Two phases of HoxD transcription take place; an initial phase during 
early limb budding which involves the activation of the HoxD genes at the 3’ end of 
the cluster. This is later followed by a second phase of transcription consisting of 
expression of the Hoxd10-Hoxd13 genes in the most distal part of the limb which is 
important in the development of the digits (Spitz et al. 2003).  Similarly to Shh, the 
HoxD cluster is also part of a complex regulatory landscape. Two distinct enhancer 
systems have been identified located either side of the HoxD cluster, referred to as 
conserved sequences B (CsB) and CsC (Spitz et al., 2003 and Gonzalez et al., 2007), 
these elements are capable of driving reporter gene expression in digits. CsB is part 
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of a Global Control Region (GCR) conserved in all vertebrates and containing 
various enhancers. It is located 180 kb upstream Hoxd13, in a 600kb large gene 
desert extending from Lunapark (Lnp) until Atp5g3. CsC is part of the Prox 
enhancer, located between Lnp and Evx2 (Gonzalez et al. 2007), which are both 
coexpressed with Hoxd genes in digits as a bystander effect (Spitz, Gonzalez, and 
Duboule 2003). The combined effect of CsB and CsC is proposed to be required for 
proper activation of Hoxd genes in digits (Gonzalez, Duboule, and Spitz 2007). 
 
2.14.5 Fgf8 
Fgf8 encodes a secreted signalling molecule expressed within a number of 
signalling centres within the developing embryo. Mice lacking Fgf8 die before E8.5 
as a result of a gastrulation defect (Meyers et al. 1998; Sun et al. 1999). Experiments 
on later embryos has identified that Fgf8 also plays a role in the development of the 
mid-hindbrain region, the limbs, the brachial arches, heart, kidney and the brain 
(Lewandoski et al. 2000; Moon and Capecchi 2000; Sun et al. 2002; Chi et al. 2003; 
Garel et al. 2003). The Fgf8 gene sits within a relatively conserved genomic region 
which also contains the conserved gene Fbxw4 (Komisarczuk et al. 2009). A number 
of regulatory elements were identified in that region; firstly, two 3ꞌ to Fgf8; CR3 and 
CR4 which drive expression within the AER, mandibular and maxillary arches, 
somites and the isthmus (Beermann et al. 2006). In addition a number of elements 
have also been identified within the exons of Fbxw4 and beyond at a distance of up 
to 90 kb away from FGF8 itself (Komisarczuk, Kawakami, and Becker 2009).  
 
2.15 Genomic Landscapes 
 
2.15.1 What directs enhancers towards their correct promoter? 
 
The distance at which some developmental enhancers sit and the potential 
complexity of additional genes within a region raises the question of how enhancers 
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act on a specific target. Some enhancers  have broad specificities acting on more than 
one target within a region such as reported for HoxD cluster whereby the limb bud 
expression of the genes Hoxd10-13, and the neighbouring Lunapark (Lnp) and Evx2 
genes, are controlled by the same group of regulatory elements (Spitz, Gonzalez, and 
Duboule 2003). This phenomenon is often termed as a ‘bystander effect’ and is 
found at a number of loci including Lmx1b, Dlx5/Dlx6 and hGh and Cd79b 
(Crackower et al. 1996; Holmes et al. 2003; Cajiao et al. 2004). 
 
The organisation of DNA is important for expression of genes. Within the 
nucleus genomic DNA is found packaged around histones and other larger chromatin 
structures. In general, compact DNA (heterochromatin) is believed to be associated 
with repression of gene expression by preventing transcription factors and RNA 
polymerases from accessing enhancer and promoter sequences. In comparison, 
chromatin found around active genes is more relaxed which increases the chance of 
access to promoter regions. Post-translational modifications of histones, through 
acetylation or methylation by chromatin modifying enzymes have been shown to be 
associated with an increase or decrease of transcriptional activity (Li et al. 2007). 
The presence of cis-regulatory regions could be important for control of chromatin 
domains. Remote regulatory elements can function to establish extensive ‘activated 
chromatin domains’. This has been demonstrated at both the human and mouse β-
globin locus whereby a locus control region (LCR) and intergenic regions are 
transcribed by RNA Polymerase II in a subset of erythroid cells in vivo which is 
required to generate and maintain an open chromatin domain (Gribnau et al. 2000).  
 
        Often genes located within close proximity at loci are found to be co-expressed. 
For example; the Lnp/Evx2 or Formin genes which have no important function in 
limb development are strongly expressed within the developing limb bud.  This 
expression however results from their position within either the HoxD or the Gremlin 
regulatory landscapes (Trumpp et al. 1992; Herault and Duboule 1996; Spitz, 
Gonzalez, and Duboule 2003; Zuniga et al. 2004). It was proposed that transcription 
of these additional genes occurs simply because of their close proximity to a strongly 
transcribed region, thus appearing as a bystander effect. Such bystander regulation 
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may either involve a shared enhancer, like the GCR at the HoxD, which may contact 
promoters surrounding strongly transcribed genes (Spitz et al. 2005). Alternately, this 
could occur as a result of the spreading of transcriptionally permissive chromatin 
structures around active genes. This is seen at the hGH/CD79B locus, where both 
genes are transcriptionally active in the pituitary, yet only hGH is found at the 
protein level, while CD79B is translated in B cells, where it is important for signal 
transduction from the B-cell receptor (Cajiao et al. 2004). This is proposed to be a 
non-functional consequence of the genes’ localization within the highly acetylated 
chromatin domain defined by the enhancer of the growth-hormone genes (Cajiao et 
al. 2004). It has also been suggested that the presence of neighbouring promoters 
may be important to fine-tune the expression level of the functionally active target 
gene, not by acting in trans but rather by interactions in cis, for instance through the 
titration of the regulatory input. The deletion or addition of genes within the HoxD 
cluster has been shown to lead to reallocation of the GCR activity, therefore 
preventing the action of the GCR on Lnp and Evx2 might also redistribute the 
regulation on the remaining HoxD genes in a way deleterious for limb development 
(Spitz and Duboule 2008).  
 
      Remote regulatory elements can be brought into close juxtaposition with target 
promoters via long-range ‘looping’ or ‘tracking’ mechanisms. Chromosomal regions 
containing transcriptionally active genes tend to loop out of the condensed 
chromosomal territory, coming close to the periphery of the nucleus in ‘transcription 
factories’. Genes that are co-expressed but separated by several megabases have been 
shown to co-localise in discrete nuclear compartments (Osborne et al. 2004). By 
measuring physical distance using 3D-FISH within cells from the ZPA, Shh and the 
Zrs were shown to have a much reduced intranuclear distance as opposed to a control 
region within the desert, suggesting that they interact via a looping mechanism 
(Amano et al. 2009). This occurs as a two-step process whereby firstly a 
chromosomal looping brings the Zrs close to the Shh promoter and interacts with it, 
Shh then moves out of its own chromosomal territory which is expected to relate to 
the genes activation. Deletion of the Zrs from its genomic region results in a dramatic 
reduction of Shh expression within the limb bud, however it was proposed that co-
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localisation of both the Zrs and Shh was still found to occur within ZPA nuclei. This 
however may not be the case as a more recent study suggests a direct relationship 
between Shh gene expression in the limb bud and chromosomal conformation, at 
E11.5 a 3´del of the Zrs results in forelimb expression inactivity but low level 
expression activity in the hind limb. A direct correlation between chromosome 
conformation measured by FISH and enhancer activity was found. Amano’s previous 
work was performed within earlier staged embryos (E10.5). Therefore, a complex 
picture is suggested in which the Zrs at the earliest stages of limb bud development is 
driven to interact with the Shh gene by as yet, unidentified element(s) but this task is 
subsequently acquired by the Zrs itself by E11.5. The 3´ half of the Zrs operates by 
boosting activity within this mechanism that mediates these enhancer/promoter 
interactions (Lettice et al 2014).  
 
Shh and the Zrs are shown to physically interact even in cells in which Shh is 
not actively being expressed such as those of the anterior of the limb bud. It is 
therefore proposed that the locus is possibly being held in three states; silent in which 
they do not contact, poised in which there is some contact and then active where the 
gene is transcribed. As the anterior of the limb bud does have the ability to express 
Shh, the poised state of the chromatin within these cells is believed to serve as a sign 
of the competence of the cells (Amano et al. 2009). Downstream promoter elements, 
TATA boxes and other tethering elements are implicated in directing promoter-
enhancer interactions, suggesting that the core promoter mediates enhancer 
interactions and could determine specificity of the enhancer (Butler and Kadonaga 
2001; Calhoun et al. 2002). It could be that these elements play this role by 
facilitating or stabilising chromosomal loops.  
 
Some genomic landscapes are more complicated than others. The HoxD 
landscape in particular has been shown to be complex with multiple enhancer 
elements spread over 800 kb of gene desert. This region has been designated to 
function as an archipelago whereby multiple element islands are brought into the 
vicinity of Hoxd13 via chromatin looping. In the digits these islands contact each 
other leading to multiple simultaneous interactions between distinct elements. In 
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such an instance, it is hypothesised that transient interactions would also occur 
between islands, rather than only between enhancers and promoters (Figure 2.4). In 
tissues where the gene is not expressed (such as the brain) a less elaborate structure 
may occur in a default or poised position. Whereas, in the limb it is speculated that 
additional specific factors may initiate transcription such as chromatin modifying 
factors and RNAPII to active chromatin loops (Montavon et al. 2011).  
 
 
Figure 2.4:HoxD Regulatory Landscape 
Schematic representation of transcriptional output of HoxD locus (i) the regulatory landscape covering 
approximately 800 kb upstream of the HoxD cluster. Multiple regulatory islands (ovals) are required 
for HoxD activation in limbs, either by acting as enhancers or anchoring points. When HoxD genes 
are not expressed, the landscape is in a ground state with only some regulatory islands contacting but 
insufficient to activate transcription. (ii) Additional contacts are made in expressing cells, islands 
become active (green) as a result of histone marks and recruitment of RNAPolII. HoxD is expressed 
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throughout the limb. (iii) Modifications to the islands in terms of spacing or order results in a 
modification to the amount and spatial expression of the gene resulting in pathological modifications. 
 
 
Experimental approaches have shown that the mere position of a gene with 
respect to an enhancer can be important for function (Tarchini and Duboule 2006). 
The importance of the genomic context has been shown at the Fgf8 locus. A number 
of enhancers are present within the Fgf8 region; however these do not all drive Fgf8 
expression. It is suggested that cis-interactions between these different modules may 
reinforce the frequency of their association with the target gene (Marinic et al. 2013). 
The multiple enhancers in proximity to Fgf could lead the region to adopt a defined 
structural conformation that could favour regulatory interactions between enhancers 
and specific positions of the locus instead of specific promoter sequences, thus 
filtering out the activity of non-essential enhancers (Marinic et al. 2013).  The FGF8 
locus is therefore proposed to behave as a ’holoenhancer’. Holoenhancers are a 
complex of regulators that together control a complex developmental expression 
pattern.  It is suggested that the regulatory locus cannot be defined by its basal 
components with instead the output of the entire region determined by the relative 
distribution of genes and enhancers along the locus (Marinic et al. 2013) (Figure 




Figure 2.5: FGF8 Regulatory Landscape 
 (i) The Fgf8 gene region comprises multiple enhancers (coloured rectangles) which drive expression 
within the mouse embryos (shown above colour coded). 
(ii) In Fgf8 expressing cells multiple modules with overlapping activities act together either by their 
own dynamic one-to-one interactions or (iii) by combining their activities to form a holoenhancer (iv) 
in these scenarios other elements active in other cells types (red) may only have short range activities 
and therefore minimal influence. 
Enhancer status is indicated (filled, active, empty not active) with halo representing their range of 
action. Transcriptionally active genes represented by black arrow. 
 
 
2.15.2 What prevents enhancer activity? 
 
Boundary elements, or insulators, have been defined in part by their ability to 
block enhancer activity when located between an enhancer and a promoter (Geyer 
1997). The most well-characterized examples of such elements include SCS/SCS8, 
originally identified in the Drosophila 87A7 heat shock locus, the Gypsy 
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retrotransposon, also in Drosophila, and in vertebrates 58 HS4 from the chicken β-
globin LCR (Chung et al. 1993). 
 
Data from Hi-C experiments (a method for identifying higher order 
chromatin interactions genome wide) suggests the genome of mice and humans is 
organised in large chromatin interaction domains known as ‘topological domains’. 
These domains are believed to correlate with regions of the genome that constrain the 
spread of heterochromatin and consist of highly self-interacting regions in which tens 
of genes and hundreds of enhancers reside (Dixon et al. 2012). It is speculated that 
these domains could constrain looping interactions between enhancers and promoters 
and set the boundaries of coordinated gene regulation, and indeed Shh and the Zrs are 
found to occupy the same topological domain (Smallwood and Ren 2013). At the 
edges of these topological domains there are narrow segments in which chromatin 
interactions appear to end abruptly. These regions are believed to represent 
‘boundary regions’ which are enriched for the CTCF binding sites, housekeeping 
genes, transfer RNAs and short interspersed element transposons (SINEs) and 
believed to share the enhancer/promoter blocking feature of classical ‘insulators’. 
 
       CTCF is a highly conserved DNA binding zinc finger protein that displays 
nearly 100% homology between humans, mice and chick. It is critically important 
during a variety of cell processes, shown by the fact that CTCF homozygous mutant 
mice exhibit early embryonic lethality (Heath et al. 2008). Maternal depletion of Ct 
has also been shown to disrupt progression to the blastocyst stage (Fedoriw et al. 
2004). In adult animals, CTCF is found to be ubiquitously expressed similar to 
housekeeping genes. CTCF has been implicated in a diverse number of roles 
involving gene regulation including transcriptional activation and repression as well 
as genomic imprinting. CTCF is also speculated to play a role in enhancer blocking 
and/or barrier insulation i.e. blocking communication between adjacent regulatory 
elements in a position-dependent manner or buffering genes from position effects 
caused by the spread of heterochromatin. This was initially demonstrated within the 
β-globin locus. At the 5´ end of the β-globin locus sits a DNAse1 hypersensitive site 
(5’ HS4) which separates the locus from neighbouring heterochromatin, CTCF is 
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found to bind to HS4 and has been demonstrated to be responsible for insulator 
activity (Farrell et al. 2002; Bulger et al. 2003).  An accumulating amount of data 
suggests that CTCF is responsible for mediating long-range chromatin interactions 
between insulator elements, in a manner similar to insulators in Drosophila 
(Gerasimova and Corces 2001). 3C has been used to demonstrate at the β-globin 
locus that the CTCF sites present physically interact with each other, this causes 
formation of large chromatin loops just before gene activation encompassing the β-
Globin regulatory control region (LCR). It is speculated that these loops then 
facilitate subsequent spatial interactions between the LCR and its genes (Phillips and 
Corces 2009).  However analysis of CTCF within the HoxD locus suggests that 
despite this paradigmatic situation for CTCF acting as an insulator protein, the 
conditional loss of CTCF within the forelimbs does not a show evidence for such a 
function of CTCF, at least in developing limb mesenchyme (Soshnikova et al 2010).  
 
It is unlikely that CTCF sites alone are capable of acting as enhancer 
blockers. Only 15% of CTCF sites are associated with the boundary regions of 
topological domains. The rest are found distributed across the genome including in 
regions interlaced between promoters and enhancers (Dixon et al. 2012). Many 
models of enhancer landscapes suggest dynamic interactions between different 
modules during looping processes, the role of CTCF alongside Cohesin could 
therefore be to stabilise these interactions to allow gene expression within intended 
tissues. This is also likely to involve proteins involved with histone modifications, 




2.16 The Local Hopping Enhancer Detection System  
      Identifying the sequence elements and the combinatorial rules that determine 
enhancer function is necessary to fully understand how enhancers direct the spatial 
and temporal regulation of gene expression.  
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      A general accepted hypothesis is that functionally important regulatory sequences 
are under purifying selection. As a result, conserved noncoding sequences (CNSs) 
were seen as natural candidates for enhancer elements. Early studies used CNSs to 
detect putative enhancers and test their activity in zebra fish or mouse reporter assays 
(Woolfe et al. 2005; Pennacchio et al. 2006; Visel, Blow, et al. 2009). Both BACs 
and then YACs have also been utilised for the identification and analysis of 
regulatory sequences found at long distances (Nielsen et al. 1997; Kaufman et al. 
1999). While BACs provide a limited 300 kb (in the case of regulatory loci) cloning 
capacity YACs are capable of the stable maintenance of genomic fragments of DNA 
larger than 1 Mb (Burke et al. 1987); however, use of either for transgenesis requires 
laborious specialised techniques and may still not be large enough to address some 
genomic loci. Although these conservation-based approaches achieve some success, 
limitations also exist. The function and spatio-temporal specificity of CNSs cannot 
be determined by conservation alone and, therefore, requires additional 
experimentation. In addition, several studies have shown that noncoding sequences 
that apparently lack conservation (as assessed by sequence alignment) may still 
contain functional regulatory elements (Fisher et al. 2006; Birney et al. 2007; 
McGaughey et al. 2008).  
 
The mouse represents an excellent model for analysing functional genomics 
either by genome-wide random mutagenesis by a chemical or insertion mutagen, or 
pinpointing a single locus by gene targeting techniques. However, again until 
recently only limited tools have been available for the survey of large regulatory 
regions. These either involved the sequential targeting of LoxP sites into the same 
chromosome and scanning via a ‘walk and delete’ manner in comparison is very 
labour-intensive. The alternative strategy retrovirus mediated random integration 
which is not suitable for pure insertional mutagenesis with no accompanying 
deletions being formed, such as single-gene knockouts or enhancer traps in a native 
genomic context. Recently, however several systems have been devised using 
transposons which can be used to explore regulatory genomes on a large scale 




The local Hopping Enhancer Detection (LHED) system is a chromosomal 
engineering system based on the sleeping beauty transposon which has previously 
been used to examine the mouse Pax1 locus. Within the Pax1 locus it has been 
employed to show that transcriptional insulators are present between the regulatory 
gene loci of Pax1 and its neighbouring gene Nkx2-2 (Kokubu et al. 2009).  
 
 The Sleeping Beauty transposon is a binary system comprised of a 
transposon vector flanked by inverted repeats/direct repeats which can be mobilised 
via the addition of a sleeping beauty transposase in trans. To generate the LHED 
system firstly an enhancer detector system was cloned into the transposon DNA. This 
comprised an Hsp68 minimal promoter fused to the LacZ reporter gene. The 
transposon-containing the reporter gene was then inserted between a PGK promoter 
and a puromycin resistance gene so that upon excision of the transposon reactivation 
of puromycin resistance occurred. Three LoxP sites were also inserted within the 
vector, one within the transposon and two outside. This was to allow chromosomal 
engineering (deletions or inversions) between a fixed insertion site and the 
transposition site, once the transposon had been induced to hop. The complete LHED 
vector therefore combines standard knock in technology, transposon based enhancer 
detection and Cre/LoxP-mediated chromosomal engineering to allow monitoring of 
enhancer activities along a targeted genome region and generation of a nested series 
of deletion mutations to examine loss-of-function effects within a genomic 
neighbourhood (Kokubu et al 2009).  
 
The sleeping beauty transposon has a strong tendency to favour ‘local 
hopping’ and reinsert at closely linked loci during transposition. The system also 
benefits in its use of targeting into ES cells which provides a practical advantage in 
that it allows clone archiving. Both of these features of the system mean that it is 
possible to saturate a relatively large genomic distance with enhancer detectors with 
relative ease (Kokubu et al 2009). Additionally, because the system involves a single 
copy insertion, it does not suffer from undesirable rearrangements including 






2.17.1 Investigating the composition of long-range regulation within the Shh 
locus. 
 
The Shh gene is expressed within a large number of developmental tissues 
during various stages of development where it plays a number of roles. The Shh 
locus presents as a complicated regulatory landscape comprising nearly 1 Mb 
containing a number of Shh enhancers located within the Shh gene itself, within a 
large a gene desert adjacent to Shh, as well as several unrelated genes residing within 
the region (Figure 2.3). These multiple enhancers serve to drive expression of Shh 
within these multiple tissues thus contributing to the highly organised expression 
pattern of the gene within a given tissue at a given stage. Complicated long-range 
regulatory domains are a common method of regulating the expression of 
developmental genes, however, many questions remain regarding exactly how these 
function with recent data supporting a number of regulatory mechanisms. 
 
The DNA element the Zrs which drives Shh expression within the limb sits almost 1 
Mb away from the gene thus presenting as the furthest known enhancer of Shh.  The 
Zrs and other Shh enhancers operate over large genomic distances and it is 
speculated that a number of additional enhancers or shadow enhancers reside within 
this region. This organisation is highly conserved between vertebrates suggesting it 
could be intrinsic to function (Hill 2007). Recent datas suggest that regulatory loci 
are often located within topological domains flanked by boundary regions which 
prevent illegitimate interactions between enhancers and other genes. A proposed 
domain has been suggested for Shh, however it remains unclear exactly where the 
boundaries of enhancer function exist.  
 
This project will therefore involve investigating the Sonic hedgehog region with 




 Is the distance between the Zrs and Shh necessary for Zrs function? 
 Are there elements within the locus that mediate long distance promoter 
recognition? 
 Have Shh enhancers evolved activity commensurate with position or with 
distance? 
 Do any previously undiscovered elements/enhancers exist within the 
region and what is their function?  
 What restricts Zrs regulation to the Shh locus?  
 What are the genomic limits of enhancer activity? And how is this activity 
confined? 
 Can systematic deletions within the region affect enhancer activity and 
thus Shh expression? 
 Will removal of an overlapping set of enhancers provide further clues to 
Shh function in development? 
 
 
The Local Hopping Enhancer Detector (LHED) system will be employed, which has 
previously been tested (Kokubu et al. 2009). I propose to use LHED vectors inserted 
on either side of the Zrs so as transposition can be directed in either direction with a 
hope of saturating the region. This will allow the LacZ reporter gene to be utilised in 
order to map enhancer activity across the region as well as both upstream of Lmbr1 
and downstream of Shh. The orientation of vector design will be taken into account 
in order to allow Cre-mediated deletion of the region between the Zrs and Shh to 
allow analysis of the effect of deletions within this region on enhancer activity and 








3. Materials and Methods 
3.1 Plasmids 
3.1.1 DNA BAC 
BAC DNA used for amplification was PAC 542-N10 from the RCPI21 library, as 
described by Osoegawa (Osoegawa et al. 2000). 
3.1.2 Plasmids 
The pBluescript II KS (-) vector was supplied by Agilent Technologies, and used as 
described by the manufacturer. The cre plasmid used was pGK Cre bpA supplied by 
Kurt Fellenberg.  
3.1.3 LHED system 
The LHED plasmid was supplied as a gift by Chikara Kokubu, the original CMV-
SB11 transposase by P.B Hackett and the hypermutated CMV-SB100x by Zsuzsanna 
Izsvak 
3.2 DNA spectrophotometry 
DNA concentrations were measured at 260/280 nm absorbances using a Nanodrop 
1000 spectrophotometer (Thermoscientific).  
3.3 Agarose Gel electrophoresis 
Agarose powder was dissolved in 1x Tris-borate-EDTA (TBE) buffer by heating in a 
microwave and allowed to cool.  1 µg/ml ethidium bromide was added, before 
pouring the gel into a gel mould and inserting combs. DNA samples were mixed with 
6x loading buffer and loaded into the wells; one well was reserved for loading 
molecular weight markers. An electrical voltage of approximately 100-150 mV was 
applied and DNA was visualised under UV light. 
 
3.4 Sequencing 
Sequencing reactions were performed by the Technical Service Department at the 




3.5 Nucleic acid extraction 
3.5.1 DNA extraction from mouse tissues 
Tail tips were taken and incubated in 500 μl tail lysis buffer (100 mM Tris-HCl, 
pH 8.5; 5 mM EDTA; 0.2% SDS; 200 mM NaCl) with 10μl Proteinase K (10 mg/ml) 
and incubated overnight at 55
o
C. Samples were centrifuged at 13,000 rpm for 5 min 
at 4
o
C. Supernatants were transferred to fresh tubes and 500 µl of isopropanol was 
added and mixed. DNA was then spooled out and added to 500 µl H20. 
Ear clip samples were incubated in 75 µl of Base solution (1.25M NaOH, 10mM 




for 30 minutes. Samples were then allowed to cool before 
addition of 75µl of Neutralization solution (2M Tris-HCL pH 5) was added and 
mixed. 2 µl were then used per PCR reaction.  
3.5.2 DNA extraction from ES cells 
Cells were expanded to the 24-well stage before being treated with 0.5 ml of lysis 
buffer (10 mM Tris pH8, 10 mM EDTA, 0.6% SDS, proteinase K) overnight at 37 
°C.  Following Lysis, 1 ml of ice cold acetone/DMF (70% acetone, 5% dimethyl 
formamide) was added to lysis mix and vortexed. DNA was spooled out and then 
washed in ice-cold 70% ethanol for approximately 2 hours-overnight, before being 
resuspended in 50 μl of H2O and incubated at 55 °C for several hours to dissolve.  
 
3.5.3 RNA extraction from mouse tissues and cell cultures 
RNA was isolated from tissues collected from animals or from cultured mouse 
embryonic (ES) cells. For cells, media was removed and cells were washed once in 
sterile PBS. Cells were then resuspended in TRIzol® LS Reagent (Invitrogen, Cat. 
No. 10296028). For RNA isolation from tissue, fresh tissues were dissected from 
E11.5 mouse embryos, RNA was then extracted using RNAbee (AMSBio, Cat. No. 
CS-104B) according to manufacturer’s instructions. RNAs were run on agarose gels 
(1% in TBE) to check for quality and degradation, and yield was calculated with a 
NanoDropTM 1000 (Thermo Scientific). 
 
3.6 Polymerase Chain Reaction 
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For all PCR reactions oligonucleotides were rehydrated to 1 μg/μl stock solutions 
and 20 mM working solutions were set up. Master mixes were made up where 
multiple reactions were performed. All products were run on agarose gels with 1 Kb 
molecular DNA size marker (Invitrogen, Cat No. 10787-018 or New England 
Biolabs, Cat No. #N3232).  
 
3.6.1 Proofreading PCR 
PCR reactions were performed as follows 3 μl 1.5 mM MgCl 2, 5 μl 10 mM DNTPs, 
3 μl of 20 mM primers, 1 μl of 10 ng/μl DNA, 5 μl 10x buffer, 1 μl of KOD hot start 
polymerase (Merk Biosciences, Cat No. 71086) and water up to 50 μl. This reaction 
was cycled as follows: 95°C x 3 minutes, followed by 35 cycles of 95°C x 30 
seconds; 60°C x 30 seconds, 72°C x 2 minutes, followed by a single extension of 2 
minutes at 72°C. 
3.6.2 Standard PCR  
PCR reactions were performed as follows; 2.5 μl 10x Buffer, 1.5 μl MgCl2, 1 μl 100 
mM DNTPs, 4 μl 20 mM primers 0.2 μl of Taq (Invitrogen, Cat No. 10342020) and 
H2O up to 25 μl. Reactions were cycled as follows: 94°C x 3 minutes, followed by 
30x cycles of 94°C x 20 seconds; 58°C x 30 seconds, 72°C x 1 minute, followed by a 
single extension of 5 minutes at 72°C. 
3.6.3 Long Range PCR  
Reagents mixed as follows; 16 μl H20, 3.5 μl 10 mM DNTPs, 1.5 μl 10 mM primers, 
2.5 μl 10xPCR buffer 3, 1 μl Template DNA, 0.3 μl Expand Taq (Roche, Cat No  
11681842001). Reactions then cycled as follows; 94°C x 2 minutes, followed by 10x 
cycles of 94°C x 10 seconds, 58°C x 30 seconds, 68°C x 4 minutes and 25x cycles of 
94°C x 15 seconds, 58°C x 30 seconds, 68°C x 4 minutes, followed by a single 
extension of 68°C x 7 minutes.  
3.6.4 Nested PCR  
Nested PCR for identification of LHED re-insertion was performed as described by 
Ruf et al., (2011). A nested asymmetric PCR strategy using Platinum Taq 
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(Invitrogen, Cat No 10966083) was employed. A first round of PCR amplification 
was performed on a genomic DNA template from ES cells with a transposon-specific 
primer pointing outward from either end of the transposon (SB-R1 for the right end, 
SB-L1 for the left end, 20 μM) and a random primer with a 5-bp 3′ anchor (KmonP-
N7-ctcag or KmonP-N7-tcctg, 100μM) (See Table 3.1 for details). A second round of 
amplification was carried out on 1 μl of the initial PCR reaction using SB-R2 (right) 
or SB-L2 (left) and KmonP (20 μM). The final PCR product was then sequenced 
using SB-R3 for the right end or SB-L3 for the left end. These resulting sequences 
were analysed using Sequencher and aligned to the mouse genome sequence (Build 
37, mm9, using the UCSC Blat webpage. 
3.7 Single-stranded cDNA synthesis & RT-PCR 
RNA was used for single-stranded cDNA synthesis by reverse transcription. The 1st 
Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche, Cat. No. 11483188001) 
was used according to the manufacturer’s instructions using oligo-dT primers and 
with various RNA input quantities. Controls were set up for each sample without 
enzyme to identify genomic contamination.  
 
3.8 Phenol chloroform/chloroform extraction 
1 volume of 25: phenol 24: chloroform 1: isoamyl alcohol was added to each DNA 
sample and centrifuged (1 minute; 13,000 rpm; 4°C). The DNA layer was removed 
and added to 1 volume of 24: Chloroform 1: isoamyl, vortexed and centrifuged (1 
minute; 13000 rpm; 4 °C). The top layer containing the DNA was then transferred to 
a clean Eppendorf tube. 
3.9 DNA precipitation 
1/10 volume of 3M sodium acetate (pH 5.2) and 2.5 volumes of 100% ethanol were 
added to DNA samples mixed and incubated at -20°C for 1 hour-overnight. Samples 
were then centrifuged (30 minutes; 13,000rpm; 4°C). The supernatant was removed 
and the pellet washed in 70% ethanol, centrifugation followed (10 minutes; 
13,000rpm, 4°C). The ethanol was removed and the pellet air-dried for 10 minutes 
before being resuspended in H2O. 
64 
 
3.10 Restriction Enzyme Digest 
DNA digestion was performed as follows; 10 μg of plasmid DNA, 20 μl of buffer 
(10x), 100 μg of each restriction enzyme required (New England Biolabs or Roche) 
and H2O up to 200 μl. This was then incubated at the required incubation 
temperature for one hour. The reaction was scaled down when required.  
3.11 Ligations 
Ligations were performed using the Rapid DNA ligation kit (Roche, Cat No. 11 635 
379 001), according to manufacturer’s instructions. 
 
3.12 Transformation 
Transformations were performed using library efficiency DH5α (Invitrogen, Cat No. 
18263012) or JM110 (Stratagene, Cat. No. 200239) competent cells, according to 
manufacturer’s instructions.  
 
3.13 Bacterial recombineering 
EL350 cells were inoculated into 5 ml of LB broth and incubated at 32C overnight 
with shaking. The following day 50 ml of the overnight culture was seeded into 200 
ml of LB broth and grown at 32C with shaking for approximately 4 hours. Cells 
were then transferred to a 42C water bath to induce expression of genes required for 
recombination and incubated for 15 minutes with shaking before being transferred to 
ice for 30 minutes. Cells were then centrifuged (10 minutes; 3100rpm; 4C) and 
resuspended in 1 volume of ice-cold water. Centrifugation was performed again (10 
minutes; 3100 rpm; 4 C) and the pellet resuspended in ½ volume of ice-cold water. 
This was repeated once more, followed several washes in 10 % glycerol. Finally, the 
cell pellet was resuspended in 400 l 10% glycerol and aliquoted into 40 l aliquots. 
40 l of cells were then transferred to an electroporation cuvette (2mm gap) and 10-
50 ng of vector DNA added. Electroporation was performed using a Bio-Rad Gene 
Pulser under the following conditions 2.5 kV, 25 microF and  the pulse control  set to 
200 Ω. 1 ml of LB broth was then added to each cuvette, which was incubated at 
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32C for 1 hour. Cells were then spread on plates containing the appropriate 
antibiotic. 
 
3.14 Small-Scale Plasmid Purification 
Small-scale plasmid purification was performed using the QIAprep Spin Miniprep 
Kit (Qiagen, Cat. No. 27104), according to the manufacturer’s instructions. 
3.15 Large-scale Plasmid Purification 
Large-scale plasmid purification was performed using the QIAprep Spin Maxi prep 
Kit (Qiagen, Cat. No. 12162), according to manufacturer’s instructions.  
3.16 Gel Extraction 
DNA extraction from agarose gel was performed using the QIAquick Gel Extraction 
Kit (Qiagen, Cat. No. 28704), according to manufacturer’s instructions.  
3.17 ES Cell Culture 
3.17.1 Maintenance of ES Cells 
Sterile technique was applied during all procedures in the ES cell laboratory. All 
solutions were pre-warmed to 37 ˚C before use. 
The ES cells were grown on gelatinised plates. Plates or flasks were coated with 
0.1% gelatine solution (Sigma) and incubated at 37 ˚C for at least 15 minutes before 
plating. Cells were maintained in 37 ˚C and 5% CO2 incubator.  
3.17.2 E14IVtg2a /G4 ES cell culture 
Mouse E14IVtg2a were provided by Austin Smith.  Mouse E14IVtg2a /G4 ES cells 
were cultured in Dulbecco modified Eagle medium (Invitrogen, Cat. No. 11995)
 
supplemented as follows;  
 
Culture media: 
Glasgow MEM                                                   500 ml 
FCS (Globalpharm)                                             10% 
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Glutamine (Gibco)                                               0.3% 
MEM non-essential amino acids (Sigma)            0.1 mM 
Sodium Pyruvate (Sigma)                                    1 mM 
β-Mercapthoethanol (Sigma)                               0.1 mM 
Leukaemia Inhibitory Factor (LIF) was also added in order to keep ES cells in their 
undifferentiated state; this was produced by Fiona Kilanowski from a plasmid gifted 
by Austin Smith.  
3.17.3 Cell Splitting 
Since cells were adherent to the plates, trypsin was used to detach them. First the 
cells were washed with PBS twice to remove the serum containing medium. They 
were then incubated in 1 ml of trypsin at 37 C for several minutes.  9 ml of media 
was added to the trypsinised cells to stop trypsin activity and the sample was placed 
in a 15 ml Falcon tube and centrifuged for 5 minutes at 1,000 rpm. The supernatant 
was removed and the pellet was re-suspended in 1 ml media, dispersed into single 
cells and re-plated in the desired dilution. Cells were fed on a daily basis and usually 
split as 1/5 on an every other day basis.  
 
3.17.4 Cryopreservation 
2X Freezing media was prepared (20% DMSO (dimethyl sulfoxide), 80% FCS (fetal 
calf serum) and kept on ice until use. The cells were trypsinized, re-suspended in 1ml 
culture media, and disaggregated to single cells as described above. Then 0.5 ml of 
cells/media suspension was mixed with 2 ml of freezing media and quickly removed 





3.17.5 Gene Targeting in ES Cells 
E14IVtg2a cells were grown on gelatinized plates in culture medium with LIF. 1x10
7
 
cells were electroporated (240 V; 500 µF) with
 
a Gene Pulser II (Bio-Rad, Hercules, 
CA) with 100 g of targeting vector which had been linearized by Hind III. 
Electroporated cells were grown in culture medium with selection (10 days with 
G418 (150 µg/ml), after which resistant
 
clones were picked up and expanded. Single 
clones were picked and grown in 96 well plates. When the cells were confluent, they 
were split in the following manner: 80 % frozen into liquid nitrogen, 20 % plated 
into fresh 96 well plates and grown O/N as normal.  
 
3.17.6 Picking Colonies 
The plates were washed with PBS. Individual clones were placed in each well of a 96 
well “V” bottomed plate (Costar) with 50 μl of trypsin per well and incubated for a 
few minutes at 37 ˚C. The clones were transferred into a flat bottomed 96 well 
culture plate (Costar) and grown in culture medium. 
 
3.17.7 Transient Expression of Cre 
In order to remove the loxP flanked selectable cassette, 10
7
 cells of the correctly 
targeted ES clones were electroporated (settings: 3 F, 0.8 kV) with 100 μg of Cre 
plasmid. 1000 cells were plated per 10 cm dish. The clones were grown in culture 
medium without G418.  
 
3.17.8 ES cell transfection 
Transfection of ES cell was performed using TransFast Transfection Reagent 
(Promega, Cat. No. E2341) according to manufacturers instructions. Briefly; LHED 
targeted cells were plated at densities of 1x10
6 
per 10 cm plate, transiently 
transfected with 20 µg of the transposase vector pCMV-SB100x (Matessi and 
Schneider 2009), using transfast and cultured for 48 hours before the addition of 
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puromycin (2 µg/ml). After 10 days of selection, resistant colonies were picked into 
96 well plates, grown and DNA produced for analysis. 
 
3.17.9 Blastocyst Injections 
The cell lines to be injected into mice were grown in 24 well plates (Costar). One day 
before the injection, the cells were washed with PBS and trypsinised into four wells 
at different plate densities. On the injection day the best well was chosen, depending 
on the confluency and morphology, and disaggregated to a single cell suspension in 
culture media. The cells were injected into C57BL/6J blastocysts by Paul S. 
Devenney (MRC Human Genetics Unit). Briefly, female donor mice (C57BL6/J) 
were superovulated and set up for matings with C57BL/6J stud males. The following 
morning they were checked for vaginal plugs, and positive plugs were considered as 
being 0.5 dpc. Female mice were sacrificed at 2.5 dpc by cervical dislocation and 8-
cell embryos and morula were harvested and cultured overnight in M16 medium 
(Sigma) in a 37 ˚C/5% CO2 incubator. The following day, blastocysts were selected 
and injected with 12- 16 ES cells per blastocyst. Injected blastocysts were transferred 
to 0.5 d or 2.5 d pseudopregnant recipient female mice. 
As the ES cells result in chimeric progeny, male mice were set up for test breeding 
with C57BL/6J female mice to select for germline transmission. Agouti offspring 
denotes the contribution of the injected ES cells to the germline. Agouti mice were 
ear clipped and genotyped by PCR.  
3.17.10 Tetraploid complementation assay  
Cells were prepared as if for blastocyst injection. On the injection day the best well 
was chosen, depending on the confluency and morphology, and disaggregated to cell 
suspension including clumps of 4-8 cells in culture media. The cells were injected 
into C57BL/6J tetraploid blastocysts produced by electrofusion by Paul S. Devenney 
(MRC Human Genetics Unit). Blastocysts were then transferred to 0.5 d or 2.5 d 
pseudopregnant recipient female mice. 
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3.17.11 Retinoic Acid treatment of ES cells 
ES cells were seeded at defined densities onto gelatinized plates and grown on 
normal LIF-containing ES cell media. After 24 hours cells were washed x3 in PBS 
and media was changed to that lacking LIF and supplemented with 1µM all-trans 
retinoic acid (Sigma, Cat. No. R2625). At 24 hour intervals media was removed, 
cells were washed x3 with PBS and fresh media supplemented with retinoic acid was 
added. 
3.17.12 Production of Methaphase nuclei 
1 T75 of E14IVtg2a/G4 cells were taken, trypsinised, centrifuged (1000rpm, 5 
minutes) and washed in 10 mls ice-cold PBS. Cells were then resuspended in 10 mls 
hypotonic buffer (KCl, Tri-sodium acetate) and incubated for 10 minutes at room 
temperature. Again, cells were centrifuged (12000rpm, 4 minutes) and resuspended 
in 10 mls fixation buffer (3 parts methanol: 1 part acetic acid) and incubated for 10 
minutes at room temperature. Cells were washed once more in fixation buffer before 
being stored at -20 °C in fixation buffer. 
3.18 Probe labeling (Biotin) 
The following reagents were mixed in order; 2 μl NTS, 2.5 μl of  0.5 mM dATP, 
2.5μl of  0.5 mM dCTP, 2.5 μl of  0.5 mM GTP, 2.5 μl bio-16-dNTP, 1 ug template 
DNA, 1 μl DNAse1 (1:500 dilution), 1 μl DNA polymerase and incubated at 18°C 
for 90 minutes. After incubation 3 μl 0.5 mM EDTA, 2 μl 20% SDS and 65 μl TE 
were added to the reaction mix. The reaction mix was then added to a Radiolabeled 
DNA purification tube (Roche, Cat. No. 11273922001) and centrifuged (2500 rpm, 4 
minutes). The eluted DNA was collected in an eppendorf and concentration 
measured using a Dot blot.  
3.19 Fluorescent in situ hybridization (FISH) 
The following regents were mixed per slide: 80 ng labelled probe, 3 μg Cot-1, 5 μg 
sonicated salmon sperm plus 2 volumes of ethanol and dried in a spin vac. Pellets 
were then resuspended in 15 μl hybridization mix (50% deionised formamide, 10% 
20x SSC, 19% dH20, 20% Dextran Sulphate and 1% Tween) and incubated for 1 
hour at room temperature. 
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Two drops of metaphase chromosome solution were added per slide and air-dried for 
2 days. Following ageing, slides were washed in 2x SSC, 100 µg RNase at 37°C for 
1 hour. Slides were then washed quickly in 2x SSC before being dehydrated through 
70%, 90% and 100% EtOH for 2 minutes each and air-dried.  Slides were then 
warmed at 70°C for 5 minutes before being denatured in 70% formamide, 2 x SSC 
(pH 7.5) at 70°C for 1 minute before dehydration through ice cold 70% EtOH, 90% 
and 100% EtOH.  
Following incubation probes were denatured at 70°C for 5 minutes and pre-annealed 
for 15 minutes at 37 °C. 10 μl of probe then added to each slide and incubated 
overnight at 37 °C. 
Following incubation slides were washed as follows; 4 x 3 minutes 2 x SSC at 45°C, 
4 x 3 minutes 0.1% x SSC at 60°C before transferring to 4 x SSC, 0.1% Tween. Each 
slide was then incubated with 40 μl blocking buffer (4 x SSC, 5% Marvel) for 5 
minutes at room temperature.  40 μl of each antibody then added and incubated at 
37°C for 30-60 minutes followed by 3 x 2 minute washes in 4 x SSC, 0.1% Tween at 
37°C. Following final wash, slides dried and mounted with 25 μl Vectashield 
containing DAPI (Vector Labs, Cat. No. H-1200).  
3.20 Histology 
3.20.1 Whole mount X-gal staining  
Whole mount X-gal staining of tetraploids was performed at E11.5. Briefly, E11.5 
mouse embryos were dissected into cold PBS, fixed in 4% PFA for 2 hours at 4ºC, 
these were then washed 3 times in detergent buffer (7 mM Na2HPO4, 3 mM 
NaH2PO4, 2 mM MgCl2 (6H2O), 0.1% Na deoxycholate, 0.05% BSA, 0.02% Igepal) 
and stained overnight at room temperature in staining solution (detergent wash 
supplemented with 72 mM NaCl, 5 mM K3Fe (CN)6, 5 mM K4Fe (CN)6) containing 
300 g/ml X-Gal. After staining embryos were washed in detergent wash, fixed in 




3.20.2 RNA probe synthesis 
The following reagents were mixed in order at room temperature, 1 l 10x 
transcription buffer, 1 l 10x DIG-labelled nucleotide mix, 250 ng template DNA 
linearised at the 5´ end, 0.25 l RNAse inhibitor and 1 l T3 polymerase. The 
reaction mix was incubated at 37C for 2 hours; 1 l of DNAse was added and 
incubated for a further 15 minutes at 37 C. 1 l of EDTA was then added to stop the 
reaction. RNA purification was performed via the addition of 2.5 l of lithium 
chloride and 750 l anhydrous alcohol and incubation at -20C for 1 hour. Samples 
were centrifuged (13,000 rpm; 4 C; 15 minutes), and the RNA pellet was washed in 
500 l 70% DEPC treated ethanol. A further centrifugation was performed (13,000 
rpm; 4C; 10 minutes). The pellet was air-dried for 5 minutes at room temperature 
before being resuspended in 50 l of DEPC treated ddH2O before being quality and 
size checked on an agarose gel. 
3.20.3 In situ hybridisation  
CD1 mouse embryos were harvested at embryonic day 11.5 and fixed overnight in 
4% paraformaldehyde and stored at -20C in 100% methanol.  
 
Embryos were rehydrated through a methanol/DepC treated PBT series by washing 
in 75% MeOH/dPBT, 50% MeOH/dPBT, 25% MeOH/dPBT on ice, each time 
allowing the embryos to sink. Embryos were then underwent 3x 5 minute washes in 
dPBT on ice. Embryos were then digested for 20 minutes at room temperature in 10 
g/ml proteinase K in dPBT, before re-fixing in 4% PFA for 45 minutes on ice.  
 
Embryos were pre-hybridised in pre-hyb solution (25 ml Formamide, 12.5 ml 20x 
dSSC, 1 g blocking powder, 0.5 ml Triton (10%), 2.5 ml CHAPS (10%), 1 ml yeast 
RNA (50 mg/ml), 0.5 ml EDTA (0.5 M), 250 l heparin (10 mg/ml) and dH2O up to 
50 ml) by washing twice at room temperature until embryos sank, followed by 1 x 1 
hour wash at 65C and 1x 2-4 hours at 65C. 5 l of RNA probe was added to 100 l 
pre-hyb solution and denatured at 80C for 3 minutes, probe was then added to the 




Embryos washed 4x10 minutes at 65C in 100% post-hyb wash (25 ml formamide, 
12.5 ml 20xSSC, 0.5 ml Triton (10%), 2.5 ml CHAPS (10%) and H2O to 50 ml), 
75% Post-hyb/2xSSC, 50% post-hyb/2xSSC and 25% post-hyb/2xSSC, respectively. 
Embryos were then washed 2x 30 minutes at 65 C with 2xSSC, 0.1% CHAPS and 
finally 2x30 minutes at 65 C with 0.2 x SSC, 0.1% CHAPS. 
 
Embryos were then washed 10 minutes at room temperature in TNT (2.5 ml Tris 
(1M, pH 7.5), 1.5 ml Nacl (5M), 0.5 ml Triton (10%) and H2O to 50 ml) before 
incubation for 4 hours at 4C in blocking solution (7.5 ml sheep serum (heat 
inactivated), 1 g BSA, 2.5 ml Tris (1M, pH7.5), 1.5 ml Nacl (5M), 0.5 ml Triton 
(10%) and H2O to 50ml). Embryos then incubated overnight at 4 C in antibody 
solution (1:2000  DIG in fresh blocking solution).  
Finally, embryos were washed 5x 1 hour at room temperature then incubated 
overnight at 4 C in TNT, 0.1% BSA. 2x30 minute washes in NMT, 0-.1% Triton-X-
100 (5 ml Tris (1 M, pH9.5), 1 ml NaCl (5 M), 2.5 ml MgCl2 (1 M) and H2O to 50 
ml) followed. Embryos were then washed 3x 10 minutes in NMT before being 
stained in staining solution (350 g/ml NBT (Roche Cat. No. 11383213001) and 175 
g/ml BCIP (Cat. No. 11383221001)) in NMT. Finally, embryos were fixed 
overnight in 4% PFA. 
 
3.20.4 Haematoxylin and Eosin staining 
Sections were de-waxed by treating with Xylene (3x5 minutes) before being 
rehydrated in 3 x 2 minute washes in 100% ethanol followed by 1 x 2 minute wash in 
each of 90%, 70%, 50% and 30% ethanol before finally being washed in water. 
Sections were then stained in haematoxylin for 5 minutes and before being 
differentiated, for a few seconds in 1% HCl in 70% ethanol. A lithium carbonate 
solution was applied for several seconds to increase the intensity of blue stain before 
being stained in eosin solution (3 parts 1% aqueous eosin to 1 part 1% ethanol and 
0.05% acetic acid) for several minutes. Sections were then rinsed in water and then 
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100% ethanol for 3 x 2 minutes washes. Finally sections were cleared in 2 x 5 minute 
wash of xylene and mounted in DPX and cover slip.  
3.20.5 Alkaline phosphatase staining  
Sections were de-waxed by treating with Xylene (3x10 minutes) before being 
rehydrated through a series of alcohol washes (3x10 minutes 100%, 1x5 minute 90%, 
1x5 minute 70%, 1x 5minute 30%) and rinsed in dH2O. Following this slides were 
then washed for 2x5 minutes in NMT (see in situ protocol) and stained in staining 
solution in NMT before being stained in staining solution (3.3 l/ml NBT and 3.5 
l/ml BCIP) in NMT for 10 minutes. Slides were then fixed for 30 minutes in 4% 
PFA and mounted using Vectashield (Vector Labs, Cat. No. H-1400).  
3.21 Microscopy 
For fluorescence imaging, the imaging system comprised a Coolsnap HQ CCD 
camera (Photometrics Ltd, Tucson, AZ) Zeiss Axioplan II fluorescence microscope 
with Plan-neofluar objectives, a 100W Hg source (Carl Zeiss, Welwyn Garden City, 
UK) and Chroma #83000 triple band pass filter set (Chroma Technology Corp., 
Rockingham, VT) with the excitation filters installed in a motorised filter wheel 
(Ludl Electronic Products, Hawthorne, NY). For brightfield colour imaging, colour 
additive filters (Andover Corporation, Salem, NH) installed in a motorised filter 
wheel (Ludl Electronic Products, Hawthorne, NY) were used sequentially to collect 
red, green and blue images, that were then superimposed to form a colour image. 
Image capture and analysis were performed using in-house scripts written for IPLab 
Spectrum (Scanalytics Corp, Fairfax,VA). 
 
3.21 OPT analysis 
Optical projection tomography (OPT) imaging was performed as described 
by (Sharpe et al. 2002). Briefly, PFA-fixed embryos were embedded in 1% low 
melting point agarose and then immersed in methanol for 24 hours to remove all 
water. The embryo was then cleared for 24 hours in BABB (1 part benzyl alcohol/2 
parts benzyl benzoate). The sample was then scanned using a Bioptonics 3001 
scanner (www.biooptonics.com) with an image taken every 0.9 degrees (of a 360 
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degree rotation). Upon completion, images are reconstructed using Bioptonics 
proprietary software with the outputs then being viewed with Data viewer 
(Bioptonics) and Bioptonics Viewer. Additional 3D outputs were produced using 
Drishti rendering software (Ajay Limaye-Volume Exploration and Presentation 
Tool) by Harris Morrison (MRC Human Genetics Unit). 
 
3.22 Mouse lines 
The mouse lines used during the course of this study were C57BL/6 (Charles 
Rivers), CD1 (Charles Rivers), Shh knock-out line described by (Chiang et al. 1996) 
and a  germ line Cre (glcre) produced in house by DJ Kleinjan using a construct 
previously described by  (Araki et al. 1995). A bat Zrs ‘Knock-in’ line created by 
Laura lettice was also utilised.  
 
All mouse work had ethical approval and was performed under home office 
legislation using project liscence number (PPL) 60/4424 and personal lisence number 
(PIL) 60/13367. 
 
Table 3.1: Primer Sequence 
 

















Shh Arm 1(F)   
 














































         (R) 
GATCATGTCGACGAGCACAAAAGCCCTGAGAC 
GATCATCTCGACCTGAAGCCCAATGCTTTCTC 
Screening of Colony PCR 
 M13(-20)F 
               R 
CGCCAGGGTTTTCCCAGTCACGAC 
AGCGGATAACAATTTCACACAGGA 
 Hygro  F 
            R 
CTTGCTCCTTCGCTTTCTG 
TATCCACGCCCTCCTACATC 
Screening of ES cell clones for correct targeting 
 M13 TGTAAAACGACGGCCAGTGAGC 
 Neo GCCTTCTATCGCCTTCTTCTTGACG 
 SHH F1  GCACACTCATCAGTATCTCACC 
 SHH F2 
(gap) 
GCCATGTTAGTCACATCATGCAC 
 SHH R1 GTTTATTGTATGTAGTAAAGTAAG 























Screening of the SB transposon re-insertion 
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Identifying the pLHED re-insertion site 
 SBR1 CTTCTGACCCACTGGGAATGTGATG 
 SBR2 GTGGTGATCCTAACTGACCTAAGAC 
 SBR3 TCCTAACTGACCTAAGACAGG 
 SBL1 CTGGAATTGTGATACAGTGAATTATAAGTG 
 SBL2 CTTGTGTCATGCACAAAGTAGATGTCC 









 KmonP GTACGAGAATCGCTGTCCT 
Detecting LHED Deletion 
 Lactopuro CATAAAATGAATGCAATTGTTG 
 ScreenA* TATTTATAAACCTTATTAAAGCTC 
 pLHEDPac* GAACTGCCAGAACTGTAAGGC 
Cloning the in situ probes  
 Nom1 GATCATGTCGACGGCTCAGGTTCTGAGACTCG 
GATCATGCGGCCGCGTCAACACCCTCCGTAGGAA 
 Rnf32  GATCATGTCGACTCAGCCATGCCCAATATGTA 
GATCATGCGGCCGCACAGATGTGCACAGGACAGG,  
 Rbm33  GATCATGTCGACGGGCAACACTTGAGACCATT 
GATCATGCGGCCGCCTGGACATCAGTGGTGGATG, 
 Lmbr1 GATCATGTCGACCTGTGATGTCCAGAACACTG 
GATCATGCGGCCGCGATTCTGTAAGATGAATCAG. 











 Rnf32 TCAGCCATGCCCAATATGTA 
ACAGATGTGCACAGGACAGG 
 Nom1 GGCTCAGGTTCTGAGACTCG 
GTCAACACCCTCCGTAGGAA 
 Shh GCCTACAAGCAGTTTATTCCCAAC 
CAGTGGATGTGAGCTTTGGATTC 
 Mnx1 TGGACACCCGGTCTACAGTT 
CCATTGCTGTACGGGAAGTT 







 LacZ CAACTTAATCGCCTTGCAGCAC  
CGCTGATTTGTGTAGTCGGTT 




 Neo GATATTCGGCAACCACCCATC 
TGTTCCGGCTGTCAGCGCAC 
 Cre AGCTGGCCCAAATGTTGCTG 
CAATTTACTGACCGTACAC 













 Rnf32 GGGATGCCAAATTAAGGAGA 
GGGACCAGAAAGTGTATGGC 
   
Bold/underlined sequence represents restriction digest sites; NotI SalI, ClaI PacI and Asc1. 
*Primers ScreenA or pLHEDPac were used alongside Lactopuro depending on whether 


















Until recently tools that allow the survey of large genomic regions from a few 
kb to a Mb have been limited. However, recently two studies have exploited the 
Sleeping Beauty transposon for this purpose (Kokubu et al. 2009; Ruf et al. 2011). 
Sleeping Beauty is a binary system consisting of transposon DNA and a transposase 
enzyme, which were genetically reconstructed from inactive elements found within 
the salmon genome. The transposon is flanked by a binding site termed an inverted 
repeat/direct repeat (IR/DR) whereby the transposase binds and can be used for 
mobilisation. The SB transposon also has a predisposition for ‘local hopping’ 
meaning it provides a means of saturating a genomic region for study. One such 
system which encompasses Sleeping Beauty for genomic engineering is the LHED 
system which has previously been discussed (Section 2.16) (Kokubu et al 2009). The 
system allows the generation of nested deletions at defined loci using cre technology 
as well as a reporter vector which can be used to monitor enhancer activity within a 
region. The system is performed within ES cells which can then be used to generate 
mouse lines or using tetraploid complementation embryos can be generated wholly 
from ES cells. By combining these two techniques a map of enhancer activity can be 










Figure 4.1: The LHED transposon system 
 (i) The LHED system comprises the pLHED vector containing a LacZ reporter gene (light blue 
rectangle), IR/DR repeats (Yellow arrows), and G418 selection cassette with promoter (dark blue 
rectangle), puromycin selection cassette (pink rectangle), PGK promoter (purple rectangle), LoxP sites 
(red triangle) and FRT sites (green rectangles). Firstly a homology arm for region of interest complete 
with pre-positioned gap was cloned into the vector. The vector was then linearised within the gap and 
targeted into the genomic locus via homologous recombination which can be selected for using 
neomycin (ii). (iii) Once inserted within the genome the transposon elements consisting of the LacZ 
gene flanked by the SB IR/DR can be mobilised by transient expression of a transposase. Following 
transposition the PGK promoter comes in contact with the puromycin resistance gene meaning 
puromycin can be used to select for transposition. The transposon element will then reinsert within the 
genome within approximately 50% of cases and the LacZ can then be mobilised to detecting enhancer 
function. (iv) Cre recombinase can also be utilised to generate deletions between the LoxP sites of the 
original insertion site and the transposed site which can then be utilised to detect loss of function 
phenotypes. The LacZ gene also remains present so alterations to enhancer activity can also be 
analysed.  
 
Genome regulatory organization mapping with integrated transposons or 
GROMIT provides a similar technique. It again relies on the mobilisation of the 
Sleeping Beauty transposon; however, it does not require the sophisticated 
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manipulations of embryonic stem cells and is instead performed entirely within mice 
(Ruf et al. 2011). Both systems are similar in that insertions can be remobilised 
however it has been reported that the GROMIT system provides a higher frequency 
of remobilisation of one or two orders of magnitude higher than LHED (Ruf et al. 
2011). There are several other proposed differences between the systems. Firstly; 
GROMIT can be utilised to generate chromosomal rearrangements by recombining 
between chromosomes, not just deletions or inversions like the LHED system (Ruf et 
al. 2011). Secondly, GROMIT is performed entirely in mice, which is proposed to be 
more cost and time efficient. However, the generation, maintenance of mouse lines is 
still very time costly, whereas the use of ES cells means that only clones with 
insertions of interest need be generated, which makes the system less labour-
intensive. Furthermore it is well known that ES cells are capable of supporting the 
development of the entire embryo and the adult mouse when the trophoblast and 
primitive endoderm lineages are provided by tetraploid carrier embryos (tetraploid 
embryo complementation assay) (George et al. 2007). This means that by using ES 
cells to generate tetraploid embryos, a quick method of looking at enhancer activity 
can be provided.  
The LHED system was therefore chosen as a method of manipulating the Shh 
genomic locus with an aim of gaining a further understanding with regards to 
enhancer activity and also to generate deletions within the region to see how this 
affects phenotype.  
 
4.2 Designing the LHED strategy 
Firstly the LHED vector was designed to allow targeting into the region 






4.2.1 Designing homology arms for exploration of the Shh genomic 
region 
The LHED vector was designed and constructed to contain no BamHI or 
HindIII restriction enzyme sites, thus allowing the use of any genomic region 
encompassing a BamHI or HindIII site to be chosen as a homology arm containing a 
unique restriction site (Kokubu et al. 2009). 
With regards homology arm design it was proposed preferable to choose a 
region around 5-7 kb containing a large region of fairly unique DNA in order to 
increase the chance of homologous recombination. As the gene desert is comprised 
of large amounts of repetitive DNA it was deemed best to try and design vectors 
within the Lmbr1 gene.  It was decided that the best locations for the initial insertion 
vectors were 3´ of the Zrs so that resulting remobilisations would allow deletions 
between that and Shh and also 5´ of the Zrs so that subsequent remobilisations would 
allow deletions upstream of the enhancer.  
Two pLHED vectors were designed and constructed to insert either side of 
the Zrs; the first comprising a 4.8 kb genomic region 774 kb from Shh designated the 
Shh_LHED vector, and the second a 7.6 kb region located approximately 855 kb 
from Shh, designated the Lmbr1_LHED vector. Both homology arms included a 
prepositioned gap of 634 bp and 600 bp respectively since this is considered to 
improve recombination efficiency.  
As the Shh_LHED vector later proved to be problematic for carrying out 
targeting, a further pLHED vector was designed to allow exploration of the Shh 
genomic region, comprising a 7.5 kb region located adjacent to the Zrs (781 kb from 
Shh), this vector was designed as a replacement for the Shh_LHED vector and thus 
was designated Shh2_LHED.  Again a prepositioned gap was engineered comprising 




Figure 4.2: LHED targeting into the Shh region 
Three LHED vectors (red arrows) were designed to insert either side of the Zrs (pink 
rectangle) within the Lmbr1 gene (grey rectangle) these were at a distance of ~800Kb from 
the Shh promoter. The orientation of the vectors was of importance for utilisation of the loxP 
sites.  
 
4.2.2 PCR amplification and pBluescript cloning 
Often cloning large vectors is time-consuming and limited by the need for 
appropriate restriction enzyme sites. A simpler approach for generating vectors for 
ES cell targeting is homologous recombination via a process known as gap repair, 
which provides a convenient method for subcloning DNA from BACS into 
pBluescipt (Liu et al. 2003).  
The first stage of the cloning process was to design PCR primers which were 
then used to amplify 200-500 bp regions of the BAC (PAC 542-N10), which 
ultimately represent the ends of the fragment to be sub cloned by gap repair.  
Although smaller fragments can be used it has been shown that larger homology 
arms significantly increase the frequency of sub cloning by gap repair (Liu, Jenkins, 
and Copeland 2003).  
Primers were designed to amplify 300 bp regions from the 5´ and 3´ ends of 
each of the homology arms (Lmbr1, Shh and Shh2) from BAC DNA encompassing 
the Lmbr1 genomic region (See table 3.1 Targeting vector primers for further 
details). Primers were also designed to include restriction enzyme sites firstly for 
cloning into pBluescript and then additionally for cloning and positioning the 
homology arm in the correct orientation in the pLHED vector. Correct-sized bands 







(Figure 4.3 A). Ligations were then performed to clone each end separately into the 
vector pBluescript which had also been digested with the appropriate enzymes. 
Following transformation, small-scale plasmid purification was performed on a 
select number of colonies and the resulting DNA was sequenced in order to confirm 
that no mutations had been induced during the PCR for any of the clones (Using M13 
primers see Table 3.1 for further details). The vectors containing the 3´ end of the 
homology arm was then digested with restriction enzymes (NotI/ClaI) and a ligation 
set up to ligate the 5´ end of the homology arm into the same vector. Following 
transformation a colony PCR was used to identify vectors containing both ends of the 
homology arm. These positive colonies were then purified using small scale plasmid 
purification and a diagnostic digest was used to confirm that an insert representing 
both ends of the homology arm were present (Figure 4.3 B). 
 
4.2.3 Bacterial recombineering 
A gap repair method was utilised in order to sub clone the entire homology 
arm fragment from BAC DNA. This was achieved by generating double strand break 
within the pBluescript vector containing the homology arm ends. The DNA was 
subsequently electroporated into electro-competent EL350 gap repair cells carrying 
the relevant BAC, which had been induced for the recombination genes exo, bet and 
gam expression by prior growth at 42 °C. Resulting colonies were purified by small 
scale plasmid purification and a diagnostic digest was used to confirm gap repair had 
occurred and a complete homology arm was present (Figure 4.3C).  
      The homology arm fragments were then sub-cloned into the pLHED vector in 








Figure 4.3: Homology Arm Cloning 
A. 300 bp fragments from either side of the three homology arms; Lmbr1_LHED, Shh_LHED 
and Shh2_LHED were generated by PCR. Primers were designed to include restriction sites 
to enable cloning into vectors.  
B. The PCR fragments were then cloned together into the pBluescript vector by utilising the 
Not/Sal restriction sites and a restriction digest was used to show the 600 bp fragment had 
dropped out from the 3 kb vector.  
C. The p.Bluescript vector was linearised via digest using Cla1 and recombineering was used to 
generate the full homology arm of each of the vector. This was then confirmed by restriction 
digest using Not1 and Sal1. 
D. The full length homology arm was then sub cloned into the 12.5 kb pLHED vector which 
was confirmed by restriction digest. Multiple bands were present for each of the Shh_LHED 
vectors as a result of additional Pac1 sites.  
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4.3 G4 ES cell targeting 
Both Lmbr1_LHED and Shh_LHED vectors were linearised via a restriction 
enzyme site within the gap and electroporated into G4 ES cells. The G4 ES cell line 
is an F1 hybrid ES cell line from a  129 and C57BL/6 cross (George et al. 2007). The 
use of hybrid ES cell lines has previously been shown to have increased frequency 
for producing completely ES cell derived embryos with the G4 line in particular 
having been shown to support tetraploid embryos to term at frequency of 70% 
(George et al. 2007)  The transformants were then selected using G418 (the pLHED 
vector carries neomycin resistance). Following 10 days selection approximately 100 
colonies were isolated for each electroporation, these clonal cells were then 
expanded, lysed and DNA was extracted. 
 
4.3.1 PCR analysis of targeted clones 
The next step within the targeting process was to determine which clones had 
been correctly targeted with the pLHED vector into the correct genomic loci. The 
pLHED vector is targeted into a genomic region using insertion type homologous 
recombination. During this process the pre-positioned gap has been shown to be 
efficiently repaired using the chromosomal target sequence (Valancius and Smithies 
1991) and the homology arms are duplicated (Figure 4.4A). The gap therefore 
presents as a unique region of DNA which should only be present alongside the 










Figure 4.4: Homologous recombination and PCR design 
A. The insertion vector method. Vectors are linearised within a pre-positioned gap within the 
homologous region. Sequences within the locus are duplicated, and marker is inserted at the 
homologous site. 
B. PCR primers were designed against vector sequence (shown with blue arrows) and also 
within the homology arm (black arrows) which would amplification over the gap region. An 
additional set of primers were also designed within the gap region (red arrow)  which 
represents a unique region of DNA which should only repaired if the vector has inserted 
within the correct location. Primer details are given within Table 3.1 ‘Screening of ES cell 
clones for correct targeting’; M13/Neo representing vector specific primers, SHH/LMBR1 
F/R representing those which amplified over the gap and SHH/LMBR1 F2/R2 representing 
those present within the gap.  
 
PCR primers were designed  corresponding to sequence within the gap region 
of the homology arm and each end of the vector sequence (Table 3.1 ‘Screening of 
ES cell clones for correct targeting’), thus allowing identification of clones which 
had experienced homology arm duplication, gap repair and contained vector 
backbone (Figure 4.4B). PCR analysis was performed using these primers for both 
targeted cell lines however it was not possible to identify any clones positive for this 
PCR. A second PCR was therefore devised in which primers flanking the gap rather 
than within the gap were used (Figure 4.4B) and identified four clones which were 
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positive for insertion of the Lmbr1_LHED vector and homology arm duplication 
(Figure 4.5A). It was not possible to identify any Shh_LHED positive clones  
The resulting Lmbr1_LHED positive clones were retrieved from long term 
storage and grown for several days before being used to generate metaphase 
chromosomes in order to examine the karyotype. Within the cell lines in which PCR 
suggested correct targeting more than 70% of cells were found to have undergone 
massive chromosomal duplications and rearrangements. This was a phenomenon 
found only to be associated with the G4 ES cell line suggesting that these cells are 
more susceptible to chromosomal rearrangements. This number of abnormal cells 
was deemed too high to be used to generate mouse lines therefore it was decided that 
these cells could be used no further 
 
4.4 E14 ES cell targeting 
It was decided that the rearrangements found to have occurred within the 
targeted G4 cells were an artefact of the specific strain of cells rather than the 
targeting therefore a new series of targeting was undertaken using E14TG2a ES cells 
(E14), again using both the Lmbr1_LHED and Shh_LHED targeting vectors. E14 ES 
cells are not a hybrid line but instead derived entirely from 129 animals. They 
therefore do not have the same efficiency for supporting tetraploid embryos to term 
but they can support them until at least E11.5 and they can also be used for blastocyst 
injection to generate chimeric animals for mouse lines (Yang et al. 2009).   The 
vectors were linearised and electroporated into E14 ES cells before being selected 
using G418, following 10 days selection, approximately 100 colonies were isolated 
and DNA extraction was performed. 
 
4.4.1 PCR analysis of E14 targeted ES cells 
PCR analysis was performed on both the Lmbr1_pLHED and Shh_pLHED 
targeted E14 ES cell clones to determine which clones had been correctly targeted. 
Long-range PCR analysis was undertaken using two sets of primers, one  
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corresponding to vector backbone and gap DNA sequence and a second again 
corresponding to vector sequence but instead of using primers against the gap 
sequence, primers flanking the gap were utilised (Figure 4.4B/Table 3.1). 
Approximately 10% (10/98) of clones transfected with the Lmbr1_LHED vector 
were found to be positive for correct targeting as deemed by the primers flanking the 
gap (Figure 4.5B), however only 8% (7/98) were identified by primers within the gap 
(Figure 4.5D).  With regards to the Shh_LHED vector, again approximately 10% 
(7/90) of clones were believed to be positive for targeting using primers flanking the 
gap (Figure 4.5C) however when primers within the gap were utilised it was not 
possible to identify any Shh_LHED clones in which correct targeting had occurred.  
As a result of the failed attempts to target the Shh_LHED vector it was 
decided that a third vector, the Shh2_LHED vector would be used to target E14 ES 
cells.  The second Shh vector (Shh2_LHED) was homologous to a similar region as 
the first Shh vector (Shh_LHED), however, had longer homology arms and 
contained a slightly higher percentage of repetitive non-unique DNA.  
Approximately 100 clones were screened by long-range PCR using primers 
homologous to LHED vector sequence and the gap region of the homology arms 
were then used to screen ES clones. Two positively targeted clones were identified 
(2%) by PCR (Figure 4.5D).  The fact that it was possible to target the second vector 
and not the first therefore suggests that a minimum homology arm length is critical 

















A. PCR analysis of Lmbr1_LHED targeting into G4 ES cells. Long-range PCR analysis undertaken 
from both end of the vector (Neo versus M13) and primers flanking the gap. Positive clones were 
indicated by a positive PCR band at 4 kb and 3.5 kb respectively. 
B. PCR analysis of Lmbr1_LHED targeting into E14 ES cells. Long-range PCR analysis undertaken 
from both end of the vector (Neo versus M13) and primers flanking the gap. Positive clones were 
indicated by a positive PCR band at 4 kb and 3.5 kb respectively. 
C. PCR analysis of Shh_LHED targeting into E14 ES cells. Long-range PCR analysis undertaken 
from one end of the vector (Neo) and primers flanking the gap. Positive clones were indicated by 
a positive PCR band at 2.5kb. 
D. PCR analysis of Lmbr1_LHED targeting into E14 ES cells. Long-range PCR analysis undertaken 
from both end of the vector (Neo versus M13) and primers within the gap. Positive clones were 
indicated by a positive PCR band at 4kb and 3.5kb respectively. PCR analysis of Shh2_LHED 
targeting into E14 ES cells. Long-range PCR analysis undertaken from both end of the vector 
(Neo versus M13) and primers within the gap. Positive clones were indicated by a positive PCR 
band at 5 kb and 4 kb respectively. 
 
4.5 FISH analysis of correctly targeted ES cells 
In order to confirm that the LHED vectors had been correctly targeted into 
the genomic region surrounding the Zrs, fluorescent in situ hybridisation (FISH) was 
employed. Probes were generated for both the LHED vector backbone and also the 
Rnf32 gene (located adjacent to Lmbr1 on chromosome 5) thus co-localisation of the 
probes would indicate that the vector had targeted into the correct genomic region.  
Positive clones were retrieved from liquid nitrogen storage and grown before being 
used to generate metaphase chromosomes for FISH. Probes were indeed found to co-
localise for clones in which gap primers suggested correct targeting had occurred 
(Figure 4.6 B) (N=3), however random integration was found for those in which only 




Figure 4.6: FISH analysis of correctly targeted ES cell lines 
FISH analysis of ES cells targeted with LHED_Lmbr1 vector. Green probe represents pLHED vector 
and the red probe the Rnf32 gene. 
(A) Probes not co-localised suggesting random integration.  
(B) Probes co-localised suggesting correct targeting on chromosome 5.  
 
4.6 Inducing transposition in targeted ES cells 
Following targeting of the LHED vectors Lmbr1_LHED and Shh2_LHED 
into the Shh locus the next step was to mobilize the SB transposon cassette using a 
transient transfection of transposase. The Sleeping Beauty transposase binds to the 
terminal inverted repeats/direct repeats present within the transposon causing it as 
well as the LacZ reporter gene and LoxP site contained within them to ‘jump’. This 
jumping brings together a puromycin selection cassette with a PGK promoter 
meaning that puromycin resistance can be used to determine in which clones hopping 
has occurred (Figure 4.1 [iii]). 
Targeted cells were electroporated with the CMV-SBII transposase plasmid in order 
to mobilize the transposable element. Initially, puromycin selection at a 
concentration of 1 μg/ml was employed after 24 hours to identify clones in which the 
vector had mobilized.  Unfortunately all cells were found to die following selection; 
this was hypothesised to be as a result of the time required following electroporation 
for the transposase to be expressed, the transposon to jump and the puromycin to be 
expressed. The electroporation was therefore repeated with recovery times of 48 and 
92 
 
72 hours before selection was administered. However, in these experiments a further 
problem was identified in that a large number of background cells were still present 
after selection, suggesting some background puromycin resistance. Puromycin kill 
curves were performed on both targeted cell lines as well as wild-type E14 ES cells. 
100% of wild-type cells were found to die at puromycin concentrations of 1μg/ml 
after 48 hours selection; however under the same conditions approximately 5-10% of 
targeted cells were still alive. Whereas, puromycin concentrations of 2 μg/ml were 
found sufficient to cause 100% cell death within both targeted cell lines (Table 4.1). 
The puromycin resistance found within the targeted E14 ES cells was likely as a 
result of the vector being ‘leaky’. This phenomenon did not occur in the original 
study however a different cell line was used (G4 rather than E14) which may account 
for this. Electroporation was therefore repeated and selected using the higher 
concentration of Puromycin after 48 hours; unfortunately no clones were produced 
suggesting there was a fundamental problem with the LHED system.   
 
Table 4.1: Inducing hopping with LHED targeted ES cells 
Cell death analysed following puromycin treatment for 48 hours on Wild-type E14 ES cells, Cell lines 
L35 and L47 positively transfected with Lmbr1_LHED vector and cell line S32 transfected with 




Average % cells alive following 48 
hour treatment with 1µg/ml 
Puromycin 
% cells alive following 48 hour 






L35 5 0 
L47 5 0 




In order to determine what was preventing the transposition event occurring 
two further aspects of the experimental procedure were tested. Firstly, the 
transfection method was examined, electroporation had been used to transfect the 
cells previously; however, it was hypothesised that a reagent based transfection 
method might be more efficient. The second aspect of the experiment that was tested 
was the transposase, the transposase initially used was the SBII transposase as 
discussed in the original LHED paper (Kokubu et al. 2009); however, a newer 
version of the Sleeping Beauty transposase, SB100x has been produced. SB100x has 
been hyper-mutated by including six combinational units from TC1 Mariner to 
increase its efficiency 100 fold over the original transposase  (Matessi and Schneider 
2009). Transfection with the SB100x transposase (and a chemical transfection 
reagent) was therefore tested and was found to be capable of producing clones 
(Summary Table 4.2). 
Table 4.2: Summary of transfections used to optimise transposase activation within LHED 




























SB11 10 µg/µl Electroporation 24 hours 1 µg/ml 0  
2 L35 12 x 
plates, 
0.8 x 106 
cells per 
plate 

















to be lacZ 
positive 















SB11 20 µg/µl Electroporation 72 hours 1 µg/ml 0 Large number 
of background 
cells as above 




SB11 20 µg/µl Electroporation 48 hours 2 µg/ml 0  




SB11 10 µg/µl Electroporation 48 hours 2 µg/ml 0  
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SB11 10 µg/µl Electroporation 48 hours 2 µg/ml 0  




SB11 10 µg/µl Transfection 
reagent 
48 hours 2 µg/ml 0  






































4.7 Determining ‘Hopping’ and Reinsertion within LHED_SHH2 Targeted 
cell Lines 
Two transfections were performed using the Shh2_LHED targeted cell line 
(designated S32) and SB100X, each producing approximately 250 clones. DNA was 
extracted from these for analysis and a series of PCRs employed. Firstly, in order to 
detect that clones had definitely ‘hopped’ a PCR was performed using primers for the 
PGK promoter and Puromycin gene (See Table 3.1 ‘Screening of SB transposon 
site’), these two elements come together after transposition, therefore, a positive PCR 
indicated that the transposition had occurred. All clones tested were found to be 
positive for transposition. Following ‘hopping’ the transposon, was reported in the 
literature to reinsert in approximately 50% of the clones (Kokubu et al. 2009). In 
order to determine which clones had reinsertion of the LHED transposon PCR was 
performed using primers against the LacZ reporter gene (See Table 3.1 ‘Screening of 
SB transposon site’). This gene is found within the mobilised section of the LHED 
vector (Figure 4.1 [iii]) therefore a positive PCR suggests that the LHED vector had 
reinserted within the genome. Transposon reinsertion was detected in approximately 
50% of clones. Finally, in order to detect the location of reinsertion a nested 
asymmetric PCR strategy was employed, which had previously shown to be capable 
of mapping transposon insertions generated by the GROMIT system (Ruf et al. 
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2011). Briefly, the strategy involved an initial PCR using primers facing out either 
side of the transposon sequence and a random primer which was designed to amplify 
approximately every 1000 bp, therefore meaning that it should be possible to 
generate a PCR product for a high percentage of insertions regardless of where the 
transposon had inserted. A second PCR was then performed again with transposon-
specific primers and also with primers against an adaptor located within the random 
primers (For primer details see Table 3.1 ‘Identifying the pLHED reinsertion site’). 
This second PCR was then sequenced to determine where the transposon had 
inserted (See appendix table 8.1). Of the 200 clones positive for reinsertion, it was 
possible to generate long enough sequence to unequivocally map 86%. Of these 
86%, 65% were found to map within the same chromosome (chromosome 5). With  
41% of these found to map to within 1Mb of the initial insertion site (Table 
4.3/Figure 4.8).  
 
Figure 4.7: Mapping reinsertions at the Shh locus in LHED-targeted ES cells 
The Shh regulatory landscape containing the genes Mnx1, Nom1, Lmbr1, Rnf32, Shh, Rbm33, Cnpy1, 
En2 (grey rectangles-Dark 5ꞌ-3ꞌ expressing, Light 3ꞌ-5ꞌ) and various labelled enhancers (coloured 
rectangles). 
Reinsertions of the LHED targeting vector from both original insertion sites; S32 and L35 (red 
arrowheads demarked with *) were mapped via a nested high throughput PCR strategy, and their 
locations and orientation then plotted throughout the region (black arrow heads reflecting reinsertions 
in S32 line and grey triangles reflecting reinsertion within L35 line with the direction of the arrowhead 
reflecting orientation of LacZ transcription). Large amount of coverage across the region found. 
 
4.8 Determining ‘Hopping’ and Reinsertion within lmbr1_LHED Targeted 
cell Lines 
One transfection using the SB100x transposase was performed for 
Lmbr1_LHED targeted cell line (designated L35) and was found to produce 165 
clones. Again these clones were analysed using the PCR strategy discussed 
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previously. Approximately 60% of clones were found positive for reinsertion, with 
the reinsertion site of these unequivocally mapped for 93% (See appendix table 8.1). 
58% of reinsertions were found to occur within chromosome 5, with 46% of these 
within 1 Mb of the targeted insertion site (Table 4.3/Figure 4.8).  
 
The original study (Kokubu et al., 2009) suggested that approximately 78% 
of cells have a reinsertion within the same chromosome which is slightly higher than 
found within these experiments. However 42% of insertions were found within a 1 
Mb region which is similar to that found within these experiments. Again in 
agreement with the original study, an approximate 50:50 ratio was observed with 
respect to which orientation the vector was found to reinsert in for both vectors. 
Reinsertions were also found to cluster around the original targeting site (Table 4.3) 
an event which is likely as a result of the local hopping nature of the sleeping beauty 
transposon.    
Table 4.3: Distribution of LHED insertions across the mouse genome and within chromosome 5 
Majority of insertions shown to be on chromosome 5; with the biggest number of these between 20 
and 30Mbp* which is also the region of the original insertion and thus demonstrates the propensity of 









  1 5 
 0-10 4 
2 4 
 10-20 14 
3 
5 
 20-30* 81 
4 7 
 30-40 14 
5 
158 
 40-50 12 
6 
3 
 50-60 12 
7 
8 
 60-70 7 
8 
3 
 70-80 5 
9 
4 





 90-100 5 
11 
10 
 100-110 0 
12 
4 
 110-120 1 
13 
5 
 120-130 2 
14 
6 
 130-140 1 
15 
4 
 140-150 0 
16 1  
17 3  
18 3  
19 3  
x 2  
 
4.9 Conclusions 
          Two LHED vectors Shh2_LHED and Lmbr1_LHED, were successfully cloned 
and used for ES cell targeting. Originally it was planned that ES cell targeting would 
be performed using G4 ES cells which have previously been shown to be superior for 
tetraploid production (George et al. 2007). Unfortunately successful targeting of 
these cells was not found to be possible. Following PCR analysis, karyotype analysis 
was undertaken on those clones which were expected to be correctly targeted. 
However a number of chromosome rearrangements and duplications were found to 
have occurred. Other members of the lab using these cells had experienced similar 
problems, even with cells that had not been through a round of targeting. This 
potentially suggests a fundamental issue with the original stock of cells or 
alternatively as a result of trypsin sensitivity. Further work was performed in order to 
examine this. A round of targeting was employed on G4 ES cells cultured without 
trypsin, using instead TryplE express (Invitrogen) and appeared to have a normal 
karyotype, however, as a great deal of work had already been performed using the 





Developing a PCR screen capable of detecting correct insertions was 
required. The original PCR screen in which primers were designed corresponding to 
gap and vector sequence was not found to work within the first round of targeting 
into G4 cells. This was hypothesized to be as a result of incomplete gap repair, 
therefore a new PCR screen that involved amplifying across the gap was developed. 
It was believed that this PCR screen would still be able to identify correctly targeted 
clones as it detects the presence of homology arm duplication which occurs during 
homologous recombination into the region. The same PCR screens were used to 
analyse clones produced by targeting into E14 ES cells, both screens were found to 
detect positive clones, however, only those clones in which PCR suggested gap 
repair had occurred were found by FISH to have inserted into the correct genomic 
region. This not only confirms that gap repair does occur during targeting reactions 
but also that it is an essential indicator of targeting into the correct genomic region. 
The clones that had not undergone gap repair were found to have inserted at random 
into the genome. The band sizes generated by PCR analysis on clones which had 
inserted at random suggested that the homology arm had been duplicated, however as 
these vectors were not found within the desired locus it appears that a semi 
illegitimate recombination reaction has occurred, potentially in which concatemers of 
vector had inserted. Often events such as these occur if the targeting vector has not 
been fully linearised (Valancius and Smithies 1991). PCR analysis of the Shh_LHED  
vector using primers across the gap suggested that approximately 10% of clones had 
been correctly targeted. However FISH analysis suggested that these clones had 
undergone random integration. It is therefore suggested that it was not possible to 
target this vector correctly. The most obvious reason for why this has happened is 
that the Shh_LHED vector has a slightly smaller region of homology, which has 
previously been shown to affect targeting frequency (Valancius and Smithies 1991). 
 
Experimental optimisation with regards transfection method, puromycin 
selection concentration and transposase had to be employed in order to induce 
transposition within the LHED cell lines. Electroporation was originally employed 
because it had previously been demonstrated within the lab to have a reasonable 
efficiency for transfecting ES cells. However it was suggested that the transposase 
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step works more efficiently if a reagent-based transfection method was used 
(personal correspondence Chikara Kokubu). There was also an issue with regards to 
underlying puromycin resistance within non-transposed cells. All cells carrying the 
LHED vector also carry a puromycin resistance gene however without its promoter. 
It is therefore likely that the cause of this increased puromycin resistance is a result 
of low level puromycin resistance transcript being produced. This problem was 
shown to be remedied by increasing the concentration of the selection reagent 
without any detrimental effect on the cells. Finally a different transposase was tested; 
SB100X which is believed to have a 100x greater efficiency than SB11 which was 
employed within the original study. It was indeed found possible to induce LHED 
transposon mobilisation using SB100x rather than SB11. The fact that no clones 
were produced using the SB11 transposase vector suggests that there could be a 






















5. Mapping the Shh regulatory region 
 
5.1 Introduction 
As previously described, the Shh gene and its well-established regulators 
provides an example of a genomic landscape in which enhancers reside in a large 
desert extending into neighbouring genes to control the spatiotemporal pattern of 
expression. This composition coordinates a complicated series of control 
mechanisms posing a number of questions about the capacity of the regulatory 
components within these large chromatin domains. Various enhancers have been 
identified within the region which directs expression within the CNS, gut epithelium 
as well as the limb bud (See Figure 2.3).  A library of LHED insertions carrying the 
LacZ reporter gene were dispersed throughout the Shh region via targeting of the two 
LHED targeting vectors and subsequent mobilisation of the transposable element 
(Figure 4.8). These insertions thus provided a means to map enhancer activity 
throughout the Shh regulatory domain to determine a potential relationship between 
enhancer activity and its position within the locus and elucidate on a chromosomal 
scale the regulatory events displayed over a long range.  
 
The advent of powerful genomic technologies has allowed for the 
unprecedented genome-wide prediction of enhancer elements (Visel, Rubin, et al. 
2009; Rada-Iglesias and Wysocka 2011). However, to rapidly validate and 
characterize the vast number of genomic regions with regulatory potential remains a 
considerable challenge, particularly in mammals. In a typical enhancer assay, a 
putative enhancer element is placed upstream of a minimal promoter driving a 
reporter gene the expression of which is analysed in an appropriate experimental 
system (Loots 2008). There are significant drawbacks associated with many of the 
existing methodologies. For example, transient transfections of reporter constructs 
are easy to perform but assess the elements in multiple copies and in a non-
chromosomal context. At the other end of the spectrum, mouse transgenesis offers a 
more natural in vivo context, however it is expensive, time-consuming, and laborious 




ES cell tetraploid complementation embryos provide a method of generating 
mice entirely derived from ES cells. This is achieved by removing two-cell stage 
embryos from the oviducts of superovulated females and treating them with a short 
electric pulse in order to fuse two blastomeres. The tetraploid embryos then have 
their zonae pellucidae removed and are aggregated with clumps of 8-15 ES cells 
before being transferred into the uterus of pseudopregant female mice (Nagy et al. 
1993). This produces embryos derived entirely from ES cells.  Embryos can then be 
harvested at an appropriate stage and examined.  
 
5.2 Generation of tetraploid embryos 
In order to analyse cis-regulatory reporter function, it is sufficient to generate 
heterozygous embryos carrying an LHED insertion.  A number of ES cell clones 
carrying SBLac inserts (comprising a LacZ reporter gene) were selected which were 
dispersed throughout the Shh genomic locus, as well as both upstream and 
downstream. These were then injected into tetraploid blastocysts which were 
subsequently used to generate embryos derived wholly from ES cells. At E11.5 
whole mounts of the resulting embryos were analysed for enhancer activity by 
examining LacZ expression from the transposed transgene.  
 
5.3 Reporter activity across the gene desert 
The first region of the Shh regulatory landscape to be examined was the gene 
desert in which a number of the Shh enhancers reside. ES clones were chosen to 
examine the activity of reporter genes between Shh and the Rnf32 gene. The gene 
desert covers nearly 800 kb of DNA containing a number of well-characterised Shh 
enhancers (Previously described in section 2.8).  Four ES cell clones were selected in 
order to examine enhancer activity across the gene desert starting within just outside 
the Rnf32 gene (SBLac 2-120) and ending 100 kb from the Shh gene (SBLac 120) 




All four reporter insertions showed similar expression patterns of LacZ 
reporter gene activity (Figure 5.1). Expression was found to occur within the brain, 
notochord and floor plate, throughout the lungs and gut and also within the posterior 
of the limb bud.  This reflected the known Shh expression pattern as shown by in situ 
hybridisation (Figure 5.7). Enhancer activity was found to be similar regardless of 
where the insertion was placed within the region thus suggesting that the whole 
desert is open for enhancer activity (Figure 5.1). 
 
 
Figure 5.1: Enhancer activity within the gene desert 
Expression of LacZ at different locations across the gene desert. LacZ is detected within the 
CNS, the limb bud and the throughout the gut including the laryngotracheal tract. Whole 
embryo and gut expression from four insertions within the gene desert (i) 2-120 (ii) 2-67 (iii) 
131 (iv) 120. Insertions indicated by arrow heads on the gene desert map and enhancers shown 
as coloured rectangles. n numbers reflecting number of embryos examined also shown.  
 
Although tissue expression was found to be similar across the region, some 











The expression levels found from the SBLac2-120 insertion, especially in the gut 
epithelial lining appeared to be lower than those seen within the other SBLac inserts 
(Figure 5.1 [i]). Reporter expression levels within the limb and brain remained 
similar suggesting this was a phenomenon associated with the gut enhancers and the 
region the reporter gene had inserted.  Enhancers known to direct Shh expression 
within the gut, pharynx and oral epithelium at this stage have been identified and are 
found approximately 600-900 kb from Shh (Sagai et al., 2009). Additionally the 
SLGE enhancer lies close by the SBLac120 insertion (Tsukiji, Amano, and Shiroishi 
2013). This phenomenon therefore could result from the compounded effect of both 
the MACS1 enhancer and SLGE driving expression most strongly towards the Shh 
gene.  Expression within the laryngotracheal tract has been suggested to be driven 
entirely by MACS1, whereas both MACS1 and SLGE drive expression throughout the 
rest of the gut (Tsukiji, Amano, and Shiroishi 2013). Expression within the 
laryngotracheal tract of the 2-120 tetraploid (Figure 5.1 [i]) was found to mimic 
levels found within the rest of the gut suggesting that it is the activity of MACS1 that 
the reporter gene is detecting.  This therefore could suggest that MACS1 while 
capable of working at long distances is less effective as an enhancer at short range, 
further quantification however would have to be performed.  
 
5.4 Do Insertions vary in their intensity of staining? 
 
           Following staining overnight it was deemed that the majority of tetraploids 
had either reached saturation or reached the end of the reaction, therefore by 
examining embryos only in this manner it was not possible to detect all changes in 
the intensity of staining or with regards temporal staining patterns i.e. did certain 
insertion stain faster than others. A time-course experiment was therefore performed 
whereby several insertions were used to generate tetraploid complementation 
embryos or if mouse lines had been generated for the same insertion (see chapter 6), 
F1 embryos. These were harvested at 11.5 days and were then stained for LacZ 
expression, with the staining process being stopped at 1 hour, 2 hours, 4 hours and 
then lastly overnight. Four insertions were examined: SBLac120, SBLac2-67, 
SBLac2-120 and SBLac 2-200 (Figure 5.2). Overall the staining pattern was found to 
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be linear; after 1 hour staining faint LacZ expression was found within the limb buds 
and also the midbrain of all the embryos. After 2 hours’ staining, the rest of the brain 
tissues were found to start expressing LacZ and there was also faint expression 
within the notochord and floor plate. Following 4 hours’ staining, LacZ expression 
appeared to be present within all the known Shh expressing tissues of the limb, CNS 
and gut suggesting that it was possible to detect a complete pattern after this time 
period. Following staining overnight, the pattern appeared to be saturated. Each of 
the insertions resulted in some variation in staining which concurred with that 
identified using the tetraploid complementation assay, for example SBLac 2-120 was 
slightly lighter than SBLac120 and SBLac 2-67 after the overnight time point, and 
SBLac2-200 had higher limb bud staining and was missing forebrain expression. 
Although SBLac2-120 and SBLac2-67 were found to have lower limb and mid-brain 
expression at the early time points, staining was present suggesting that there were 




Figure 5.2: Enhancer activity time course 
Time course of LacZ expression at four time points 1 hr, 2 hr, 4 hr and overnight, for four 
insertions, 120, 2-67, 2-120 and 2-200. Black arrows mark limb expression at 1 hour time point 
while black arrow heads show midbrain expression. Expression is shown to begin to be detected 
within limbs and mid-brain at 1 hour, with the entire expression pattern recapitulated by 4 hours. 
Enhancer activity lost within some tissues depending on insertion sites suggesting variation in 
robustness.  
 
5.5 Reporter Gene Activity inside Genes 
As well as containing a number of enhancer elements the Shh genomic region 
also contains both the Rnf32 and Lmbr1 genes. Both Lmbr1 and Rnf32 are believed 
to be expressed ubiquitously throughout the embryo however no developmental role 
has been defined for either.   The Rnf32 promoter has been shown to be surrounded 
by enhancers related to Shh expression (See section 2.8) however its ubiquitous 
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expression suggests it is not influenced by these. To determine if there is an intrinsic 
property of the Rnf32 gene that contributes to the lack of responsiveness to the 
regulatory landscape, an insertion, SBLac2-25, which is located with an intron of the 
gene, was selected to generate tetraploid embryos for expression analysis.  SBLac2-
25 was found to be expressed throughout the CNS, brain, gut and limb in a typical 
Shh spatial pattern (Figure 5.3B [V]).  The reporter expression levels, however, in 
these embryos were consistently lower than the reporters in the gene desert, except 
perhaps for the limb buds.  This suggests that the Rnf32 which resides inside the 
regulatory landscape and a promoter which is active is resistant to outside enhancer 
influence; however, the body of the gene is accessible to the surrounding expression 
activity suggesting that the transcriptional apparatus for Rnf32 expression is 
refractory to outside influence.   
The Lmbr1 gene shows a similar resistance to the Shh regulatory landscape; 
however as its promoter is outside the regulatory region this could explain why it is 
not influenced by enhancers within the region.  The two initial targeting sites of the 
SBLac vector; SL35 and S32 both found within Lmbr1 (either side of the Zrs) were 
originally chosen to generate tetraploid embryos to examine reporter activity within 
this region (Figure 5.3). The overall expression pattern was found to be low for both 
insertions; however, in the SBLacS32 the expression pattern appeared to be complete 
except for lack of expression within the ventral forebrain and gut (Figure 5.3A [ii]). 
A similar exclusion of the ventral forebrain was found in the SBLacL35 insertion; in 
addition, expression in the neural tube and notochord were very low and expression 
within the gut was missing (Figure 5.3A[i]).  
Prior to transposition (Figure 4.1), the LacZ reporter gene remains with the 
rest of the targeting vector which contains a number of other promoters for both the 
neomycin and puromycin resistance genes, the presence of these in such close 
proximity to the lacZ reporter gene could dilute down the amount of enhancer 
activity focused on its own promoter. As there were concerns about comparing 
original insertion sites versus those which had ‘jumped’,  two  further insertions 
within Lmbr1 were examined for expression, one either side of the Zrs; SBLac2-21 
and SBlac2-200 which were comparable to the original two in terms of location but 
in the opposite orientation and had also undergone transposition.  The expression 
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pattern within the SBLac2-200 insertion was again found to be more or less 
complete, however lower levels of expression were found within the ventral 
forebrain, notochord and gut (Figure 5.3B [iv]).  In SBLac2-21 ventral forebrain 
expression was lost as was the expression within the gut, expression in the neural 
tube and notochord was also found to be quite low (Figure 5.3B [iii]).  Both 
tetraploid embryos generated within this region were found to have very high limb 
expression which could be as a result of the proximity of the reporter to the Zrs. 
Overall the expression pattern found within tetraploid embryos generated from the 
original insertion sites versus those generated from transposed insertions within the 
Lmbr1 gene were found to be comparable. The tetraploids generated post-excision 
were found to have on the whole a somewhat higher level of LacZ expression, 
potentially as a result of not being in close proximity to the remaining vector 
sequence. There did not appear to be any effect of orientation of the insertion on the 









Figure 5.3: Enhancer activity at the 5ꞌ end of the Shh regulatory landscape 
A. Expression of lacZ reporter gene with two original insertions (i) L35 and (ii) S32 indicated on 
the gene map by red arrow heads. Expression is missing from the forebrains of both embryos 
(black arrow), additionally only low level gut expression is found.  
B. Expression variation at the 5’ end of the Shh regulatory region. Whole embryo and gut 
expression from five insertions upstream of Lmbr1, within the Lmbr1 gene and within Rnf32 (i) 
3-119 (ii) 3-21 (iii) 2-21 (iv) 2-200 (v) 2-25. Neural tube dissection shown at bottom left hand 
corner for SBLac3-21 and SBLac2-200. Insertions indicated by arrow heads on the gene desert 
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map and enhancers shown as coloured rectangles. N numbers shown for number of tetraploid 
embryos generated for  each insertion. 
 
Another insertion within a gene, SBLac70, located at the other end of the 
region within Shh was used to examine reporter gene expression pattern. Tetraploid 
complementation embryos generated for this insertion were found to have very high 
expression levels within tissues, especially the mid-brain and also the gut (Figure 5.4 
[i]). The expression pattern seen within embryos generated from the SBLac3-70 
insertion could suggest a focusing of enhancers within the region of Shh. 
Alternatively the known mid-brain enhancer SBE1 resides within the Shh gene, 
which could suggest proximity to the enhancer is the reason for the high degree of 
expression seen within these tissues. However as the gut is also shown to have a very 
high expression pattern, transcriptional read-through could be occurring due to the 
orientation of the insertion within the gene in the same direction as the gene itself,  
resulting in very high levels of expression.   
 
 
5.6 Defining the boundaries of Shh enhancer activity 
 
A series of tetraploid complements were generated to examine the boundaries 
of the Shh region. Upstream of Lmbr1, two tetraploid complements were generated, 
SBLac3-21 and SBLac3-119. In the former line, the reporter locates approximately 
10 kb from the 5´ end of Lmbr1 and in the latter, 100 kb from Lmbr1 past the next 
gene, Nom1. Both insertions were found to show some LacZ expression however in a 
pattern dissimilar from the known Shh expression. Within SBLac3-21 expression 
was exhibited both in the neural tube and also in the limb (Figure 5.4 B [ii]). SBLac 
3-119 was also shown to express LacZ within the motor neurons and faintly within 
the hind limb (Figure 5.4 B [i]). No Shh-related expression was found within the guts 
of embryos generated from these insertions. These embryos were dissected and 
sectioned in order to detect if the neural tube expression seen was related to Shh. The 
neural tube of the SBLac3-21 embryos was found to have an expression pattern 
unlikely to be Shh related, with expression found in two stripes within the dorsal root 
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ganglia region rather than within the floor plate and notochord as seen with Shh 
expression. Limb expression from these two insertions was also found to be slightly 
altered as opposed to the Shh related tetraploids with expression only present within 
the posterior hind limbs.  
 
Three insertions were also examined downstream of Shh, firstly SBLac3-41 
located within the intergenic region between Shh and the nearest neighbouring gene 
Rbm33 approximately 5 kb from Shh. Secondly, an insertion within an intronic 
region of the Rbm33 gene SBLac24, 100 kb from Shh and lastly an insertion between 
Cnpy1 and En-2, SBLac1-66. The expression pattern of SBLac3-41 was shown to 
reflect that of the Shh pattern within the CNS, gut and limbs. However expression 
levels were much lower than those seen within Shh and also the other side of Shh 
(Figure 5.4 [ii]). The following insertion SBlac24 located within the Rbm33 gene 
showed no Shh-related expression, instead expression was found within the hind 
brain-mid brain junction (Figure 5.4[iii]). A similar expression pattern was found for 
the final insert SBLac1-66, thus suggesting that these insertions lay within another 















Figure 5.4: Enhancer activity at the 3ꞌ end of the Shh regulatory landscape 
Expression variation at the 3´ end of the Shh regulatory region. Whole embryo and gut 
expression from three insertions downstream of Shh and within the Shh gene and (i) 3-70 (ii) 3-
41 (iii) 3-24 (iv) 1-66. Black arrow used to show loss of forebrain expression within SBLac 3-41 
whereas black arrow heads highlight expression within mid-brain hindbrain junction within 
SBlac3-24 and SBLac 1-66. Insertions indicated by arrow heads on the gene desert map and 
enhancers shown as coloured rectangles 
 
5.7 How robust are enhancers within the Shh regulatory region? 
 
            Overall the enhancers found within the Shh genomic region appeared to have 
fairly consistent expression patterns and activity across the region. However some 
variations were seen with regards how robust single enhancers were.  
 
Optical Projection tomography (OPT) analysis was used in order to the 
compare whole embryo LacZ expression patterns for several different insertions. 
OPT allows visualisation of tissues throughout the embryo that cannot necessarily be 
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visualised by microscopy alone.  Four embryos were selected for analysis, SBLac120 
located 100 kb from Shh, SBLac2-67 within the middle of the region, SBLac3-41 
located 10 kb downstream of Shh and SBLac2-21 located at the 5ꞌ end of Lmbr1.  
Embryos were found to show similar expression patterns, however, some differences 
were found. Both SBLac120 and SBLac67 were found to show the full pattern of 
expression within the CNS, gut and limb (Figure 5.5 [ii] [iii]). However the 
SBLac120 insertion was found to be expressed more highly in most embryonic sites 
(Figure 5.5 [ii] [iii]). SBLac3-41 was found to show expression within the mid-brain, 
some parts of the notochord and also within some of the gut and the posterior of the 
limb bud, however at lower levels (Figure 5.5 [iv]). Brain, limb and a little notochord 
expression was exhibited within SBLac2-21, with gut expression and fore-brain 
expression found to be missing (Figure 5.5 [i]).  This data goes to show us that 
although the whole region of the desert is open for reporter activation there are some 
variation in how enhancers work. The three enhancers SBE2, SBE3 and SBE4 located 
within the middle of the region which control expression within the forebrain and 
telencephalon are found to be the most sensitive to changes in distance. Whereas,  
SBE1 which is found within intron 2 of the Shh gene and responsible for driving 
expression within the mid-brain from E10.0 onwards is found capable of acting at a 
very long distance over 700 kb away. This again demonstrated the variation in 
enhancer activities but also goes to reveal that enhancer proximity to the promoter is 
not necessarily critical for function.  
 
 
Figure 5.5: OPT analysis of insertions across the Shh region 
OPT images showing sagittal view of four separate insertions (i) 2-200 (ii) 2-67 (iii) 120 and (iv) 3-
41. LacZ expression pattern is represented in red with the structures of the embryo shown in grey. 
SBLac120 is shown to recapitulate the entire Shh expression pattern, with the other insertions showing 




5.8 Does the transposon vector carry any genetic information when it 
jumps? 
 
A concern with using a transposon based method of chromosomal 
engineering was the possibility that its mobilisation would result in indels within the 
region. In order to evaluate whether this had occurred sequence from 65 insertion 
sites was examined, of these it was possible to deduce that within at least 80% of 
insertions no changes had occurred to sequence after insertion, with the number 
potentially being higher if sequence quality had been higher. When the transposon 
mobilised only the sequence located between the inverted/direct repeats is supposed 
to ‘hop’ (Figure 4.1). However as tetraploid embryos across the region were shown 
to have very similar expression pattern it was decided that two insertions out with the 
Shh regulatory region should be examined in order to ensure that no genetic 
information from the original insertion locus was carried with the transposon when it 
jumped. Two separate inserts; SBLac 189 and SBLac 2-89 which are both located on 
chromosome 5; however at distances of 12 and 23 Mb from Shh, respectively, were 
used to generate tetraploid complementation embryos. SBLac189 was found to yield 
no staining whatsoever, suggesting it had landed within a region of the genome with 
no enhancers in range or it had landed within a region of closed chromatin (Figure 
5.6 [i]). SBLac 2-89 was found to have some staining at the top of the mid-brain and 
also within some regions of the lungs and gut (Figure 5.6 [ii]). However this pattern 
was very different from the one demonstrating Shh type expression. Both these 
insertions go to show that no information from the original insertion site was carried 





Figure 5.6: LHED transposition does not result in insertions within the genomic region 
Tetraploids generated from two insertions located elsewhere on chromosome 5 (i) 189 and (ii) 2-88. 
SBLac189 shows no expression pattern suggesting no enhancer is functioning within range of the 
insertion. SBLac2-89 shows expression within structures of the gut and the top of the mid-brain. A 
different expression pattern to that of Shh.  
 
5.9 What are the expression patterns of neighbouring genes within the 
Shh region? 
A number of genes are located within, and in close proximity to the Shh 
regulatory locus. It was of interest whether any of these genes are influenced by any 
of the enhancers located within the region.  
 
5.9.1 In situ hybridisation probe cloning 
 
In order to evaluate how the genes both within and in close proximity to the 
Shh region are expressed an In situ hybridisation screen was undertaken. Primers 
were designed to amplify approximately 500 bp regions spanning at least one exon 
from whole embryo cDNA (Figure 5.7A[i]) (Table 3.1 ‘Cloning in situ probes’). 
Sequencing and restriction digest was then used to ensure the correct sequences had 
been cloned (Figure 5.7 A[ii]). In situ hybridisation was performed on E11.5 
embryos in order to determine expression pattern at this stage. Shh was shown to be 
expressed within the posterior of the limb bud as well as the brain and the gut (Figure 
5.7 B [v-vii]) similar to what is reported within the literature (Echelard et al. 1993).  
In situ hybridisation of embryos with probes designed against both Lmbr1 and Rnf32 
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resulted in embryos showing staining across the embryo suggesting these genes 
could be ubiquitously expressed (Figure 5.7B [ii-iii]). RT-PCR (for primers see table 
3.1 ‘RT-PCR analysis’) was also employed using RNA generated from tissue of the 
limb, the head and the rest of the embryo; both genes were shown to be expressed 
within all these tissues.  Upstream of Lmbr1 two genes were examined, Nom1 and 
Mnx1. Nom1 was again found to result in an in situ and RT-PCR pattern suggesting 
ubiquitous expression (Figure 5.7B [i]). Mnx1 was found to have some expression 
within the posterior of the limb bud (Figure 5.7B [iv]) a pattern which has previously 
been reported by (Rock et al. 2007). In addition, (Thaler et al. 1999) suggested that 
Mnx1 is also expressed within motor neurons.  
The expression pattern of three genes downstream of Shh was also 
determined by performing in situ hybridisation on E11.5 embryos. In accord with 
published data (Paek et al. 2012) both Cnpy1 and En2 were found to be expressed 
within the mid-brain hind-brain junction suggesting the expression pattern seen 
within the SBLac3-24 and SBLac1-66 tetraploids could reflect an enhancer element 
controlling these two genes (Figure 5.7B [ix-x]). in situ and RT-PCR suggested that 
Rbm33 was again potentially ubiquitously expressed throughout the embryo (Figure 
5.7B [viii]). The ENCODE project has also enabled examination of the genomic 
region surrounding Shh in detail (Consortium 2011; Shen et al. 2012). RNA polII 
sites which demarcate actively transcribed genes were examined in ES cells and 
shown to be present at the promoters of Nom1, Lmbr1, Rnf32 and Rbm33 suggesting 
these all indeed have active promoters (Figure 5.8). 
These expression patterns served to show that the surrounding genes neither 
reflected Shh expression patterns nor show a general up-regulation in Shh domains, 
suggesting that apart from some potential ZRS activation of Mnx1 the surrounding 
genes are shielded from the activity of the Shh enhancers. 
 
5.9.2 Is the Zrs capable of acting on Mnx1? 
In order to determine whether the expression of Mnx1 found within the limb 
was driven by the Zrs, in situ hybridisation was also performed on embryos from a 
line where Shh is misexpressed within the limb as a result of modification to the Zrs 
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(See section 3.22). Mnx1 was similarly misexpressed suggesting that the Zrs does 
indeed function beyond its regulatory domain and is also capable of functioning on 
another developmental gene (Figure 5.7B [iv]).  
 
      Further analysis was used to examine tissue from either the anterior or posterior 
of the limb bud. RT-PCR showed that both Shh and Mnx1 were expressed only 
within the posterior of the limb bud. A β-actin control was shown to be expressed 
equally within both regions (Figure 5.7C). This adds more evidence to Mnx1 
expression being driven by the ZRS as it is expressed within the same region at the 












Figure 5.7: Expression of genes neighbouring the Shh regulatory landscape 
A.  (i) 500bp PCR fragments were generated for the genes Rnf32, Mnx1, Nom1, Cnpy1, Rbm33 
and En2 (labelled).  
(ii) PCR fragments were cloned into the p.Bluescript vector (3 kb) and a restriction digest 
with Not1 and Sal1 used to excise the 500 bp fragment.  
B. In situ hybridisation of 11.5 day embryos for the genes Nom1, Lmbr1, Rnf32, Shh and 
Rbm33. Mnx1 staining performed on limb buds from wild-type (right) and Zrs mutant (left). 
Shh staining on guts and sagittal head of 11.5 day embryo also shown.  Staining of sagittal 
head of 11.5 days embryo rather than whole embryo is shown for Cnpy1 and En-2. RT-PCR 
on cDNA generated from whole wild-type embryos minus head, head only and limb only for 




C. RT-PCR on cDNA generated from tissue of the anterior and posterior of the limb bud for the 
genes Shh and Mnx1 also shown with that of a positive control Actb.  
 
5.10 Is there a topological domain surrounding Shh? 
    While this work was being undertaken, a topological domain stretching from Shh 
past Lmbr1 has been reported for the Shh regulatory region (Figure 5.8A) with a 
definite boundary at the Shh end of the region and a less defined boundary within 
Lmbr1 (Smallwood and Ren 2013). Data generated from the tetraploid 
complementation embryos with regards boundaries suggests that the topological 
domain suggested could indeed be correct. Topological boundary regions are 
believed to be enriched for the insulator binding protein CTCF, as well as 
housekeeping genes, transfer RNAs and short interspersed element (SINE) 
retrotransposons (Dixon et al. 2012) which prevent illegitimate enhancer-promoter 
interactions.  Many known insulator or barrier elements are bound by the zinc-finger 
containing protein CTCF. Within the Shh and Lmbr1 region a number of such sites 
were found, mainly at either end of the regulatory domain. No direct relationship was 
identified between the position of the CTCF sites and the loss of enhancer activity 
(ENCODE 2011).  For example, there is a CTCF site between SBLac2-200 and 
SBLac2-21 (Figure 5.8) but Shh expression pattern does not appreciably change 
(Figure 5.3). At the Shh end of the region, a CTCF site is found between Shh and 
SBLac3-41 (Figure 5.8B) which could play a role in the down regulation of 
expression exhibited by this insertion (Figure 5.4). The gradual loss of expression 
toward the limits of the Shh topological corresponds with multiple CTCF sites; 
however there is no direct correlation suggesting there are additional mechanisms 








Figure 5.8: Summary of the topological domains surrounding the Shh regulatory region 
A. Hi-C analysis from mouse ES cells (taken from the Mouse ENCODE website), and the 
boundaries of the topological domain determined by the directionality index and marked by 
dotted lines.   The relationship between the positions of these features and the genes and 
insertions within the Nom1 to En2 region are indicted.  
B. Below the genes is the track showing the positions of RNA polymerase II and CTCF sites 
(marked with black lines) in E14.5 limb buds taken from ENCODE.  
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C. A summary of relative expression activity driven by individual enhancers in particular tissues 
(Zrs driving expression in the limb bud, SBE2 in the forebrain, SBE1 in the midbrain and 
MACS1 in the laryngotracheal tube) at each of the SBLac insertions. The solid coloured lines 
show an estimate of the relative expression levels throughout the genomic interval. 
Expression at the 5′ end shows that reduction inexpression occurs over an interval of greater 
than 100 kb, whereas limb bud expression is still detectable at the furthest insertion site. 
 
5.11 Conclusions 
          By generating a series of tetraploid complementation embryos from cells 
carrying insertions spanning the Shh regulatory locus it has been possible to 
construct a map of reporter gene activity. Many of the regulators responsible for Shh 
embryonic expression within tissues such as the CNS, gut and limb are well 
characterised (Epstein, McMahon, and Joyner 1999; Lettice et al. 2002; Sagai et al. 
2004; Sagai et al. 2005; Jeong et al. 2006; Sagai et al. 2009) and the combination of 
these can account for the expression pattern seen within this data.  
         Reporter gene activity across the gene desert suggests that position plays a 
minor role in enhancer activity. Regardless of where the reporter gene was positioned 
across the desert it was shown that there was very little change in expression pattern. 
This suggests that the entire region is open for activation. One potential issue with 
this is that some enhancers in particular SBE1 have been reported to function 
alongside redundant sometimes unidentified enhancers, however as only SBE1 
functions at the E11.5 time point it is expected this should not influence the reporter 
output.  These data contrast completely with that which suggests that cis-regulatory 
landscapes function as ‘holoenhancers’ or archipelagos (Montavon et al. 2011; 
Marinic et al. 2013). In these two models it has been suggested that multiple 
regulatory elements, many of which lie inside genes, act together to generate a 
complex developmental expression pattern. The enhancer activity and the expression 
pattern are highly dependent on the position of the gene relative to the regulatory 
elements suggesting a complex interaction of the regulatory elements. The Shh 
developmental locus therefore may represent a more common genomic composition 
(Symmons and Spitz 2013) relying on a regulatory domain primarily composed of 
regulators that contribute to the spatiotemporal expression pattern as a summation of 
the individual enhancer activities.  
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       Variation is seen in terms of the distance in which the various Shh enhancers 
work (Figure 5.8) Both the Zrs and SBE1 were shown to be capable of driving 
expression at large distances even though in the case of SBE1 it is in fact located 
close to the promoter of the gene its acting upon. This suggests that long-range 
activity is something inbuilt into enhancers. The MACS1 enhancer which drives 
expression within the gut was shown to act at long-range and in fact does this better 
than at short range. SBE2, SBE3 and SBE4 which are located within the middle of the 
region have been shown to be the least robust and do not appear to function as well at 
long distances.  
           The Rnf32 gene which is located within the middle of the Shh landscape does 
not appear to be affected by the enhancers surrounding it and positioned within it. It 
has been shown that the actual body of the gene is open for enhancer activity 
suggesting there is something different about the promoter which shields it from 
activity. This is a phenomenon that may be quite common within developmental 
landscapes. Both upstream and downstream of the Shh locus lie several other genes; 
the Shh enhancers do not appear to function much downstream of Shh suggesting the 
presence of a fairly strong genomic boundary. Although some activity is detected 5 
kb downstream by the time the next gene, Rbm33 is reached 100kb further 
downstream it has been lost entirely and instead an entirely different regulatory 
landscape identified (Figure 5.4). The Rbm33 gene itself appears to be in range of a 
putative regulatory element driving expression of Cnpy1 and En2 while like Rnf32 its 
promoter remains refractory to its influence. This suggests that a scenario whereby a 
gene’s promoter being intensive to the enhancers within or close by it (as shown with 
both Rnf32 and Rbm33) could be a common occurrence within regulatory 
landscapes.  
     The boundaries surrounding the Shh regulatory landscape do not appear to be 
absolute.  At the Lmbr1 end of the domain enhancer function is found to tail off 
incrementally within the gene (Figure 5.3). Laryngotracheal expression is also 
reduced between SBLac2-25 and SBLac2-200, while the expression in the lung 
primordium is lost between SBLac 2-200 and SBLac2-21.  Finally, the ventral 
midbrain and the limb expression levels are drastically reduced between SBLac2-21 
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and SBLac3-21 although low levels of Shh in the limb are still detectable within this 
insert and potential the next SBLac3-119. The Zrs therefore appears to function 
upstream of the region where it is responsible for driving expression of Mnx1 within 
the posterior of the hind limb. The Zrs appears to act on Mnx1, whether this for 
functional purposes however remains unclear. Patients with Currarino syndrome 
have been found to have mutations involving deletions within the Mnx1 gene. These 
patients exhibit anorectal, sacral and pre-sacral anomalies however it has not been 
noted whether they show any signs of limb malformation (Holm et al. 2013).  The 
topological domain previously suggested for Shh (Smallwood and Ren 2013) fits 






















        As well as allowing mapping of regulatory activity across a region, the presence 
of LoxP sites both within the initial LHED insertion vector and also within the 
transposed transposable element means the system also provides an experimental 
platform for to generate deletions in mice to look at loss of function effects (Kokubu 
et al. 2009) (Figure 4.1). This technology therefore allows regions within a locus to 
be removed to see how these deletions affect phenotype, as a result of the elimination 
of enhancer or insulator elements. By creating these deletions the dissection of 
enhancer function can be performed. Even as of yet unidentified elements can also be 
identified by this technology, as well as allowing the locus to be disrupted to see how 
this affects the rest of the region.  Additionally, if inserted within the correct 
orientation such a deletion does not remove the LacZ reporter gene meaning that 
reporter gene expression can be used to monitor loss of function effects within a 
regulatory region.  
      As previously discussed (Section 2.8) a number of known enhancers reside 
within the region between Shh and the ZRS. Three insertions distributed across the 
Zrs to Shh region were therefore chosen to generate mouse lines. These were 
generated from the original Shh2_LHED insertion 3ꞌ to the Zrs and located 
approximately 700 kb (SBlac2-120), 500 kb (SBlac2-67) and 100 kb (SBlac120) 
from Shh. These three insertions when treated with Cre recombinase would allow 
nested deletions of firstly MACS1 and MFCS4, and then all three epithelial enhancers 
and finally all three epithelial enhancers as well as the three forebrain enhancers. In 
the final deletion only the known enhancers located closest to Shh which drive 
expression within the midbrain and floor plate would remain, as well as the Zrs 
(Figure 6.1). In addition to removing the enhancers within the region these deletions 
would also serve to disrupt any requirement for the large distance found between Shh 
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and the Zrs and potentially reveal the location of as yet unidentified enhancers or 
regulators.    
 
Figure 6.1: Deletions within the Shh region 
Schematic diagram representing the location of the three deletions generated; g/2-120, g/2-67 and 
g/120 within the Shh region. Enhancers shown as coloured rectangles with the various SBLac 
insertions shown as triangles and the original insertion sites as red triangles demarcated with *.  
 
6.2. Mouse line production 
ES cells were injected into C57Bl/6 embryos to generate chimeras. Chimeras were 
then crossed to C57Bl/6 mice in order to produce F1 offspring, which was confirmed 
by PCR using primers against the LacZ reporter gene and designated with SBLac and 
the insertion number e.g. SBLac120. F1 mice from each of the SBLac lines were 
subsequently crossed to germ line Cre animals (g/Cre) in order to induce a deletion 
between the two LoxP sites (See materials for further details). Primers (Table 3.1 
‘Genotyping LHED deletion 3ꞌ’) were designed either side of the deleted region, 
which would produce a positive PCR band only if the intermediate region was 
removed and tail tip DNA was used to genotype mice. Mice positive for the deletion 
are designated; SBLac
Δchr5: start of deletion-end of deletion e.g. SBLac120Δchr5: 29567195- 28793641 
however for simplicity will be referred to as g/ and their SBLac insert number e.g. 
g/120 for the remainder of this text.  
 
6.2.1 Expression analysis 
        F1 mice from each of the insertions before and after Cre recombinase mediated 
deletion were crossed to CD1 females in order to generate embryos heterozygous for 
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the LacZ reporter gene. These embryos were then harvested at stages between E9.5 
and E14.5 and stained using X-gal in order to map how reporter gene expression and 
thus the activity of the Shh enhancers varied across time and also to determine the 
effect of the three deletions on the expression pattern.  
 
6.2.2 Phenotype analysis 
     Heterozygous F1 mice from each of the deletion lines were found to be to be 
viable and developmentally normal. This was not surprising considering the Shh null 
mutant is also viable and developmentally normal as a heterozygote (Chiang et al. 
1996). Therefore matings were set up to produce homozygotes for each line. 
However genotyping from a number of litters from each of the lines suggested that 
no homozygous pups were found shortly after birth or at weaning it was therefore 
hypothesised that the phenotype could be lethal at embryonic or neonatal stages (See 
Figure 6.2 for numbers). Additional matings were therefore set up with the intent of 
harvesting the pups prior to birth at either early stages to look at LacZ expression or 
later stages of E15.5 and E17.5 in order to examine phenotype. Of the three lines, 
homozygotes were only identified at E12.5 for the largest deletion g/120, this was as 
a result of breeding issues rather than embryo death. A large number of reabsorption 
sites were however identified for all three lines at later stages of development 
suggesting embryo death. All the deletions encompass the Rnf32, which has so far 
not been characterised, however is expressed ubiquitously during development. It is 
therefore possible that homozygous deletion of Rnf32 could be responsible for the 
embryonic lethal phenomenon exhibited in all three of the lines. In order to combat 
this, heterozygous male mice from each of the deletion lines were crossed with 
female mice carrying a Shh null chromosome, in order to generate compound 
heterozygous mice with one remaining copy of Rnf32 and only capable of Shh 
expression from the enhancers not located within the deleted region, these were 
designated with Shh
 -/+





 reflects a compound heterozygote for the g/120 line 
(with + being the wild type chromosome in both cases). Genotyping was undertaken 
on a number of litters post-birth (Figure 6.2) for each of the lines and revealed no 
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mice which were positive as compound heterozygotes.  This again suggesting a lethal 
phenotype was occurring. Embryos were therefore again harvested at early stages 
(E11.5/E12.5) to look at LacZ expression and also later embryonic stages of E17.5 to 
examine phenotype. Compound heterozygotes for each of the lines crossed with the 




* used to denote 
varied craniofacial 
defect** used to 
denote gut phenotype 









Figure 6.2: Mouse crosses and resulting pups 
Mouse crosses set up for each of the lines and actual pup numbers shown for the various stages as 
well as calculated expected numbers based on observed total pup numbers. Lack of expected 
homozygotes/compound heterozygotes suggests embryo death. * used to denote varied craniofacial 




6.3 How do deletions within the Shh region affect enhancer activity and 
development? 
 
6.3.1 LacZ reporter gene analysis of SBLac lines 
     In order to provide a reference to compare each of the lines to embryos from the 
SBLac lines carrying a wild-type chromosome (prior to deletion) were examined. 
The staining pattern within these embryos was found to be consistent across the three 
insertions. All three insertions exhibited a similar expression pattern with regards to 
the tissues of expression with only minor variation in the levels of expression, similar 
to what was previously found within the tetraploid complementation embryos (See 
previous chapter). The SBLac2-67 line, is therefore, shown as a representative for all 
three (Figure 6.2). Within the 9.5 day embryos, expression was found to occur within 
the brain and also within tissues of the floor plate and notochord as well as within the 
gut.  By E10.5, LacZ expression was found extensively throughout the central 
nervous system, the gut and also within the posterior of the limb bud. At E11.5,a 
similar expression pattern was found, with staining present within the CNS, the gut 
and the limb; it was also possible to note expression within the pharyngeal arches. 
The guts were also dissected from the E11.5 day animals with strong expression 
found throughout the structures of the lung, stomach and oesophagus. By E12.5, 
expression began to be detected within structures of the head, it now being possible 
to detect staining within the whisker buds, limb expression was also found to start to 
fade. By E13.5 the expression within the limb was severely reduced and by E14.5 it 
had disappeared completely. Strong expression was also found within the umbilicus 
at E13.5. At E14.5,  LacZ expression was found within individual hair follicles on 
the skin, it was also found strongly within the stomach and covering the taste buds of 
the tongue.   
      One limitation of using LacZ to monitor enhancer activity is perdurance of β-
galactosidase activity may give an erroneous impression of a longer duration of 
activity. It is therefore unknown whether the expression pattern found within the 
embryos reflects the actual presence of RNA transcripts, however as expression is 
shown to turn on and off and also as expression for example in the limb is shown 
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only within the lineage of cells also known to express SHH this does not appear to be 
a problem. Employing RT-PCR or in situ hybridisation would help to confirm this.  
 
 
Figure 6.3: Reporter gene activity in a LHED control line 
LacZ expression analysis of SBLac2-67 heterozygous LHED carrying embryos prior to Cre deletion, 
from stages E9.5 to E14.5. Notochord/floor plate and dissected gut is also shown for E11.5 days and 
gut and tongue for E14.5 days. Magnification of skin of E14.5 day embryo shown in box in bottom 
right hand corner with small box on embryo reflecting where image is taken from.  
 
6.3.2 LacZ reporter gene analysis of g/2-120  
        The mouse line g/2-120 was generated which contains a deletion of 
approximately 80 kb of DNA encompassing the 3’ end of the Lmbr1 gene, Rnf32 and 
two known Shh enhancers MACS1 and MFSC4 which are believed to control Shh 
expression within the epithelium of the gut and pharynx. This was confirmed by PCR 
on tail tip DNA, with primers designed either side of the deleted region.  
       Heterozygous mice were harvested between the stages of E9.5-E14.5 and 
analysed for LacZ expression. Embryos were found to recapitulate the expression 
pattern found within the control SBLac mice in all the tissues of the CNS and the 
limb throughout the stages (Figure 6.4). 
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         The major difference found was a reduction in expression within the gut of the 
embryo of the g/2-120 line. This deletion was found to result in the loss of the 
majority of LacZ expression within the lungs and oesophagus leaving only low-level 
expression relative to other tissues. Expression was also found to be lost from the 
pharyngeal arches, however it was possible to show by dissecting the heads of these 
animals that, like the gut, residual expression remained (Figure 6.5). 
        Later stage embryos containing the g/2-120 deletion were also examined to 
determine expression pattern. E12.5 embryos were found to have a similar 
expression pattern within the face to those carrying a wild-type (undeleted) 
chromosome, with expression found within the whisker buds. At both E13.5 and 
E14.5, embryos also appeared to be fairly similar to the control mouse line and it was 
evident that reporter gene expression was still present within the developing follicles 
of the skin. At E14.5, embryos were also dissected to remove the guts with a similar 
tissue distribution identified to the E11.5 guts whereby a global reduction in 
expression was found as compared to the control. The tongue was also examined at 
this stage and shown to have undergone a loss of reporter expression from the 
posterior of the tongue although not the anterior thus suggesting a previously 
undescribed regionalization of expression.  
        MACS1 and MFCS4 have been reported within the literature as driving 
expression within the gut and pharyngeal epithelium (Sagai et al. 2009). The 
reduction in expression within the tissues of the gut and pharyngeal structures within 
the g/2-120 line suggests this is indeed the case. However, the presence of remaining 
residual staining within the tissues of the gut and pharynx even after deletion of the 
enhancer responsible suggests that a shadow enhancer is present out with the deleted 
region which can drive expression within these tissues. A second gut enhancer SLGE 
has been identified close to Shh (Tsukiji, Amano, and Shiroishi 2013) and thus 
unaffected by the g/2-120 deletion, which is likely to be responsible for driving 





Figure 6.4: Reporter gene activity in the heterozygous g/2120 mouse line 
LacZ expression analysis of following g/2-120 deletion. Embryos stained from E9.5 to E14.5 
including dissected guts and neural tube at E11.5 and gut and tongue at E14.5. Skin follicles also 




Figure 6.5: Reporter gene activity within sagittal head sections from LHED mouse lines 
Sagittal section of embryo head from SBLac120, g/2-120, g/2-67 and g/120 lines. Expression shown 
within the forebrain, midbrain, hindbrain and pharyngeal structures of SBLac120. Region of 
pharyngeal expression highlighted by black box, it is shown to be present within the SBLac120 
control line and although reduced within g/2-120 and g/2-67 some LacZ expression remains (black 
arrows). No pharyngeal expression is however found within the g/120 line.  
 
6.3.3 Phenotype analysis of the g/2-120 line 
         




) were identified at E17.5 from 
crosses of the g/2-120 line with the Shh null line (Figure 6.2). Outwardly these 
animals appeared phenotypically normal with no defects noted within the structures 
of the face or limb (associated with Shh misexpression). As the g/2-120 deletion had 
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resulted in removal of the gut enhancer MACS1 and expression analysis suggested 









 animals. The stomachs of the animals were found to be much 
smaller than litter mate controls and were also abnormally shaped. The intestines of 
these animals were measured and found to be approximately 20% shorter than those 
of the controls (Figure 6.6A).  




 animals were 
fixed and embedded before being sectioned. H&E staining was undertaken on slides 
in order to look at gross morphology of the tissues. There were some obvious 
morphological differences with respect to the mutants and controls. The stomachs of 
mutant animals were found to have an altered morphology as compared to the wild-
type  with the epithelium found to be enlarged and overgrown (Figure 6.6B [ii] 6.6C 
[ii]). Within both the large and small intestine of the mutant eosin staining was seen 
between villi, which does not occur within the control animal (Figure 6.6B [i] 6.6C 
[i]). Eosin is known to stain basic structures such as the cytoplasm, cell wall and 




 animals is 
becoming overgrown. Lungs of both mutant and wild-type mice were found to be 
fairly similar with normal morphology (Figure 6.6B [iii] 6.6C [iii]). 
         Shh null animals have been reported to display overgrown stomach epithelium, 
occlusion of the duodenum by overgrown villi and also intestinal transformation of 
the stomach (See section 2.4). To determine if the latter was also true within g/2-120, 
mutants alkaline phosphatase staining was undertaken. Alkaline phosphatase is 





and wild-type mice were both found to have high alkaline phosphatase activity 





 embryos was found to stain strongly for alkaline phosphatase. The 
stomach of the mutant were not found to have increased alkaline phosphatase 
staining as compared to a wild-type control (Figure 6.6D [ii] E[ii]) thus suggesting 




 mutant stomach is not a result 
of intestinal transformation. Antibody staining was also undertaken using an αSMA 
antibody in order to examine smooth muscle within the stomachs of both wild-type 
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(Figure 6.6F (i) and mutant animals as this is reported to be abnormal within the Shh 
null (Ramalho-Santos, Melton, and McMahon 2000), however again no differences 
were observed (Figure 6.6F(ii)).  
 
Summary 




 mice was found to resemble that 
of  both Wnt5a knock-out and gain of function mice whereby a similar outgrowth 
defect within tissues including the gut is exhibited (Bakker et al. 2013). The 
phenotype observed within the Wnt5a study is hypothesised to be as a result of 
failure of the intestine to elongate suggesting a potential role in cell proliferation.  
Studies of targeted gene deletion and over-expression of Wnt5a using a lung-specific 
promoter showed that Wnt5a, Fgf10, and Shh signalling pathways are functionally 
interacting with Wnt5a negatively regulating Shh signalling in the lung (Li et al. 





 mouse line, similarly to the Wnt5a mutant, could be as a result of changes to 
cell proliferation.   
 




 mutant are not 
as severe as those exhibited within the Shh null mutant. As previously shown by 
reporter gene expression however, the expression within the guts of g/2-120 
heterozygotes was not completely lost, it could be possible this remaining 
expression, potentially from the SLGE enhancer is preventing a more severe 
phenotype. Within the Shh null mice, lungs fail to develop, within the g/2-120 
heterozygous mice reporter gene expression also appears to be vastly down-regulated 
within the lungs suggesting enhancer function is also reduced. Surprisingly animals 
were found to have normal lung morphology. The lack of lung phenotype suggests 
firstly MACS1 may not be the only enhancer driving lung expression, and this could 
be the case as SLGE is also proposed to play a functional role. Additionally, this data 
suggests that SHH is still being expressed within the lungs of the g/2-120 mutant 








   
g/2-120+/- ;Shh-/+







A. Stomach and intestines of E17.5 mouse embryos in both g/2-120+/- ; Shh-/+
  
(top three) and 
wild-type (bottom two) mice. Noticeable size differences in the length of the intestine 
between mutant and wild type mice. Stomachs (black arrow) are also shown to be smaller 
and also misshapen in the mutant as compared to the wild type.  
B. H&E staining of sections from E17.5 (i) wild-type intestine (ii) wild-type stomach lining (ii) 
wild-type lungs. Space is shown between the intestinal villi (black arrow), folding within the 
stomach is shown to be compact (Black arrow head). Lung morphology remains normal.  










lung. Tissue is shown to be present within the villi 
of the intestine (black arrow), the stomach is shown to have lost the tight folding seen within 
the wild type mouse (Black arrow head). The lung morphology is shown to be normal.  
D. Alkaline phosphatise staining of sections from E17.5 (i) wild-type intestine where staining is 
shown to be normal with space between villi (black arrow) (ii) stomach lining which is also 
shown to be normal. 
E. Alkaline phosphatase staining of sections from E17.5 (i) g/2-120+/- ; Shh-/+
  
intestine which is 
shown to stain very darkly with the alkaline phosphatase with no space present between the 
villi (white arrow) (ii) g/2-120
+/-
 ; Shh-/+stomach lining which is shown to stain comparably to 
the wild type control. 
F. Antibody staining against smooth muscles within the stomachs of E17.5 (i) wild type 




compound heterozygote. The stomachs of both animals are 
shown to be comparable.  
 
6.3.4 LacZ reporter gene analysis of g/2-67 heterozygote  
         The g/2-67 line contains a deletion of approximately 248 kb of DNA including 
the 80 kb deleted within the g/2-120 mouse line as well as the oral epithelium 
enhancer MRCS1 and a large amount of both repetitive and unique DNA of 
‘unknown function’. This was confirmed using the same PCR strategy on tail tip 
DNA as used with the g/2-120 line.  Embryos were harvested at stages E9.5-E14.5 
and stained for LacZ expression (Figure 6.7). Expression patterns of the g/2-67 
embryos appeared to be very similar to those seen within the g/2-120 mouse lines.          
        All regions of known Shh expression were recapitulated apart from a reduction 
of pharyngeal expression and again a down-regulation of gut expression at E11.5 
which was maintained until E14.5 (Figure 6.5/6.7). The major difference between 
g/2-120 and g/2-67 was the loss of the oral epithelium enhancer MRCS1. MRCS1 is 
reported (Sagai et al. 2009)  to be responsible for driving Shh expression within the 
epithelia of the incisor and molar teeth as well as the lingual papillae at E12.5. At 
E13.5, expression is within the whisker buds, tooth primordial and the rugae of the 
hard palate. Expression in these domains continues at least until the palatal structure 
is established at E15.5. At E14.5-15.5, the enhancer is also suggested to drive 
expression within the hair and nail buds (Sagai et al. 2009). It is evident that reporter 
gene expression is still present within the whisker buds of the g/2-67 E13.5 day 
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embryos and the developing skin follicles and tongue which had expression similar 
to that of the SBLac control line at E14.5 (Figure 6.7).  The apparent maintenance of 
whisker bud expression within the g/2-67 embryos would suggest that MRCS1 is 
either not required for driving expression within this tissue or alternatively is not the 
only enhancer driving this expression.  
 
 
Figure 6.7: Reporter gene activity in the g/2-67 mouse line 
LacZ expression analysis of following g/2-67 deletion. Embryos stained from E9.5 to E14.5 including 
dissected guts and neural tube at E11.5 and gut, skin and tongue at E14.5. As compared to the SBLac 
control; reporter gene expression is found to be reduced within the tissues of the gut and also lost from 
the pharyngeal arches (black arrow).  
 
6.3.5 Phenotype analysis of the g/2-67 line 




compound heterozygous embryos were harvested at both E11.5 
and E17.5 (Figure 6.2). E11.5 embryos were stained with X-gal and expression 
pattern examined. As compared to the g/2-67 heterozygote (Figure 6.8A[i], the 
compound heterozygote (Figure 6.8A[ii]) had normal expression pattern with regards 
to staining present within the CNS and limbs as well as reduced expression within 
the gut. However some differences were identified with regards to pharyngeal 
expression and in addition the development of the lower jaw appeared to be 





Figure 6.8: Phenotype analysis of the g/2-67 mouse line 
A. X-gal staining of LacZ reporter gene expression within 11.5 (i) g/2-67 and (ii) g/2-67+/-; -
Shh
-/+ 
compound heterozygotes. Non-fused pharyngeal arch shown by black arrowhead, 
whereas the outline of normal jaw development in the heterozygous mouse is highlighted. 
B. (i) Dissected head from E17.5 wild-type mouse embryo showing normal cranio-facial 
development. (ii) Dissected brain from E17.5 wild-type mouse embryo showing normal 
morphology.  
C. (i) Dissected head from E17.5 g/2-67+/-; Shh-/+
 
mouse embryo with altered morphology 




mice exhibiting pointed face phenotype, morphology appears somewhat 
deformed however the brain structures are present.  
Scale bars used to show 100 microns.  
 




mutants were again found to exhibit a facial defect as 




embryos a phenotype was identified whereby the snout appeared pointed and the 
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lower jaw was underdeveloped, the tongue was also completely missing (6.8C [i[). 
The brain itself also appeared smaller and somewhat deformed in shape, however, it 
appeared to have all the correct structures present (Figure 6.9A) (Figure 6.8C[ii]) as 
compared to the brain of the wild type control (Figure 6.8C[iii]) (Personal 
communication Professor David Price). This could therefore be as a result of the 







(Figure 6.9C) were sectioned and stained with 
H&E. However, this failed to show any differences to brain morphology. The skull 
of wild type (Figure 6.9D) and g/2-67 compound heterozygote (Figure 6.9E) mice 
were also sectioned and stained, craniofacial malformations in the form of a 
shortened lower jaw and absent tongue were identified in the g/2-67 compound 
heterozygotes. Again the brain appeared to be abnormally shaped however all the 








mutant whereby an increased amount 




Figure 6.9: Histological analysis of the g/2-67 mouse line 
A. Mouse brain anatomy in the wild type mouse, schematic shown above with H&E staining of 
sagittal sections through the brain of E17.5 wild-type embryo shown below. Brain structures 
labelled.   
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B. H&E staining of sagittal sections through the brain of E17.5 g/2-67+/-; Shh-/+
 
embryo 
exhibiting pointed face phenotype. Brain structures labelled, with no structures found to be 
missing.   
C. H&E staining of sagittal sections through the skull of E17.5 wild-type embryo exhibiting 
normal development. Structures of the brain labelled and whisker buds (WB), cerebral 
cortex, striatum, cerebellum, eye socket (ES) tongue (T) and lower jaw (LJ) indicated.   
D. H&E staining of sagittal sections across the skull of the E17.5 g/2-67+/-; Shh-/+
 
embryo 
exhibiting pointed face phenotype. Structures of the brain labelled and whisker buds (WB), 
cerebral cortex, eye socket (ES), lower jaw (LJ) indicated.  The lower jaw is shown to be 
stunted and curve in under the upper jaw, a white arrow is also used to indicate the missing 
tongue.  
E. (i) H&E staining of sections across the abdomen of an E17.5 wild-type embryo exhibiting 
normal development.   




exhibiting pointed face phenotype. Intestines shown to have dark staining between the 
intestinal villi (black arrow) as compared to the wild-type animal.   
Scale bars used to show 100 microns.  
 
Summary 
        The g/2-67 deletion encompasses the MRCS1 enhancer responsible for 
expression of Shh within the oral epithelium (Sagai et al., 2009) in addition it also 
removes the MFCS4 enhancer which drives some expression within the oral 
epithelium and the palatal shelves of the soft palate (Sagai et al. 2009).  
 
         Within the developing face, mandibular processes give rise to the lower jaw 
skeleton and the pharyngeal epithelium influences the patterning and growth of the 
mandibular skeleton. The first pharyngeal arch (PA1) in mammals gives rise to jaws, 
skull wall, teeth, middle ear and part of the tongue, which is formed at E8.25. The 
arch rapidly increases in size as it is populated by mesenchyme derived from cranial 
neural crest cells (NCCs) (a population of highly migratory multipotent precursors 
that arise at the junction between the prospective neural tube and epidermis during 
early stages of vertebrate development (Gammill and Bronner-Fraser 2003) and 
develops into the mandibular and maxillary arches at E9.5. Shh is required for 
outgrowth of PA1 by regulatory epithelial-mesenchymal interactions that promote 
survival of mesenchymal cells.  Reduction of Shh within the pharyngeal structures 
results in initial formation of a bilateral PA1 which then becomes hypoplastic 
resulting in a single fused structure in the midline by E9.5. Transgenic mice were 
utilised in order to produce NCCs lacking Shh, these were then shown to result in a 
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phenotype including a hypoplastic PA1 with midline or facial defects (Yamagishi et 
al. 2006). The mandibular arch is similar to limb buds in that both rely on 
interactions between mesenchyme and epithelium and both employ many of the same 
key regulatory genes (Schneider 1999). Regulation of limb size is believed to 
function via a signalling feedback loop involving Shh and Fgf8, in which cellular 
interactions are sensitive to distance within the growth field (Allard and Tabin 2009). 
It has been hypothesised that mandibular growth is regulated by a similar signalling 
feedback loop. Shh expression in the pharyngeal endoderm is essential for 
mandibular development, where it directs neural crest survival and outgrowth 
(Ahlgren and Bronner-Fraser 1999; Brito et al. 2006, 2008; Balczerski et al. 2012). 
Exogenous Shh, when placed in the mandibular arch environment, activates Bmp4 
and Fgf8 expression in the oral ectoderm, resulting in the development of 
supernumerary mandibles (Brito, Teillet, and Le Douarin 2008). Development of the 
tongue requires complex epithelia-mesenchymal interactions in order to generate a 
structure capable of multiple biological functions. Shh plays a key role in the 
epithelial-mesenchymal interactions which are necessary for papilliogenesis. During 
early stages of embryogenesis, Shh, Ptch1 and Gli1 are expressed diffusely is the 
tongue (Hall et al. 1999). Shh, Bmp2 and Bmp4 expression is subsequently localised 
to regions of the anterior of the tongue where fungiform papilla form (Jung et al 
1999). Inhibiting Shh with cyclopamine has been shown to result in enlarged papillae 
in ectopic regions (Jung et al. 1999).  
      Shh expression from the pharyngeal structures is therefore suggested to be 
important for lower jaw development. This implies that the pharyngeal enhancer 
would be important for development of the lower jaw; however, a lower jaw defect 
does not appear to result until deletion of both MRCS1 and MFCS4 has been 
undertaken as no facial defects are found within the g/2-120 line. Additionally 
MFCS4Δ/MFCS4Δ mice have previously been described within the literature and 
shown to exhibit defects of the epiglottis but not the face (Sagai et al. 2009).  These 
data therefore suggests that the combination of the function of both these enhancers; 
MFCS4 and MRCS1, are required to pattern the lower jaw.  As both enhancers have 
been shown to be expressed within the both the palatal shelves and the tongue, it 
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suggests these structures are those which are affected by the g/2-67 deletion resulting 
in the observed phenotype.  
6.3.6 LacZ reporter gene analysis of g/120  
 
        The g/120 deletion encompasses a 678 kb deletion including all three Shh 
epithelial enhancers as well as those which drive Shh expression within the forebrain. 
This deletion also brings the ZRS and Shh within 170 kb of each other (Figure 6.1). 
This deletion was confirmed as previously described by tail tip PCR. 
         Again, embryos were generated and harvested at stages E9.5-E14.5 to examine 
reporter gene expression (Figure 6.10). Forebrain expression within these animals 
was missing within embryos from E9.5, however, expression was still found to be 
present within the midbrain, hindbrain and the floor plate. At E11.5 the embryonic 
intestines were completely devoid of any LacZ expression, in contrast to g/2-120 and 
g/2-67 mice in which some degree of residual expression remained. This 
phenomenon was also seen within the guts of E14.5 day embryos thus suggesting an 
additional gut enhancer had been disturbed by this deletion, presumably SLGE which 
is located at close to the insertion site (Tsukiji, Amano, and Shiroishi 2013). The 
same was true of pharyngeal expression which was found to be undetectable. To 
date, no second enhancer has been reported for pharyngeal activity, these data 
however suggests it is possible that one is present (Figure 6.10). Embryos were also 
still found to have expression within the whisker buds and hair follicles as well as the 
anterior tongue within the older embryos. In addition the g/120 mouse line (as well 
as the two smaller deletions) exhibited LacZ expression within the umbilicus. This 
again goes to suggest that yet unidentified enhancers still exist within the region and 
also that the expression found within the umbilicus is separable from that of the gut.  
          Despite Shh and the Zrs now being in such close proximity, limb expression 
still appeared to be normal within embryos at E9.5-E12.5. The g/120 embryos did 
appear to have a slightly higher level of limb bud expression at E13.5 compared to 
the SBLac control; however, this expression was not detectable by E14.5. The E13.5 
embryos analysed were potentially a bit young, therefore this could be as a result of a 
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staging issue; repeating the staining at this stage would serve to confirm this. E11.5 
embryos were dissected and were also found to exhibit a loss of notochord 
expression. Previously, it has been speculated that two notochord enhancers lie 
within 150 kb-600 kb from Shh (Jeong et al. 2006), although neither has so far been 
identified. Notochord expression was still found to be present within the g/2-67 line 
suggesting that the enhancers lie somewhere within the 430 kb between these two 
insertions (96-526 kb from Shh). SBE1 is responsible for the maintenance of Shh 
expression in the midline of the  midbrain and caudal diencephalon from E10.5 
onwards; is believed to act in concert with an additional enhancer which controls Shh 
transcription at earlier time points as well as driving expression within the Zli (See 
section 2.8). As no loss of midbrain or Zli expression occurs within the g/120 line it 
would suggest this additional enhancer is not located within the deleted region.  
 
Figure 6.10: Reporter gene activity in the heterozygous g/120 mouse line 
LacZ expression analysis of the g/120 deletion in heterozygous mice. Embryos stained from 
E9.5 to E14.5 including dissected guts, and neural tube at E11.5 and gut, skin and tongue at 
E14.5.Forebrain expression is shown (black arrow) to be missing from E9.5 onwards. No 
loss of Zli expression was found (white arrow).  No expression is found within the gut at 
either stage and although floorplate expression is still present at E11.5 no notochord enhancer 




6.3.7 Phenotype analysis within the g/120 
        Homozygous pups were identified for the g/120 line at E12.5 and examined for 
both LacZ reporter expression and phenotype (Figure 6.2). While heterozygous 
embryos at this stage (Figure 6.11A), showed normal development with lacZ reporter 
expression within the mid-brain, floorplate, limbs and whisker buds, homozygous 
g/120 embryos were found to have a highly variable phenotype. At the more severe 
end of the scale embryos were completely devoid of the facial structures, leaving 
only proboscis with one single eye located underneath it (Figure 6.11E).  X-gal 
staining performed on these embryos demonstrated only staining within the forelimb, 
with all the structures of the brain, floor plate, notochord and gut devoid of stain. The 
phenotype exhibited in less affected embryos was found to be comprised of an upper 
jaw which appeared to have been split in half (Figure 6.11 B/C). Expression within 
these embryos was present within the midbrain and hindbrain as well as the floor 
plate and limb. However the forebrain LacZ expression was missing as was the 
notochord expression similarly to g/120 heterozygotes. Surprisingly staining within 
the gut (n=2) (Figure 6.11 D) and also the pharyngeal arches was present as was 






Figure 6.11: Phenotype analysis of the g/120 mouse line at E12.5 
LacZ expression analysis within the g/120 homozygote 12.5 day embryos. (A) Normal development 
and staining pattern within g/120 heterozygous mouse. (B/C) variations of moderate mutant 
morphology and staining pattern within g/120 homozygotes. The upper jaws of moderately affected 
embryos shown to be split as demonstrated by the presence of whisker buds (black arrows) on both 
parts of the jaw. The embryo from (C) was dissected and loss of notochord enhancer although not 
floorplate shown in box within bottom right hand corner. The stained gut was also removed from this 
embryo (D). (E) More severe g/120 homozygous phenotype shown with LacZ reporter expression 
only found within the posterior of the limb bud (white arrow). (F) Comparable g/120
+/-; Shh-/+
 
compound heterozygote shown at E12.5 again severe phenotype shown with staining only present 
within the limb buds (white arrow). 
 
 




compound heterozygous embryos were also examined at E12.5 
with animals shown to display a phenotype very similar to that of the severely 
affected homozygote (Figure 6.11F). These were stained with X-gal and again shown 





heterozygous embryos were also examined; similarly to E12.5 there was variation in 





mutants exhibiting a facial phenotype whereby the skull appeared 
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misshapen with a pointed snout and an absent tongue (Figure 6.12B[i]) as compared 










well as the control were removed and found to have no obvious morphological defect 
(Figure 6.12B [ii]) as compared to the wild-type (Figure 6.12A [ii]). The brains were 




mutants (Figure 6.12D) and wild-type 
(Figure 6.12C) appeared to be very similar. The guts of these animals were also 
examined by sectioning them and staining with H&E. Remarkably while the guts of 
both the g/2-120 and g/2-67 animals (Figure 6.6/6.9) were morphologically abnormal 




heterozygote animal (Figure 6.12B [iii]). Instead the gut of this animal was found to 












A. (i) Dissected head from E17.5 day wild type embryo exhibiting normal development. (ii) 
Dissected brain from E17.5 day wild type embryo (iii) H&E stained section taken from 
sagittal section through the abdomen of wild-type E17.5 day embryo. 
B. (i) Dissected head from g/120+/-; Shh-/+
 
E17.5 day embryo exhibiting a mild phenotype. The 
head is shown to be pointed, with a truncated lower jaw which does not appear to have fused 
(black arrow) and missing tongue.  




E17.5 day embryo exhibiting mild facial phenotype. 
Brain was shown to look somewhat morphologically abnormal.  




E17.5 day embryo exhibiting mild phenotype. No differences found with respect to the 
control.  
C. H&E stained section taken from sagittal dissection of a brain from of a wild-type E17.5 day 
embryo. Brain structures labelled and indicated with black line.  
D. H&E stained section taken from sagittal dissection of brain of g/120+/-; Shh-/+ E17.5 day 
embryo exhibiting mild facial phenotype. Brain structures present (labelled and indicated 
with black line).  






compound heterozygote was also identified at E17.5 exhibiting a 
moderate phenotype. This comprised a very obvious facial phenotype; this time the 
animal’s snout was found to resemble a split upper jaw whilst the lower jaw was also 
severely truncated suggesting the pharyngeal arches had not fused. This embryo was 
much smaller than its littermates with respect to body and head size and also 
exhibited a loss of the eyes and its ears also appeared abnormally placed (Figure 
6.13A). Sectioning of the head suggested that although an eye socket was present the 
eye itself was not; the tongue was also shown to be absent. Although neural tissue 
was present within the brain of the animal it was not patterned as expected. The 




animals was that the 
striatum was missing (See Figure 6.9A), the cerebral cortex as well as the 
hippocampus were present although they had collapsed without the support of the 
ventral brain tissues (personal communication Professor David Price) (Figure 6.13B). 
The guts within this animal were also sectioned, and an obvious gut defect was 
identified (Figure 6.13C [ii]). However, unlike the two previous smaller deletions 
where the guts were shown to have increased amount of tissue within the villi with 
respect to the control (Figure 6.13C [ii]) these animals were in fact found to have an 
less tissue within the intestine, which was a similar phenotype to that found within 
the Shh null mice (Figure 6.13E [ii]).  
 




mutant found was one which was most 
similar to the Shh null (Figure 6.13E[i]) with the only difference being this embryo 
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had formed legs and digits (Figure 6.13E[i] F), appearing to be of normal size, 
although twisted potentially as a result of the reduced size of the embryo. Most of the 
head and facial features were missing and the forebrain was found to represent an 





embryos were also found to exhibit a curled tail and a kinked neural tube 





embryo was also sectioned and stained with H&E (Figure 6.13D [ii]), 




embryo as well as the Shh null (Figure 6.13E [ii]); whereby, an increased amount of 

















Figure 6.13: Phenotype analysis of moderate/severely affected g/120 mice at E17.5 
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A. Dissected head from g/120+/-; Shh-/+ E17.5 day’s embryo exhibiting moderate phenotype. 
Split upper jaw indicated by black arrow.  
B. H&E stained section taken from sagittal dissection of skull from g/120+/-; Shh-/+ E17.5 day 
embryo moderate facial phenotype as shown in (A). Cerebellum (Ce), cerebral cortex (CC), 
eye socket (ES), whisker buds (WB), upper jaw (UJ) and lower jaw (LJ) all designated. Split 
upper jaw/proboscis indicated by black arrow. Missing forebrain structures highlighted by 
black arrow head. 
C. (i) H&E stained section taken from sagittal dissection of abdomen of a wild-type E17.5 day 
embryo exhibiting normal development. (ii) H&E stained section taken from sagittal 




E17.5 day embryo exhibiting moderate phenotype. 
Black arrow indicates decreased tissue with regards morphology as compared to wild-type 
embryo.  
D. (i) g/120+/-; Shh-/+ embryo at E17.5 exhibiting severe phenotype including craniofacial 




E17.5 day embryo exhibiting 
severe phenotype presence of decreased tissue indicated by black arrow. 
E. (i) Shh null embryo at E17.5 exhibiting craniofacial phenotype and truncated limbs. (ii) H&E 
stained section taken from abdomen of Shh 
-/-
 E17.5 day embryo presence of increased space 
indicated by black arrow. 
F. g/120+/-; Shh-/+ embryo at E17.5 (left) versus Shh null embryo at E17.5 (right) showing size 
difference between embryos.  
Scale bars used to show 100 microns.  
 
Summary 




mouse mutant could be 
attributed to the loss of the oral epithelial enhancer. However; as both, the severe and 




phenotype it would suggest that forebrain expression of Shh is also important for the 
development of the face. Data from HPE3 patients who carry translocations with 
breakpoints 250 kb upstream of SHH have been shown to exhibit forebrain and mid-
face defects including a mild HPE craniofacial defect, aplasia of the premaxilla, 
hypotelorism, midline cleft lip and hearing loss (Belloni et al. 1996). SBE2 is found 
250 kb from SHH which would therefore be disrupted by such a breakpoint.  
     The embryonic telencephalon, which is located at the most rostral end of the 
neural tube, is divided into the dorsal telencephalon, which gives rise to the 
neocortex, and the ventral telencephalon, which forms the striatum and is the origin 
of cells that populate the olfactory bulb, globus pallidus, and some cells that also 
populate the cortex (Evans et al 2012). Shh is first secreted from the notochord, 
which underlies the posterior structures of the brain (Echelard et al. 1993; Roelink et 
al. 1995; Ye et al. 1998). Shh operates through a concentration gradient that spans 
the DV axis of the brain at different time points to confer different neuronal identities 
on the developing precursors, and expression is first seen in the ventral telencephalon 
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from E11.5 (Kohtz et al. 1998; Jessell 2000). Shh expression directs neural 
progenitors to a ventral fate and importantly is both necessary and sufficient to 
induce specific ventral forebrain markers (Chiang et al. 1996). Shh is expressed in 
the ventral telencephalon where it interacts with the Gli proteins and is thought to 
maintain Fgf8 expression as well as induce expression of forebrain markers (Ohkubo 
et al. 2002).  
     The inhibition of the Gli3 repressor complex in the ventral region facilities 
telencephalon development; therefore, the primary function of Shh is to prevent the 
production of excessive Gli repressor. In Shh null mutants, the ventral markers Dlx2, 
and Gsx2 are reduced, whereas in Gli3 null mouse mutants the expression pattern of 
these genes is extended dorsally (Rallu et al. 2002). Shh null mutants show more 
severe telencephalon abnormalities than the Gli3 null mice (Grove et al. 1998; Theil 
et al. 1999). In Shh mutants, there is a loss of ventral telencephalic cells leading to an 
altered morphology of the ventral telencephalon together with the ectopic expression 
of dorsal forebrain markers (Chiang et al. 1996; Rallu et al. 2002). However, if Shh is 
knocked-out at E8.5, there are severe defects of all ventral telencephalic regions 
(Fuccillo et al. 2004). However, in knockouts at E10-12 using a Nestin-Cre, there are 
limited defects in ventral telencephalic patterning and cortical interneurons are 
affected rather than gross patterning deficits (Xu et al. 2005). Therefore between E9 
and E12.5, Shh acts mainly by inhibiting the formation of the Gli3 repressor and 
contributes to the establishment of DV patterning (Chiang et al. 1996; Rallu et al. 
2002; Fuccillo et al. 2004). Secondly, SHH signalling also supports the expansion of 
progenitors of the ventral telencephalon by inducing and maintaining the expression 
of Nkx2.1 until at least E14 and later into neurogenesis (Xu, Wonders, and Anderson 
2005). 
         Shh is produced by multiple epithelia in the head including forebrain neuro-
ectoderm, frontonasal and maxillary ectoderm and pharyngeal endoderm (Marcucio 
et al. 2005). Studies conducted in mammals and birds suggest that the severity of 
HPE defects correlate with the stage in which interruption of signalling occurs. Null 
Shh mutations within the mouse disrupt neural plate patterning and cause cyclopia. 
Disruption of Shh expression by the teratogen cyclopamine (See section 2.6) results 
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in a varied phenotype, with the time-point at which Shh signalling response is lost 
being pivotal for phenotype. If cyclopamine exposure takes place before Shh is 
established in the telencephalon, embryos had a single fused telencephalic vesicle 
and also exhibited extreme hypotelorism. In these cases the facial defects arose as a 
consequence of the underlying structural alterations in forebrain architecture. By 
contrast, if cyclopamine was delivered after Shh expression was established in the 
forebrain but before its induction in the face, embryos had two well-delineated 
telencephalic vesicles that were morphologically and histologically normal. However 
despite the normal appearing brains the embryo was still shown to exhibit severe 
hypotelorism and were found to down-regulate target genes in the adjacent 
mesenchyme, which leads to a narrow and truncated face as a result of patterning 
defects (Marcucio et al. 2005; Chong et al. 2012).  
 
        NCCs are also likely to play a role; their diverse fates include several cell types 
within the peripheral nervous system, melanocytes, endocrine cells, and most of the 
bone, cartilage, and connective tissue of the face and skull (Santagati and Rijli 2003). 
NCCs that contribute to the face originate from the caudal forebrain, midbrain, and 
rostral hindbrain. These cranial neural crest cells (CNCCs) follow well defined paths 
to the ventrolateral side of the head, where they populate the mesenchyme of the 
facial primordia such as the frontonasal prominence (FNP) and pharyngeal arch; 
(Osumi-Yamashita et al. 1994; Kontges and Lumsden 1996). Once positioned, the 
NCCs proliferate and differentiate into distinct craniofacial elements (Helms and 
Schneider 2003; Santagati and Rijli 2003). Mice in which Shh has been inactivated 
within the NCC appear indistinguishable from the wild type embryos until E10.5, 
when they have slightly smaller FNPs and mandibular lower jaw. The growth 
deficiency of the Shh NCC mutant facial primordia is very obvious by E12.5, and as 
a result, mice are born with a dramatically truncated face and also lack a tongue 
(Jeong et al. 2004). It is suggested that the role of SHH within NCC is to support cell 
survival during early stages and promotes proliferation at later stages to control the 




           Expression of Shh within the notochord has been shown to be important for 
patterning of the floorplate, hind-brain and mid-brain (See section 2.3). Experiments 
have also shown that if the notochord is separated from midbrain floor plate during 
development, the brain vesicles exhibit abnormal folding and collapse (Britto, 
Tannahill, and Keynes 2002).  The g/120 mouse line has been shown by reporter 
gene analysis to result in a loss of expression within the notochord at all stages 
examined. 
 
      Expression of Shh and its many roles in the development of both the face and 
brain is therefore complex. The variable phenotype seen within the g/120 mouse 
could therefore be as a result of various factors. Temporal changes may play a role 
whereby embryos in which Shh has been lost from the forebrain earlier may result in 
the more severe forebrain phenotype, whereas, those where the expression has been 
lost later result in milder defects. Reporter gene analysis suggests that LacZ 
expression is lost from E9.5 in the g/120 heterozygote (Figure 6.10). Whereas 
staining of the homozygote embryos, even with the milder phenotype suggests 
forebrain expression appears to be missing from E12.5 days (Figure 6.11) (younger 
embryos were not examined) suggesting no temporal changes were found with 
regards to loss of enhancer activity. Alternatively the variation in forebrain 
phenotype could therefore be a result of genetic rescue within the milder phenotype. 
How this could be occurring remains unclear; Shh is known to be a diffusible 
morphogen capable of working at large distances. Shh has also been shown to 
emanate from various structures including the Henson’s node and pattern the 
forebrain. Ihh has been suggested to be capable of rescuing deleterious phenotypes 
within the CNS (Wijgerde et al. 2002). Additionally, the HPE phenotype results in a 
broad spectrum of clinical phenotypes observed in families with identical mutations. 
This variation in has been attributed to there being a threshold of SHH protein; below 
this threshold causes a phenotype, above does not (Jeong et al. 2008). It could 
therefore be proposed that Hh signalling from other tissues, especially if the 
threshold levels are low could be responsible for rescuing the forebrain defect.  
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The variation in phenotype could also be attributed to result from the compound 
effect of the loss of notochord and forebrain Shh expression. The milder phenotypes 
could, therefore, be as a result of only forebrain disruption; whereas, the more severe 
phenotypes as a result of disruption of SHH expression in both tissues leads to the 
collapse of the structures of the brain and floorplate. Reporter gene expression 
analysis of both compound heterozygous and homozygous embryos at E12.5 could 
support this theory (Figure 6.11). Within the more severely affected embryos, 
enhancer expression within tissues such as the hindbrain, mid-brain and floorplate 
were also missing. Due to the severity of the phenotype within these embryos this 
was hypothesised to be as a result of the failure of these tissues to form; i.e., if the 
tissues did not develop it would not be possible to detect LacZ expression within 
them. This theory also suggests that rescue of tissues by very low level SHH protein 
production is likely to be occurring within tissues of milder affected embryos.  
          Although g/120 heterozygous embryos were shown to lose reporter gene 
expression within the gut and pharyngeal arches, the homozygotes with milder 
phenotypes were actually found to have LacZ expression within these tissues (Figure 





also shown to have normal gut morphology (Figure 6.12) as opposed to both the g/2-
120 (Figure 6.13) and g/2-67 lines (Figure 6.9). This suggests some form of 
mechanism exists whereby enhancer function can be rescued. Critical developmental 
control genes sometimes contain ‘shadow’’ enhancers that can be located at large 
distances and in locations, including the introns of neighbouring genes. They 
nonetheless produce patterns of gene expression that are the same as or similar to 
those produced by primary enhancers. Gene expression levels naturally fluctuate 
between individuals in a population and between cells in a tissue. Genetic variation 
and environmental instability can exacerbate these differences. If the expression of a 
developmental regulator dips below a minimum threshold level, cell fate 
specification or differentiation will be affected, which can result in a morphological 
defect. Developmental programs can be buffered against minor variations by 
maintaining super-threshold expression levels of important regulators. Shadow 
enhancers help foster robustness in gene expression in response to environmental or 
genetic perturbations (Frankel et al. 2010; Hobert 2010; Perry et al. 2010). The SLGE 
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enhancer which had recently been identified is believed to represent one such 
shadow enhancer which works in combination with MACS1 to drive expression 
within the gut. The g/2-120 versus g/120 deletion lines suggests that loss of MACS1 
but not SLGE prevents a complete loss of reporter gene activity within the gut as well 
as more severe gut defects (Figure 6.7/6.10).  It is therefore entirely possible that 
additional shadow enhancers also exist which are capable of rescuing Shh expression 
in a number of tissues.  
 
 
6.4 How does the presence of multiple promoters affect enhancer 
activity? 
 
        Within the developing embryo enhancers are rarely permitted promiscuously to 
activate transcription from non-target promoters. Chromatin structural organization 
and insulators are thought to play a role in regulating enhancer-promoter interactions 
(Celniker and Drewell 2007; Wallace and Felsenfeld 2007; Bushey et al. 2008). 
Previous work (see section 5.11) also suggests that the promoters of certain genes 
such as Rnf32 and Rbm33 present within the cis-regulatory regions of Shh and En-2 
are refractory to enhancer activity. Positive and negative control regions have been 
shown to be shared between promoters within adjacent Hox genes (Sharpe et al. 
1998). Enhancer elements have also been shown at the HoxD locus to activate 
neighbouring genes, a so called ‘bystander effect’ (Spitz, Gonzalez, and Duboule 
2003). This is believed to be either as a consequence of chromatin activation of a 
region or alternatively due to ‘promoter competition’ providing a way to filter out 
some enhancer activity from the target promoter. Various examples of loss or gain of 
expression have been reported following transgene insertion at the proximity of 
regulatory elements (Olson et al. 1996; Sharpe et al. 1999; Qin et al. 2004; Aubert et 
al. 2010)  potentially caused by complex titration-like mechanisms of either positive 
or negative regulations. 
 
        The LHED system which was utilised to distribute the LacZ reporter gene 
throughout the Shh region provided a means to examine whether the enhancers 
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surrounding Shh are firstly capable of activating more than one promoter within a 
tissue and also whether any form of promoter competition exists.  
 
         The SBLac120 mouse line contains the SBLac insertion approximately 100 kb 
from Shh prior to Cre recombinase-generated deletion. SBLac120 mice were crossed 
to generate mice homozygous for the insertion i.e. had a LacZ reporter complex 
including a HSP68 promoter located 100 kb from Shh (Figure 6.14A). Generating 
these homozygotes would enable investigation of whether enhancers within the 
region can activate both the LacZ reporter gene and the Shh gene within the same 
tissue, determined by whether development of these tissues remains normal despite 
activation of LacZ. 
 
 
Figure 6.14: The effect of multiple promoters within a genomic locus 
A. Schematic diagram illustrating the presence of the LacZ reporter genes, one on each 
chromosome (blue rounded rectangle) including promoter inserted 100 kb from Shh. 
Presence of various enhancers designated by coloured rectangles and genes by grey 
rectangles. Insertion sites of the three SBLac lines investigated shown by black arrow heads.  
B. (i) LacZ expression analysis of E11.5 SBLac120 embryos within heterozygous mice. 
Expression found within the CNS, gut epithelium and posterior limb bud (ii) LacZ expression 
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analysis of E11.5 SBLac120 embryos within homozygous mice, missing expression from the 
forebrain with abnormal expression found within the facial structures and a facial defect also 
observed (iii) Developing pharyngeal arches within the SBLac120 heterozygous embryo 
shown in (i). Development appears to be normal. (iv) Developing pharyngeal arches within 
the SBLac120 homozygous embryo shown in (ii) fusion of the pharyngeal arches has not 
occurred (black arrow head).  
C. (i) LacZ expression analysis of E11.5 SBLac2-120 heterozygous embryos exhibiting normal 
expression pattern found in the CNS, gut and limb. (ii) LacZ expression analysis of E11.5 
SBLac2-120 homozygous embryos also found to exhibit a normal expression pattern. 
D. (i) LacZ expression analysis of E12 SBLac2-67 heterozygous embryos, exhibiting normal 
expression pattern in the CNS, gut and limb. (ii) LacZ expression analysis of E12 SBLac2-67 
homozygous embryos exhibiting normal expression pattern.  
 
 
         No SBLac120 homozygotes were found after birth suggesting that the 
phenotype generated could be lethal (Figure 6.2). Embryos were therefore harvested 
at both E11.5 days and E17.5 days, with SBLac120 homozygotes identified at these 
time points. At E11.5 days embryos were assessed for phenotype and also stained 
with X-gal in order to analyse LacZ reporter expression. At 11.5 days LacZ reporter 
expression was found throughout the CNS, gut and limb of heterozygous SBLac120 
embryos and no abnormal phenotypes were observed (Figure 6.14B [i/iii]). In 
contrast, homozygous SBLac120 embryos were found to have malformed facial 
development with a somewhat shortened face and also non-fusion of the pharyngeal 
arches, the rest of the embryo including the limb however appeared normal (Figure 
6.14B [ii/iv]).  With respect to LacZ expression, despite having two copies of the 
LacZ reporter gene the overall expression pattern (with the exception of the limb 
bud) appeared to be less intense than the heterozygote carrying one copy. A normal 
expression pattern equivalent to the heterozygote was found within the neural tube as 
well as the limbs, gut and midbrain. The forebrain expression was missing, whilst 
within the pharyngeal structures mis-expression appeared to have occurred. Embryos 
were also generated in order to examine homozygous embryos from both the 
SBLac2-120 (Figure 6.14C) and SBLac2-67 (Figure 6.14D) lines so as to examine 
the effect of multiple promoters at other regions within the locus. These embryos 
were harvested at approximately E11.5 and stained using X-gal to look at LacZ 
reporter gene expression. Surprisingly the expression pattern did not appear to differ 
between the homozygotes (Figure 6.14C/D [ii]) and heterozygotes (Figure 6.14C/D 





         At E17.5 days SBLac120 homozygous embryos were again shown to have 
variable cranio-facial phenotypes as compared to the SBLac120 heterozygous 
embryos (Figure 6.15A). Homozygous embryos had a reduced bottom jaw with or 
without the presence of a tongue (Figure 6.15 B/C).  In addition, homozygotes 
appeared to have shortened snouts, as well as a somewhat pointed faces as compared 
to heterozygotes, both phenotypes previously attributed to loss of late Shh forebrain 
expression (Marcucio et al. 2005; Chong et al. 2012). The heads from the 
homozygous embryos were sectioned and staining with H&E was undertaken. From 
this it was shown that both the upper and lower jaw was truncated, with the tongue 
present within one embryo but not the other (Figure 6.15 B/C [iii]). The forebrain 
was also disrupted as compared to a wild-type animal (Figure 6.14 A [iii]) with the 
cerebral cortex being present, however, with no structures of the forebrain such as 
the striatum present underneath (Figure 6.15 C/D [iii]) (See Figure 6.9A). The rest of 
the embryo appeared phenotypically normally with no outwardly adverse effects to 
the gut or limb exhibited.  The guts were sectioned and stained with H&E (Figure 
6.15 D (ii)) and found to be comparable to those of a wild-type control (Figure 6.15 
D (i)). Overall the craniofacial defects exhibited within the SBLac120 homozygotes 
would suggest that these embryos were suffering from defects of the forebrain 






Figure 6.15: Phenotype analysis of SBLac120 homozygous mice at E17.5 
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A. Front (i) and side view (ii) of E17.5 head of a wild-type mouse showing normal cranio-
facial development. (iii) H&E stained section taken from sagittal section of skull from a 
wild-type E17.5 day embryo exhibiting normal facial development.  Eye socket (ES), 
tongue (T), upper jaw (UJ) and lower jaw (LJ) all designated and brain structures 
indicated.  
B. (i) Front and (ii) side view of E17.5 head of SBLac120 homozygote mouse showing one 
presentation of abnormal cranio-facial development including shortened/pointed face 
and shortened lower and upper jaw (iii) H&E stained section taken from sagittal section 
of skull from SBLac120 homozygous E17.5 day embryo shown in (i/ii) exhibiting facial 
phenotype. Eye socket (ES), Tongue (T), whisker b (WF), upper jaw (UJ) and lower jaw 
(LJ) all designated and brain structures indicated. Black arrow head used to indicate the 
loss of forebrain structures such as the striatum.  
C. (i) Front and (ii) side view of E17.5 head of SBLac120 homozygote mouse showing 
second example of abnormal cranio-facial development  including shortened/pointed 
face and absent or missing lower jaw (iii) H&E stained section taken from sagittal 
section of skull from SBLac120 homozygous E17.5 day embryo shown in (i/ii) 
exhibiting facial phenotype. Eye socket (ES), Tongue (T), whisker follicle (WF), upper 
jaw (UJ) and lower jaw (LJ) all designated and brain structures indicated. Black arrow 
head used to indicate the loss of forebrain structures such as the striatum. Black arrow 
indicates the loss of the tongue.  
D. (i) H&E stained section taken from a section of abdomen of a wild-type E17.5 day 
embryo exhibiting normal development. (ii) H&E stained section taken from a section of 
abdomen of a SBLac120 homozygous E17.5 day embryo exhibiting facial defect but no 
gut abnormalities.  


















6.5.1 Expression analysis 
 
 
Figure 6.16: How do deletions within the Shh region affect reporter gene expression and 
phenotype? 
Top: Shh locus shown with each enhancer represented by a coloured bar, location of the original 
LHED insertion site, S32, shown as a red triangle. The location of the three re-insertions used to 
generate the lines g/2-120, g/2-67 and 6/120 represented by black triangles and the region deleted 
within these lines shown by dotted line. Bottom: Activity of the Shh enhancers within the wild-type 
embryo shown, with the tissues of activity colour coordinated with the enhancers shown above. 
Expression found within the CNS, epithelial linings and the limbs. Enhancer activity following each 
of the deletions showed which results in loss or reduction of enhancer activity within various tissues. 
Phenotypes generated in each of these lines also stated.  
165 
 
          All three deletion lines were shown to result in changes to expression across 
the embryonic time course; however, none appeared to affect the temporal 
expression pattern but instead the spatial pattern only, with one exception being the 
limb buds within the g/120 line which needs to be further examined. Each expression 
pattern was shown to reflect that of a deletion of the corresponding enhancer with the 
g/2-120 line resulting in loss of gut expression, and g/120 resulting in loss of gut and 
forebrain expression. Unexpectedly however, loss of the oral epithelial enhancer 
within SBLac2-67 (and SBLac120) did not appear to effect whisker bud expression 
as hypothesised. The expression patterns also demonstrated the modular nature of the 
Shh enhancers. A number of Shh enhancers have already been identified which also 
include secondary enhancers responsible for driving expression in the various tissues. 
The three deletions generated within this study show that deletion of one enhancer 
does not affect the activity of the remaining enhancers in the region i.e. it is possible 
to remove the gut and forebrain enhancers without disrupting activity of the Zrs or 
mid-brain enhancer SBE1(Figure 6.16).  This suggests that the Shh region is not 
behaving in the nature of an archipelago or holoenhancer such as that reported for 
other developmental regulatory landscapes within the literature (Montavon et al. 
2011; Marinic et al. 2013) but instead each enhancer is independent of the others, 
with even secondary enhancers playing independent roles. The order of the Shh 
enhancers was established in early vertebrate evolution and is highly conserved 
(Hadzhiev et al. 2007). It has been suggested that this conservation means that this 
conserved landscape is important for enhancer function; however this seems unlikely 
to be the case. Deletions of up to 700 kb of DNA from this region do not appear to 
affect how the remaining enhancers behave. The Zrs, in particular, is located nearly 1 
Mb away from Shh and it was believed that this distance could be important to 
function; however, reducing the distance does not appear to result in major changes 
to reporter gene expression (Figure 6.16).  
            The gut enhancer MACS1 and pharyngeal enhancer MFCS4 were deleted 
within all three lines however a complete loss of reporter expression within the gut 
was not seen until the largest deletion was undertaken (Figure 6.16). The SLGE 
enhancer has recently been identified as an additional gut enhancer which is 
comprised of 1.7 kb of sequence reported to lie ~100 kb from Shh. The g/120 
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deletion is located 96kb from Shh and appears to lie close to the SLGE enhancer and 
could thus capable of disrupting its function (Figure 6.16). The loss of the additional 
expression within the gut could therefore be as a result of the inactivation of SLGE 
however, what causes complete loss of pharyngeal expression remains unknown. 
           None of the three mouse lines resulted in a loss of expression within either the 
whisker buds or the skin follicles. Mice develop a coat containing four distinct types 
of hair in addition to several specialized hairs such as vibrissae (whiskers) and tail 
hair. The generation of such diversity of hair types is due to signalling pathways that 
drive the patterning and induction in a specific spatial and temporal manner 
(Duverger and Morasso 2009). Shh has been shown to play an important role in both 
embryonic and adult hair development. During embryogenesis, Shh is expressed in 
the proliferating epithelial cells at the distal tip of the developing follicle (Bitgood 
and McMahon 1995; Iseki et al. 1996). In mice lacking Shh, mature hair follicles fail 
to develop although hair follicle formation is initiated and the dermal condensates 
form, suggesting that Shh is required for the proliferation and subsequent down-
growth of the follicular epithelium, and for the maturation of the dermal papillae 
(Chiang et al. 1996; St-Jacques et al. 1998; Karlsson et al. 1999). Treatment with a 
Shh-blocking antibody has also been shown to cause reversible alopecia, as follicles 
become arrested, indicating that SHH is also required for hair cycling in postnatal 
skin (Wang et al. 2000).  
    In mice, the development of vibrissae follicles starts at E12.5, and at birth, 
vibrissae hair shafts have already emerged.  By E14.5 the wild-type whisker pad on 
the upper lip has been shown to consist of a vertical row of four large hair follicles 
alternating with five rows of varying numbers of follicles (Mill et al. 2003). Mice 
mutated in the Eda/Edar pathway (related to the tumour necrosis family (TNF)) form 
vibrissae at E12.5, while they do not form primary coat hair placodes at E14.5. In 
contrast mice mutated in the Noggin/Lef1 pathway do not form vibrissae at E12.5 or 
secondary hair placodes at E16.5, but do form primary coat hair placodes at E14.5 
(Botchkarev et al. 2002). Therefore, even though vibrissae are induced prior to the 
initiation of coat hair development, the mechanisms involved in vibrissae 
development seem to be more closely related to the induction of secondary coat hair 
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placodes than to the induction of primary coat hair placodes. Although follicle 
morphogenesis within the skin is completely abolished in Shh
−/−
 mice, whisker 
follicles are reported to still develop in Shh
−/−
 mice as well as in Gli2
−/−
 mice   (Mill 
et al. 2003).  
     The MRCS1 enhancer drives Shh expression within the oral epithelium as well as 
the whisker buds and the developing hair follicles (Sagai et al. 2009). The three 
deletion lines suggest that regulation may be more complex with all three shown to 
retain reporter gene expression within both the whisker buds and hair follicles. 
Although Shh is expressed in both tissues it does not appear to have the same role, 
with it being pivotal for hair follicle development but not whisker barrel. Therefore, 
it is difficult to determine whether a single enhancer or multiple enhancers are 
required for driving expression within the two tissues of the hair follicles and 
whisker buds.  
      Although speculated from BAC analysis that potentially two Shh notochord 
enhancers exist within the Shh regulatory region 150 kb-600 kb upstream of the gene 
(Jeong et al. 2006) these have previously never been pinpointed. The notochord 
enhancer function appears to be removed between the g/2-67 and g/120 deletion 
suggesting these enhancers lie somewhere in the region between 100 and 530 kb 
upstream of Shh.  
 
6.5.2 Phenotype analysis 
 
         All three deletions within the Shh-Zrs region were examined both as 
homozygotes and also with a Shh null allele within compound heterozygotes. From 
the litters examined so far no homozygous animals were found at birth, at E17.5 days 
or at E15.5 however they were found at E12.5 from the g/120 line (Figure 6.2). 
Resorbed sites were also present at E17.5 and E15.5 suggesting some degree of 
embryo death at these stages. The lack of embryos homozygous for these deletions 
could suggest that homozygous deletion of even as little as 80 kb results in lethality 
at later stages in development. The Rnf32 gene resides within this region and is 
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deleted within all three mutants. It has also been shown to be ubiquitously expressed 
from early stages during development but no mouse mutants have been identified 
(See section 2.11). Embryonic death between the stages of E9.5-E12.5 is usually a 
result of placental failure, membrane abnormalities, cardiovascular abnormalities 
including blood vessel development and heart failure, abnormal yolk sac formation, 
loss of cell cycle regulation or defects in patterning (Papaioannou and Behringer 
2012; Ward et al. 2012). By contrast, death between the stages of E12.5-E19.5 is 
often as a result of haematopoietic and neuronal abnormalities (Papaioannou and 
Behringer 2012; Ward, Elmore, and Foley 2012). Although the role of Rnf32 is yet to 
be determined it could have a role in the haematopoietic system and thus result in 
mid-gestational death. The deletion of Rnf32 within all three mouse lines could 
therefore be the cause of the lethality. Another ring finger gene; Rnf213 has been 
shown to be involved in vasculopathies (Kobayashi et al. 2013).   
 
        The g/2-120 line was found to result in a gut defect potentially due to 
proliferation defects based on the similarities between it and Wnt5a mutations. The 
g/2-67 line was shown to result in a lower jaw defect; this is likely as a result of the 
loss of pharyngeal and oral epithelial Shh expression and again could potentially be 
as a result of changes to proliferation.  The g/120 line was found to exhibit a highly 
varied phenotype affecting the structures of the face and brain. Why there is variation 
with regards to phenotype remains unclear, the HPE and PPD phenotypes are highly 
variable with related individuals carrying the same mutation exhibiting very different 
phenotypes. This has been hypothesised to be as a result of genetic factors but also as 
a result of variations in SHH protein levels within individuals. It is believed that 
there exists a threshold for SHH protein levels above which no phenotype is 
observed. However if protein levels are found to be below the threshold severe 
malformation can occur. Inheritance of HPE and PPD in humans is complex as 
haploinsufficiency is found at the SHH locus, however, variations have also been 
identified in mice.  Recently it has also been shown that attenuated expression 
produced by a Zrs 3′ end deletion within mice revealed variability inherent in 
regulating digit number. The variation in the limb phenotype ranged from a Shh null 
phenotype in the fore limbs to two to four digits with deletions and fusions of tarsal 
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and metatarsals in the hind limbs and has been attributed to protein levels and 
temporal extent of exposure (Lettice et al. 2014).  Temporal changes in when Shh 
expression is lost could also go some way to explain the variation seen within the 
g/120 line. Shh is known to be expressed within several signalling centres within the 
face with expression from the forebrain being important at early stages for forebrain 
development and at later stages for development of the upper jaw and nose 
structures. It has previously been shown that the timing of Shh loss within the 
forebrain can affect whether a forebrain or facial defect is observed (Marcucio et al., 
2005, Chong et al., 2012).  
 
      Genetic rescue could also play a role in the observed varied phenotype. As only a 
low level of Shh protein is required to reach a normal development threshold it is 
possible that expression from yet unidentified redundant/shadow enhancers or due to 
rescue from other sources of Hh could result in varying the phenotype. This could 
suggest why, for example, the mildly affected g/120 embryos appeared to have 
rescued the gut phenotype that is present in the smaller deletions. However 
expression analysis within both compound heterozygous and g/120 homozygote 
embryos suggests that a different mechanism could be at play. Staining of these 
embryos to examine reporter gene expression shows that within those with a severe 
phenotype reporter gene expression is lost from all tissues except those of the limb. 
This could suggest that the tissues such as the floorplate, mid-brain and gut have not 
formed. The notochord source of Shh extends into the floorplate and brain where it is 
required for ventrally patterning a number of cell types within the hindbrain and 
midbrain. Loss of this source of Shh results in collapse of the brain structures (As 
previously described Section 2.3). The g/120 deletion has been shown to result in 
loss of reporter gene expression within the notochord suggesting one or several 
enhancers are present within the deleted region which could drive expression here. It 
is possible therefore that the severe phenotypes are as a result of loss of both 
forebrain and notochord expression whereas in the less affected animals some or 




    The alternative explanation is that the g/120 deletion disturbs the region in a way 
that even enhancers which have not been deleted are affected. This seems unlikely; 
expression analysis within heterozygous animals suggests the remaining enhancers 
function normally both temporally and spatially (Figure 6.10), additionally within the 
homozygous and compound heterozygous animals the Zrs is still found to function 
(Figure 6.10). Previous reports within the literature suggest some developmental loci 
function as archipelagos or holoenhancers where each of the component parts being 
important for the overall expression pattern (Discussed section 2.15.1). In such a 
scenario loss of one component part can result in an uncoupling of the entire domain.  
Although redundant/shadow enhancers have been identified at the Shh locus, no 
evidence has so far suggested that it behaves as a holoenhancer or archipelago, 
instead it is proposed that each of the individual enhancers will function regardless of 
the presence of the remaining enhancers.  
 
 
6.5.3 The effect of multiple promoters on enhancer activity 
 
        Mouse lines were also generated in order to examine the effect of multiple 
ectopic promoters on enhancer function. Mice homozygous for both the SBLac2-120 
and SBLac2-67 lines appeared developmentally normal and were capable of 
recapitulating a LacZ expression pattern similar to the heterozygote (Figure 6.14). 
These data, therefore, suggest that it could indeed be possible for an enhancer to 
contact two promoters within a single tissue, as shown by the fact that the enhancers 
within SBLac2-120 and 2-67 homozygote embryos are capable of contacting LacZ as 
well as Shh (as suggested by the lack of phenotype). However the phenotype and 
changes in expression pattern exhibited within SBLac120 homozygotes suggests this 
is not always the case.  The overall expression pattern within SBLac120 homozygote 
embryos was found to be less intense than that seen within the heterozygote despite 
carrying two copies of LacZ, suggesting that although the enhancer is capable of 
driving both the promoters within the same tissue, it is at a reduced amount 




        Both the forebrain and facial enhancers appear to be more susceptible to the 
interference of the extra promoter within SBLac120 homozygotes as compared to the 
enhancers such as the Zrs as well as those within and close to the Shh gene. This 
could suggest that these enhancers are simply less robust than the others within the 
region and serve to confirm the variation between the enhancers.  Alternatively this 
could be as a result of directionality; the two LacZ promoters are located 100 kb from 
Shh within this line and thus lie between the promoter and both the forebrain and 
facial enhancers. The floor plate and midbrain enhancers sit after these additional 
promoters and therefore would not necessarily be ‘blocked’ from reaching the Shh 
promoter by them. The ZRS is located at a large distance from Shh and is proposed 
to interact via chromosomal looping meaning it would be possible bypass the extra 
promoters within the region.  
 
The fact that such an extreme phenotype is found within the SBlac120 homozygotes 
whereas apparently no phenotype or change in expression pattern is exhibited within 
either the SBLac 2-120 or SBLac 2-67 lines suggests that the position of these extra 
promoters is important in how they affect the region (Figure 6.14A). Both of these 
insertion sites are downstream of the forebrain enhancers; however, they both sit 
between the pharyngeal enhancer MFCS4 and Shh which is also likely to be involved 
within the craniofacial phenotype shown within the SBLac120 homozygotes 
considering expression within the pharyngeal structures was shown to be disrupted. 
This suggests that there are sites within the Shh region which are more susceptible to 
being disrupted by multiple promoters.  The phenotypes seen within the g/120 mice 
must therefore be taken with caution, not only could these be arising as result of the 
deletion but the multiple promoters present within this site could also complicate 
matters and potentially are another factor which could be accountable for the 












     The Shh genomic region encompasses a complicated regulatory locus comprising 
a series of regulatory elements which serve to drive expression of the gene within 
specific tissues of the central nervous system, gut and posterior of the limb bud 
(Epstein, McMahon, and Joyner 1999; Lettice et al. 2003; Sagai et al. 2004; Jeong et 
al. 2006; Sagai et al. 2009). These enhancers lie within the gene itself, within a gene 
desert upstream of the gene and also within the introns of neighbouring genes, 
spanning a distance of nearly 1 Mb.  A great deal of work has been performed on 
developmental loci including the Shh domain in recent years with an aim to 
understand how these developmental regions function.  
 
7.1.1 Targeting of an LHED vector into the Shh region 
     Utilisation of the LHED system (Kokubu et al. 2009) has enabled us to study the 
Shh region in depth. Firstly, three separate LHED vectors were designed and cloned, 
one within the 5´end of Lmbr1 and the other two within the 3´end. Of these, the 5´ 
end and one of the 3´ end vectors were successfully targeted into E14 ES cells. The 
remaining vector could not be successfully targeted into the correct genomic region. 
When designing the homology arms for targeting, two specifications were taken into 
account firstly the homology length and secondly how much unique DNA is included 
within this homology as both are important to allow the cellular DNA repair 
mechanisms to align a targeting vector with its corresponding region of homology 
and result in recombination into the chromosome. For recombination to occur within 
a cell, around 2 kb of sequence homology is required (Melton 2002). However, 6-14 
kb of homology is typical for targeting constructs. Although the 3ꞌ targeting vector 
which failed to recombine was 4.6 kb and thus should have had a long enough 
homology arm to insert within the genome it was not possible to detect this. The 
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actual targeted event takes place in only a small percentage of cells (Hall et al. 2009). 




 of the DNA integrations are 
homologous recombination events (Melton 2002). Thus it is possible that simply not 
enough clones were analysed to detect positive insertion of this vector.  
     Vectors with a double stand break within the homologous counterpart of the 
chromosomal sequences have been termed insertion vectors and usually recombine 
through a single reciprocal double stand break repair pathway. A vector that targets 
via this pathway will integrate the entire vector to form a duplication of the 
homology arm. The utilisation of primers homologous to sequence within this double 
strand break was found to be the only reliable way of determining correct targeting 
of the vector into the genomic locus.  It is thus essential for this unique piece of DNA 
to be repaired in order for the full homology arm to become inserted within the 
genome (See Figure 4.4).  
 
 
7.1.2 Remobilisation of the LHED vector  
 
       The process of remobilising the LHED vector in vitro was optimised. It was 
found that the SB100x transposase (Mates et al. 2009) was much more efficient than 
the SB11 transposase within the original study (Kokubu et al. 2009). A chemical 
transfection method rather than electroporation was also found to be more reliable 
for treating LHED-carrying cells with the transposase vector. Finally, it was 
discovered that a higher level of puromycin was required in order for selection to 
occur.  
 
      Within the original LHED study (Kokubu et al. 2009) a splinkerette-type PCR 
was used for screening ES clones in order to establish where reinsertions had 
occurred. However a somewhat simpler method to establish Sleeping Beauty 
reinsertion within mouse lines was more recently detailed by (Ruf et al. 2011). This 
involved an asymmetric nested PCR and sequencing and was, therefore, employed in 
order to analyse the LHED clones generated from both targeting vectors. This system 
appeared to be highly reliable; altogether it was possible to map sequence for nearly 
174 
 
90% of clones analysed and indeed this number could potentially be increased by 
repeating the PCR and sequencing (See appendix Table 8.1). Approximately 40% of 
these reinsertions were found to occur within 1Mb of the original insertion site 
(Table 4.2). This provided a good distribution of re-insertions across the region 
(Figure 4.8). One limitation of the system was that the orientation in which the 
transposon reinserted was important for whether the LoxP sites could be utilised for 
generating deletions and maintain the LacZ reporter gene. Although there was a 
roughly 50:50 ratio for orientation of reinsertion, there was, in fact, a somewhat 
limited number of insertions which proved useful for generating deletions. In order to 
map the region more thoroughly it may be required to generate more insertion sites, 
either by targeting another vector perhaps in the middle of the region, which could be 
done with relative ease now the system is completely optimised. Alternatively, one 
of the existing insertion sites could be re-mobilised by additional treatment with the 
transposase, the only limitation of this being that it will not be possible to utilise the 
Puromycin resistance cassette to determine those clones in which mobilisation has 
occurred.  
 
7.2 Use of the LHED system in vitro  
 
One of the benefits of using the LHED system over other Sleeping Beauty systems 
such as Gromit (Ruf et al. 2011) was the ease of using it within ES cells rather than 
mice. Although targeting the LHED system into the ES cells and subsequent 
mobilisation of the transposon was somewhat laborious, the fact that it allowed 
selection of appropriate clones was helpful to the further study. This meant the ES 
cell lines could be split into two categories, those that were beneficial for generating 
tetraploid embryos (fairly quickly) to examine reporter gene expression and thus map 
the region, and those which were to be used to generate mouse lines to look at the 







7.3 Mapping the Shh region using LHED 
 
A series of LHED insertions were used to generate tetraploid embryos in order to 
look at how reporter gene expression varies across the Shh region, this was done with 
an aim of looking at reporter gene expression within the gene desert, within 
neighbouring genes as well as within the boundary regions flanking the locus.  
Reporter genes were inserted into four positions throughout the 729 kb gene desert, 
analysis of which suggest that the desert is in an open conformation over its length 
and each reporter is receptive to all the known enhancer activities.  Each of the 
inserts recapitulated spatial patterns that reflected Shh expression upon examination 
of the whole embryo and the dissected gut. This suggests that the gene desert 
flanking Shh is broadly open to transcriptional activity. Additionally, the spatial 
pattern of expression was independent of the position of the reporters within the 
desert suggesting that there is no segmentation of the regulatory terrain into open and 
closed chromatin and that the chromatin within the gene desert is functionally 
indistinguishable.  
Although the global expression pattern within each of the desert inserts 
suggests a lack of variation, the activity levels are not equivalent across the domain.  
The most distal enhancer, the Zrs limb -specific enhancer lying in the Lmbr1 gene 
showed a trend in which the reporter closest to the enhancer was expressed at a high 
level with a decrease in expression toward the middle of the domain and an increase 
with the reporters near the Shh gene.  This increase in pLHED-derived reporter 
activity nearer the gene was also reported for the Pax9 gene (Kokubu et al. 2009). 
Alternatively, the MACS1 gut enhancer is found within the Rnf32 gene (Sagai et al. 
2009) and expression driven by MACS1 in the laryngotracheal tube suggests a 
mechanism more focused in the direction of the gene working less efficiently closer 
to the enhancer itself. Finally, the SBE1 enhancer which lies within the Shh gene was 
found capable of working across the entire gene desert suggesting its proximity to the 
target promoter is of no consequence for its activity.  
      Analysis of the Fgf8 locus has suggested that interactions between multiple 
enhancers may lead the region to adopt a defined structural conformation that could 
favour regulatory interactions between enhancers and specific positions of the locus 
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instead of with specific promoter sequence (Marinic et al. 2013) (See section 2.15.1). 
Although it is possible to disassemble these regulators into autonomous modules, the 
whole region is speculated to work as an integrated regulatory assembly, whereby 
overall activity cannot simply be determined by the addition of its basal components. 
In this model, dynamic interactions between the different active elements, involving 
eventually additional interspersed structural elements, determines where the 
regulatory influences are exerted; hence, the output of the entire region would reside 
in the relative distribution of genes and enhancers along the locus. Within the 
‘holoenhancer’ system the reporter gene frequently showed only a subset of the 
expression of the endogenous gene, suggesting that although all domains could be 
captured by an endogenous promoter, they were not (Marinic et al. 2013). From this 
it was suggested that regulatory elements that control gene expression may have 
distinct ranges of action, thereby defining different regulatory landscapes and 
ultimately resulting in differential genes expression at different positions within a 
locus, as a result of the functional consequence of chromatin and conformational 
structures as well as the spatial range of enhancers and of their extensive interactions 
(Marinic et al. 2013).  What is reported for holoenhancers seems to contrast with 
what is seen at the Shh locus, indeed there does not appear to be any correlation 
between the position of the reporter and activity, with enhancers seemingly acting 
regardless of location and not always focussed towards the gene in question. 
Additionally, none of the inserts examined both within genes and also within the 
gene desert showed only a subset of the gene expression pattern, instead they were 
found to recapitulate the pattern (although with tailing off at the boundaries) 
suggesting that if the promoter of the reporter gene was in contact with the 
enhancer(s) they acted upon it.   
 
Further, Gromit (Ruf et al. 2011) also suggests that within a regulatory 
domain, the expression level detected by the reporter can vary quantitatively and 
reveal positions apparently refractory to activation known as cold-spots. The purpose 
of these cold-spots is speculated to be a way to shield genes from the influence of 
surrounding enhancers (Marinic et al. 2013), adding to other mechanisms of 
specificity such as core promoter sequences (Ohtsuki et al. 1998). Again a different 
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scenario is found within the Shh locus. The Shh regulatory domain contains 
neighbouring genes including the ubiquitously expressed Rnf32.  Although the gene 
body of Rnf32 appeared to be open to enhancer activity the promoter was resistant. A 
similar situation was also found downstream of Shh whereby the ubiquitously 
expressed Rbm33 gene located within the Cnpy1/En2 was open to enhancer activity 
although the promoter appeared refractory. This therefore suggests a common 
mechanism within large regulatory domains may be that ubiquitously or widely 
expressed genes are not sequestered by insulators or boundaries but are able to 
occupy domains within the range of enhancer activity by containing promoters that 
are simply resistant to remote regulatory activity.  Overall the general conclusion 
from analysis of the Shh region suggested that it is not acting as a holoenhancer.  
 
      The boundaries surrounding the Shh region were also examined and defined by 
looking at insertions both within and upstream of the Lmbr1 gene as well as 
downstream of Shh. At the 5´ end of the region a more gradual decline in enhancer 
activity was found where individual enhancers were lost in increments. The 3´ end of 
the region seemed more definitive whereby loss of all enhancer activity was found 
fairly closely downstream of Shh. A similar situation was found at either end of the 
region whereby as soon as Shh expression was lost a new expression domain was 
found. Downstream of Shh this involved Cnpy1/En2 whereas upstream of Lmbr1 an 
expression pattern likely to involve Mnx1 was identified. There was little overlap 
between the domains however it was possible that the Zrs was still functioning 
upstream of Lmbr1, long after the other Shh enhancer activity was lost. The region 
appears to comply with the Topological Activity Domain (TAD) previously 
suggested (Smallwood and Ren 2013) (Figure 5.8). Within this model the Lmbr1 end 
of the TAD appears quite ‘messy’ which also both fits with the data found and could 
explain the overlap in expression between the Shh and Mnx1 domain. Recent work 
by (Symmons et al. 2014) has shown that despite the overall inclusion of regulatory 
domains into TADs, the positions of the relative transitions were not always exactly 
superimposed, similarly to chromatin domains, which do not exactly correlate with 
TADs (Hou et al. 2012). These differences have been suggested to partially arise 
from the low resolution of Hi-C, which can locate topological transitions with only 
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limited precision (20 kb). Furthermore, topological transitions may not necessarily 
constitute absolute barriers, but act more like dampers (Andrey et al. 2013). 
 
      Many known insulator or barrier elements are bound by the zinc-finger 
containing protein CTCF. Within the Shh and Lmbr1 region a number of such sites 
were found, and notably, these lie not in the gene desert but are enriched at either end 
of the regulatory domain. However there is no direct relationship between the 
position of the CTCF sites and the loss of enhancer activity. The conditional loss of 
CTCF within the forelimbs does not suggest it acts as an insulator at least in 
developing limb mesenchyme (Soshnikova et al. 2010). A similar global analysis has 
been performed by (Symmons et al. 2014) which also suggested that, by and large, it 
appeared difficult to match the distribution of the CTCF/cohesin sites with the 
distribution of regulatory activities, highlighting that, within TADs, the binding of 
cohesin/CTCF, defined by chromatin-immunoprecipitation, may not be a sufficient 
indicator or regulator of regulatory boundaries.  
 
7.4 The effect of deletions on reporter activity  
 
      The LHED system was also used to generate deletions within the Shh region 
(g/2-120, g/2-67 and g/120); the effect of these was then determined by examining 
reporter gene expression. Embryos were examined between stages E9.5 and E14.5, 
none of the deletions reported however showed any temporal changes in expression 
at these stages, only spatial.  
 
      Deletion of enhancers with known expression patterns appeared to result in a 
fairly consistent loss of reporter gene expression within those tissues involved. For 
example loss of MACS1 resulted in a down-regulation of expression within the gut, 
loss of the enhancer SBE2-SBE4 resulted in loss of expression within the forebrain 
tissues, whereas loss of MFCS4 appeared to result in at least changes with respect to 
expression within the pharyngeal arches and tongue. No aberrant or spurious 
expression patterns were identified following deletion of DNA from the locus 
suggesting that removal of the various regions did not result in gain of any enhancer 
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functions. In a similar respect no changes in expression pattern of any remaining 
enhancers were identified.  
 
       Reporter gene expression following deletion suggested the possibility of shadow 
enhancers within the region, which are expected to help foster robustness in gene 
expression. Within both the smaller deletions, although gut expression is reduced 
following deletion of the MACS1 enhancer, is it not completely lost (Figure 6.3).  A 
second gut enhancer SLGE is also present within the region (Tsukiji, Amano, and 
Shiroishi 2013) and although this is not necessarily deleted in full within the large 
deletion, it is disrupted and thus could be accountable for the complete loss of gut 
expression (Figure 6.9). A similar situation to the gut was found for the pharynx 
whereby expression was shown to be reduced following the g/2-120 and g/2-67 
deletions before being completely lost with the g/120 deletion (Figure 6.4).  MFCS4 
has been shown to drive expression within the pharyngeal tissues and no additional 
enhancers have so far been identified. These data however suggest an unknown 
shadow enhancer potentially exists, which acts alongside MFCS4, or alternatively. 
perhaps SLGE has additional function beyond just the gut.  
     The MRCS1 enhancer was previously reported to drive Shh expression within 
tissues of the oral epithelium, as well as hair follicles and whisker buds (Sagai et al. 
2009). However, this was found not to be the case, the two deletions in which this 
enhancer was removed were still found to exhibit reporter gene expression within 
both the hair follicles and whisker buds (Figure 6.6/6.9).  MRCS1 therefore does not 
adhere to the expression pattern previously reported.  In vivo reporter experiments 
often rely on “minimal” enhancer fragments which do not always perfectly replicate 
the precise spatial boundaries of expression of the native gene in the endogenous 
context, thus it is entirely possible that the expression pattern reported for MRCS1 
does not necessarily reflect the true expression pattern of the enhancer.  Alternatively 
it could suggest the presence of one or more shadow enhancers are capable of driving 
expression within these tissues. Within the Shh null mouse hair follicles do not form 
although whisker buds do (Mill et al. 2003). This suggested the two developmental 
pathways for these tissues are independent of each other. It also suggests at least in 




      SBE1 is responsible for the maintenance of Shh expression in the midline of the  
midbrain and caudal diencephalon from E10.5 onwards; is believed to act in concert 
with an additional enhancer which controls Shh transcription at earlier time points as 
well as driving expression within the Zli (Jeong et al. 2011). Within all three 
deletions mid-brain expression is present from E9.5 onwards and expression is 
shown within the zli suggesting that this additional enhancer is not present within the 
region which has been removed. The presence of a notochord enhancer was also 
confirmed in this experiment via the loss of notochord expression between the 
middle and largest deletion. The presence of two notochord enhancers has previously 
been postulated from enhancer trap analysis (Jeong et al. 2006), these data therefore 
serves to both confirm the presence of these and also narrow down the region in 
which they lie.  
 
 
7.5 The effect of deletions on phenotype  
 
     Three deletions were generated to examine phenotype, all of which were shown to 
be lethal before birth as both compound heterozygotes with a Shh null chromosome 
and also as homozygotes. Within the homozygotes this lethality could be as a result 
of the presence of Rnf32 as these animals appeared to die at earlier stages than the 
compound heterozygotes.  
 
      The g/2-120 deletion which was the smallest deletion was found to result in a gut 
defect as a result of loss of some gut enhancer function during development. The guts 
were shorter and the stomachs were malformed, however the phenotype was not 
found to be similar to the Shh-null gut defects. These embryos were found to have 
residual LacZ expression within the guts suggesting enhancer function (potentially 
SLGE) within this tissue had been reduced but not lost. Loss of enhancer function 
within the gut was not actually achieved until the final deletion g/120 which was 
found to result in a gut defect similar to the Shh-null.  The lungs of g/2-120 animals 
appeared structurally normal as compared to Shh-null animals which are completely 
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devoid of lungs. The lack of a lung phenotype within the g/2-120 deletions seemed 
strange considering that although there was residual reporter expression within the 
lungs of these animals, a large decrease in enhancer activity comparable to the rest of 
the gut had occurred. This lack of phenotype could therefore suggest that the lungs 
are less sensitive to reductions of Shh protein levels or are rescued more easily by 
other sources of Hh.  Within some of the g/120 homozygotes a surprising 
phenomenon occurred in that reporter gene expression was found to be present 





embryos exhibiting milder facial defects did not 
appear to have the same gut defect as seen with the two smaller deletions suggesting 
the phenotype had somehow been rescued (Figure 6.11). This rescue of 
phenotype/expression again suggests the presence of shadow enhancers present 
within the region which are activated upon the loss of MACS1. The SBLac120 
insertion occurred within the enhancer SLGE which potentially functions as a 
shadow enhancer to MACS1. Following the deletion, loss of enhancer activity was 
found to occur within the guts of g/120 heterozygous mice suggesting this enhancer 
was no longer functioning, however, some of the SLGE sequence remains, which 
could be functioning to turn on SHH expression thus rescuing the phenotype.  
However, why this rescue of expression pattern and phenotype within the smaller 
deletions does not occur is unclear. 
 
 










mice this resulted in a phenotype comprising a truncated lower jaw and an 
absent tongue, these mice were also found to exhibit a pointed face, attributes 
reminiscent of failure of both lower jaw development (derived from pharyngeal 
structures) and also late forebrain expression. However, the brains of both lines 
exhibiting this facial defect were found retain their structures. Deletion of the 
pharyngeal enhancer both within a previously published study  (Sagai et al. 2009) 
and also within the g/2-120 mutant suggests that a jaw phenotype is not found unless 
both this pharyngeal enhancer as well as the oral epithelial enhancer is removed. This 
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likely suggests that the tissues in which both of these enhancers are being expressed 
are affected by the loss of Shh, resulting in the facial phenotype.  
 
     The g/120 mouse line was found to result in a varied phenotype. Genetic rescue of 
tissues in which reporter gene expression has been abrogated could explain the 
phenotypic variance as a result of Hh expression from other tissues. Ihh expressed 
from the gut endoderm has previously been suggested to be capable of rescuing CNS 
development including defects in the telencephalon (Zhang et al. 2001). Temporal 
effects could also be the cause of the varied phenotype seen within the g/120 line. 
Previously, studies have shown that early removal of SHH from the forebrain results 
in severe forebrain defects; whereas, later removal is restricted to malformations of 
the upper jaw (Marcucio et al. 2005; Chong et al. 2012). Reporter gene analysis 
suggests that within the mutant forebrain expression is lost from E9.5 days onwards 




compound heterozygotes suggests that 
this loss of forebrain expression is found in E12.5 embryos exhibiting moderate 
phenotypes (Figure 6.10). Whereas within those with a more extreme phenotype 
reporter genes expression is not only lost within the forebrain but also within the 
remaining structures of the CNS. The notochord source of Shh is important for floor 
plate as well as hind brain and mid brain development (Kaellen 1965; Britto, 
Tannahill, and Keynes 2002) and has also been shown to be lost within g/120 mutant 
mice (Figure 6.9). This could suggest the varied phenotype found within the g/120 
line could be as a result of the compounded effects of the loss of forebrain and 
notochord Shh sources.   
 





Variations in limb phenotype occur  following deletion of part of the Zrs as a result 
of temporal changes or as a result of changes in Shh protein levels (Lettice et al. 
2014).  Within individuals with HPE; phenotypic variation has been attributed to 
threshold levels of Shh protein (Jeong et al. 2011).   Although enhancer function has 
been shown to be lost/reduced following the deletions within the three lines Shh 
protein could still be present. Variations in phenotype could therefore be as a result 




     Despite deleting the large gene desert between Shh and the Zrs, no alterations in 
either Zrs-driven reporter gene expression or limb phenotype were observed, 
suggesting the distance at which the Zrs operates at is not important for function.  As 
previously discussed, recent studies at other developmental loci suggest that 
regulatory domains act together in order to drive expression of their target gene (See 
section 2.15.1). Marinic et al., (2012) suggest that in intact endogenous loci 
regulatory control is exerted by coordinated and not individual action, of enhancers 
suggesting integration is orchestrated at the level of the regulatory domain, not at 
endogenous gene promoters. Genetic dissection of the 800 kb large genomic 
intervals centromeric to HoxD13 indicated that various elements contribute in a 
partially redundant fashion to the transcriptional activation of HoxD genes 
(Montavon and Duboule 2013).  
It is unknown if either of these models are applicable to the Shh domain, the 
information generated from mapping the region suggests that the regulatory domain 
is primarily composed of regulators that contribute to the spatiotemporal expression 
pattern as a summation of the individual enhancer activities. Deletion of these 
various elements also confirms this whereby each of the individual enhancers deleted 
resulted in a loss of the spatio-temporal expression from such an enhancer without 
resulting in any changes to any remaining enhancer activity or the overall output of 
the domain. The differences between the Shh domain and other regulatory loci such 
as Fgf8 and Hoxd could therefore suggest that the coordinated gene expression 
controlled by long distance enhancers falls into a number of different but possibly, 
overlapping mechanistic classes. 
 
7.6 The effect of multiple promoters on enhancer activity  
 
      A final strand of this work involved examining whether the presence of multiple 
promoters affected reporter gene expression and also phenotype. This was done with 
an aim of examining whether enhancers were capable of contacting multiple 
promoters within a single tissue. This is believed to occur at loci as ‘promoter 
competition’ is speculated to provide a way to filter out enhancer activity from target 
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promoters as described at the HoxD locus (Spitz, Gonzalez, and Duboule 2003). 
SBlac120 mice were crossed in order to generate homozygous individuals thus 
containing a LacZ reporter gene and corresponding Hsp68 promoter on both 
chromosomes. Embryos were shown to have disruption of forebrain and pharyngeal 
reporter gene expression resulting in a craniofacial defect (Figure 6.13/6.14). 
Homozygous embryos generated for the two other inserts SBLac 2-120 and SBLac 
2-67 had no changes to reporter gene expression or phenotype as compared to 
heterozygous controls (Figure 6.13). The presence of comparable LacZ expression 
and phenotype within SBLac 2-120 and SBLac 2-67 heterozygotes and homozygotes 
suggests that it is possible for an enhancer to contact both the endogenous and an 
additional promoter within a single tissue. However, as the overall expression pattern 
within SBLac 120 homozygous embryos was found to be less intense than that seen 
within the heterozygotes despite carrying two copies of LacZ than some degree of 
promoter competition occurs at least at some sites within the region resulting in a 
phenotype.  
      A phenotype was found within SBLac120 homozygous mice but not within either 
of the other homozygous insertions suggests that some sites within the Shh region are 
more susceptible to being disrupted by multiple promoters than others. This is maybe 
a result of complicated chromosomal dynamics within this locus which are yet to be 
elucidated. 
 
 7.7 Perspectives and further work  
 
      By utilising the LHED system it has been possible to generate a series of SBLac 
insertions throughout the Shh regulatory region. The system has also been optimised 
which provides a further possibilities of exploiting the system in order to answer a 
great deal of possible questions.  A number of the insertions generated were made 
use of in order to map regulatory activity across the gene desert, and at the 
boundaries of the region by employing a tetraploid complementation assay. 
Additionally three mouse lines have been generated in order to examine loss of 
function effects within the region. The mutations generated within these mice were 
shown to reflect defects of gut and craniofacial development; although numbers and 
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generation remain low therefore further work will be required to further verify this 
and examine phenotype on additional backgrounds. A great deal of variation was 
found with regards the largest deletion (g/120) although again a limited number of 
embryos were studied. A number of possible hypotheses have been drawn with 
regards to the cause of this variation including differences in temporal expression, 
variations in protein levels and rescue of expression/phenotype however potentially a 
multitude of these reasons could be in play. Finally analysis was performed on 
homozygote SBLac embryos, from this it was concluded that certain sites within the 
region are more susceptible to the influence of multiple promoters. This suggested 
another potential caveat which could play a role in the phenotypic variation seen 
within the g/120 line.  Again however embryo numbers will require to be boosted in 
order to really study this in depth.  
     With regards future work further backcrossing of all the lines is required in case 
variation is background-dependent. Further characterisation of the phenotypes 
generated must also be undertaken using further antibody or in situ markers. 
Additionally elucidation of how Shh still contributes to cells within the deletion lines 
would also be useful. GFP/Cre Shh ‘knock-in’ mouse lines exist which could be 
crossed with the deletion lines in order to recombine both the deletion and the 
GFP/Cre Shh alleles onto the same chromosome and thus produce double marked 
LacZ/GFP cells.  
As the presence of multiple LacZ promoters at certain locations has been shown to 
affect phenotype it would also be beneficial to test the effect of LacZ removal on the 
lines. This currently cannot be done in the current arrangement therefore re-
engineering would have to be undertaken in which case it may be beneficial not to 
delete within the middle of the SLGE enhancer.   
Analysis within the region has also suggested the presence of a number of additional 
enhancers or shadow enhancers for example those which control notochord 
expression; fine mapping of the region by generating smaller deletions would 
potentially allow narrowing down of their location. Enhancer marks could also be 
used to pinpoint enhancer sequences and reporter transgenics utilised to test enhancer 
function. The effect the deletions have on the Shh topological domains would also be 
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of interest, this could be investigated by employing 5C. Finally, the CRISPR system 
(Sander and Joung 2014) is currently being used within the lab with success and 
therefore it may be beneficial to combine both this and the LHED system for further 
























8.1 Developing a FISH/ES cell system to establish the chromosomal 
dynamics at the Shh locus 
Although the LHED system was initially employed to be used to generate 
tetraploid embryos and mouse lines, the use of ES cells also meant it was possible to 
do some analysis within the cells themselves. The Shh locus has been shown to 
interact with the ZRS via chromosomal looping within cells of the ZPA (Amano et 
al. 2009). It is possible that the composition of the Shh regulatory landscape is 
important for this interaction.  
 
8.1.1 Inducing Shh expression within ES cells 
Wild-type ES cells do not express Shh. Therefore, in order to induce Shh 
expression, cells were treated with 1 μM retinoic acid over a period of 72 hours. 
Retinoic acid causes the cells to differentiate down a neuronal pathway. At 24 hours 
intervals RNA was extracted from these cells as well as a non-treated control and 
used to produce cDNA. The resulting cDNA was then analysed by RT-PCR using 
primers for Shh as well as the differentiation marker Oct4. Expression of Shh was 
detected following 48 hour treatment with retinoic acid (R.A). Whereas, Oct4 
expression was shown to gradually decrease over the timescale indicating the cells 
were differentiating (Figure 8.1A). 
 
8.1.2 What are the chromosomal dynamics at the Shh locus? 
FISH analysis was undertaken in order to examine the configuration of the 
Shh locus both in wild-type and Shh expressing ES cells. Metaphase nuclei were 
prepared from both control cells and those which had been treated with R.A for 48 
hours. FISH was then performed using probes against Shh, the Zrs, Rnf32, SBE4 and 
Dpp6. Within wild-type ES cells Shh and the Zrs were found to have a much smaller 
interprobe distance than Shh and Dpp6 (Figure 8.1B [i] [ii]). Rnf32 and SBE4 were 
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also found to be within close proximity to Shh, thus suggesting the whole locus is 
held in a compact configuration rather than a ‘looping-out’ event occurring between 
the Zrs and Shh (Figure 8.1B [iii] [iv]). In comparison, within Shh expressing cells, 
the interprobe distance between Shh and the ZRS was found to be substantially 
smaller than that between the same probes in wild-type cells (Figure 9.1B [v]). This 
therefore suggests that expression of Shh causes an even tighter compaction of the 
Shh locus. The Zrs is not believed to be the target of retinoic acid as it is not 





Figure 8.1: Chromosomal dynamics at the Shh regulatory locus 
A. RT-PCR expression profile of B-actin, Shh and Oct4 within Wt and R.A treated ES cells. B-
actin levels shown to be consistent in all cell types. Shh is shown to turn on in ES cells 
treated for 48 hours with R.A and a small amount is still found at 96 hours. Oct4 is shown to 
slowly turn off following retinoic acid treatment.  
B. FISH analysis of ES cells with probes for Shh (green) and Zrs (red) in wt cells (i) and 
Retinoic acid treated cells (v). FISH also shown for Shh (green) and Dpp6 (red) (ii) and 
Rnf32 (red) (iii) and SBE4 (red) (iv).  
C. Box-plot of average interprobe distances over an average of 100 cells. Shh-ZRS is shown to 
be much more compact than Shh-Dpp6, this is shown to reduce further following R.A 
treatment (shh-zrs exp).  
(i)                              (ii)                               (iii)                             (iv)                             (v) 
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8.2 Generating deletions in vitro to examine the chromosomal dynamics 
at the Shh locus 
In order to examine whether there is anything special about the Shh locus 
which affects its dynamics, four of the LHED insertions were taken and used to 
generate deletions within the cell lines. These included a series of three insertions 
between the Zrs and Shh (2-120, 2-67 and 120), located approximately 100 kb, 500 
kb and 700 kb from Shh. A further insertion 100 kb upstream of Lmbr1 was also 
chosen (3-119) as it would allow deletion of the transcriptional start site of Lmbr1 
and potentially any boundary elements in the region.  
1x10
7 
cells from each line was taken and electroporated using 100 µg of a 
Cre recombinase expressing vector. 1x10
5 
cells were then plated out and left to grow 
on antibiotic free media for approximately 7 days. 100 clones were picked per 
transfection and PCR analysis employed to determine if the deletion had occurred 
using primers designed either side of the LoxP sites which would only provide a PCR 
band if the deletion had indeed occurred. Approximately 10% (10/100 picked) of 
clones for each transfection were found to carry the appropriate deletion (Figure 8.2).  
Positive deletion cell lines were grown up and used to produce metaphase 
nuclei for FISH analysis.  
 
Figure 8.2: in vivo LHED deletions within the Shh region 
Long range PCR analysis of LHED targeted lines treated with cre recombinase. Primers were 





8.3 Generation of deletion lines upstream of the ZRS 
          The predicted protein product of the Lmbr1 gene is a novel multipass 
transmembrane protein that does not fall into any known functional class but has 
been highly conserved in different organisms (Clark et al. 2001). Its structure 
suggests that it may encode a membrane anchoring protein, adhesion molecule, 
transporter, or cell surface receptor  (Clark et al. 2001). Lmbr1 which is located 
within the Shh region and contains the Zrs within one of its introns appears to be 
ubiquitously expressed during development. To test the requirement for the Lmbr1 
gene during development, a mutation in the Lmbr1 gene has been created that deletes 
the first known exon that contains the predicted site of translational initiation for both 
known Lmbr1 products (Clark et al. 2001). Mice carrying this allele show greatly 
reduced expression of Lmbr1 transcripts but still express low levels of novel 
transcripts. Mice heterozygous or homozygous for the Lmbr1
ATG
 mutations are viable 
and fertile and do not show typical Zrs related limb defects. Instead, homozygous 
mutant mice show a very low incidence of limb defects, including oligodactyly, 
reduction in length or number of phalanges, and soft tissue or bony syndactyly. The 
placement of enhancers within functional neighbouring genes is not a novel concept 
and a similar phenomenon has been found in several developmental loci including 
those of Pax6 and Gremlin (Kleinjan and van Heyningen 1998; Zuniga et al. 2004). 
Indeed at the Shh locus, the gut enhancer MACS1 is also found within the Rnf32 gene 
as well as several brain and floor plate enhancers within the Shh gene itself (Epstein, 
McMahon, and Joyner 1999; Jeong et al. 2006; Sagai et al. 2009). Whether there is a 
functional reason for these enhancers being within expressed genes remains unclear. 
One possible explanation could be that the enhancers benefit from being within a 
region of open chromatin. In order to test this theory a series of mouse lines were 
generated in which the 5´ end of the Lmbr1 gene was disrupted.  
        Two LHED insertions were used to generate mouse lines which would allow 
disruption of the Shh regulatory locus upstream of the Zrs. These insertions were 
firstly, SBLac3-119 located approximately 100 kb away from Lmbr1 which could be 
used to generate a large deletion removing the 5ꞌ end of Lmbr1 as well as the next 
gene Nom1. A second insertion SBLac3-21 was also decided upon, this is located 
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approximately 25 kb upstream of Lmbr1 and within the orientation which would 
allow the 5ꞌ end of Lmbr1 to be inverted without deleting anything of importance.  
        ES cells were injected into C57Bl/6 embryos to generate chimeras. Chimeras 
were then crossed to C57Bl/6 mice in order to generate F1 offspring, which was 
confirmed by PCR.  
 
8.3.1 g/3-21 mouse line expression/phenotype analysis 
         
        F1s positive for carrying the transposon insertion were crossed to a germ line 
Cre expressing line (g/cre) in order to utilise the presence of the LoxP sites within 
the targeting vector and generate an inversion encompassing the 5´ end of the Lmbr1 
gene. So far no mice positive for the inversion have been born and in fact low pup 
numbers have been found consistently during crosses of 3-21 males with Cre female 
mice (data generated from 4 litters).   
 
8.3.2 g/3-119 mouse line expression/phenotype analysis  
 
         ES cells positive for the SBLac3-119 insert were injected into C57Bl/6 
embryos to generate chimeras. They were also treated with a Cre recombinase in 
vitro to generate a deletion within the cell line; this was confirmed by PCR and again 
used to generate chimeras. Of the chimeras generated only one, generated from the 
pre-deletion ES cells was found to be fertile. This chimera generated a low number 
of F1 offspring positive for the SBLac insert which were themselves runted and 
unable to breed (n=4/16 from 4 litters). It was therefore not possible to generate a 
deletion mouse line using this ES cell line.  
 
8.4 Generation of Lmbr1 knock-out line  
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8.4.1 Designing a targeting vector to ‘Knock-out’ Lmbr1 
          In order the complement the lmbr1_LHED work it was decided to design a 
targeting vector which could be used to delete the 5´ end of Lmbr1. A targeting 
vector was designed which when used in combination with Lmbr1_LHED targeted 
cells would allow the ‘knocking-out’ of the Lmbr1 gene. This deletion would 
encompass the Lmbr1 transcriptional start site as well as some upstream region thus 
allowing investigation to determine if Lmbr1 transcriptional activity is required for 
Zrs activity.   
          The vector was designed to contain a 6.4 kb genomic arm homologous to a 
region approximately 20 kb upstream of Lmbr1. The vector was also designed so that 
a LoxP site as well as a hygromycin resistance gene could be inserted within the 
homology arm in an orientation so that when targeted alongside Lmbr1_LHED 
(which also contains LoxP sites) the 20 kb region upstream of Lmbr1 could be 
deleted and the gene could be rendered transcriptionally inactive.  
8.4.2 Vector Cloning 
        Primers were designed to amplify 300 bp regions from the 5´ and 3´ ends of the 
homology arm from BAC DNA encompassing the Lmbr1 region (Figure 8.3A [i]). 
Primers were also designed to include restriction enzyme sites for cloning into 
pBluescript (Not1/Cla1 or Cla1/Sal1). Ligations were then performed to clone the 5´ 
homology arm PCR fragment into the pBluescript vector and visualised by colony 
PCR. Following transformation, small-scale plasmid purification was performed on a 
select number of colonies and the resulting DNA was sequenced using M13 forward 
and reverse primers, which confirmed no mutations had been induced during the 
PCR. The vectors containing the 5´ end of the homology arm was then digested with 
Not1 and Cla1 and a ligation set up to ligate the 3´ end of the homology arm into the 
same vector. Following transformation restriction digest was used to identify vectors 
containing both ends of the homology arm (Figure 8.3B[i]). 
        In order to generate the full homology arm bacterial recombineering was 
employed. A double strand break was generated into the vector using the restriction 
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enzyme Cla1 and the DNA was subsequently electroporated into electro-competent 
EL350 gap repair cells. 
        A mini-targeting vector containing a hygromycin resistance gene was designed 
to insert within the homology arm. PCR was used to generate 200 bp fragments 
homologous to sequence within the homology arm (Figure 8.3A [ii]). Primers were 
designed to allow the addition of restriction sites either side of the PCR fragments 
(Not/Xho or Xho/Sal). These fragments were then ligated into a pBluescript vector 
which already contained a Floxed Hygro Cassette (Figure 8.3B [ii]). Following 
completion of cloning the mini-targeting vector was linearised using Not/Xho and 
was electroporated alongside the targeting vector into EL350 recombinant cells 
(Figure 8.3C). Colony PCR using primers homologous to the hygromycin gene were 
used to screen the resulting colonies. Positive clones were then grown up and 
purified using small-scale plasmid purification before restriction digest was used to 
confirm correct cloning of the vector (Figure 8.3C).  
8.4.3 ES cell Targeting 
        Following completion of cloning and sequence verification, the Lmbr1 knock-
out vector was linearised using Sal1 and electroporated in E14 ES cells already 
targeted with the Lmbr1-pLHED vector. Cells were then selected for approximately 
10 days using Hygromycin. Following selection, approximately 100 clones were 
picked and DNA was extracted from them. Long range PCR was employed to 
identify positively targeted clones using primers against the hygromycin cassette and 
out with the homology arms. One clone (out of 100 analysed) was found to have 






Figure 8.3: Cloning of an upstream Lmbr1 targeting vector 
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A. PCR fragments were generated for 300 bp homology arm ends (dark blue) (ii) and 200 bp 
internal fragments (red) (ii). 
B. Upstream Lmbr1 Fragments were cloned into the pBluescript vector and confirmed by 
restriction digest with Not1/Sal1 (i). Internal hygro fragments were cloned either side of a 
loxP/hygro cassette, confirmed by restriction digest (ii). 
C. Both vectors were electroporated simultaneously into EL350 recombineering bacteria.  
D. A pBluescript vector containing a complete homology arm including LoxP/hygro cassette 
was confirmed by restriction digest with Not1/Sal1. 
E. The finished vector was linearised using Sal1 and targeted into E14 ES cells, this was 
confirmed by PCR. 
 
8.5.4 Lmbr1 ‘Knock-out’ Mouse production 
        Cells positively targeted with both Lmbr1_LHED and Lmbr1 ‘Knock-out’ 
vectors were used for blastocyst injection into C57BL6/J super ovulated females. 
Four chimeric mice were produced. These chimeras were then used to generate F1s 
by crossing them with C57BL6/J females. The resulting litter were genotyped by 
PCR using primers against LacZ (LHED insertion) and hygromycin (additional LoxP 
site). It became evident that during targeting the second insertion had actually 
inserted on the opposite chromosome. A cross was therefore set up instead to cross 
the LHED mice to Cre expressing females to generate mice positive for the insertion 
and Cre recombinase. These mice were then crossed to LoxP carrying mice in order 
to recombine the inserts onto the same chromosome and generate the deletion. 
Resulting pups from three litters (approximately n=34) were genotyped however it 
was not possible to identify any which had undergone the recombination of both 
LoxP sites onto the same chromosome.  
         
8.6 Conclusions  
 
        It was shown to be possible to examine the chromosomal region surround 
Shh within ES cells. In wild-type ES cells Shh and the Zrs were found to be held 
in a tighter conformation than expected despite the gene not being expressed. 
This phenomenon has also been previously observed within anterior limb bud 
cells, where an interaction is still seen between the Zrs and Shh despite Shh not 
being expressed (Amano et al. 2009). This is attributed to the Shh locus 
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being held in one of three conformations, silent, poised or active  (Amano et al. 
2009). It is therefore suggested that within wild-type ES cells the Shh locus is held in 
a poised position even though Shh is not expressed. When the ES cells were treated 
with retinoic acid and Shh expression induced, the region was found to compact with 
very small interprobe distances found between Shh and the Zrs. This is likely to 
reflect an active conformation.  
 
      Unlike what is reported with the literature (Amano et al. 2009) the FISH analysis 
does not suggest that Shh and the ZRS are experiencing ‘looping’. If this was the 
case it would be expected that probes for regions within the middle of the locus 
would be found at larger distances from Shh than the ZRS. However, instead the 
whole region appears to be found at relatively small distances. This would suggest 
that instead the locus is actually just very compact and upon Shh expression it 
compacts further.  
 
     It was hoped that the region upstream of Lmbr1 could be examined via 
deletion/inversion with a hope of disrupting the boundaries previously indicated by 
both already defined TADs and also tetraploid complementation mapping. 
Breakpoints within complex loci have been shown to result in overt developmental 
phenotypes; rearrangements of the PAX6 locus have been shown to be associated 
with aniridia (Kleinjan and van Heyningen 1998; Kleinjan et al. 2001). Within the 
Hox cluster, any condition which interrupts this interval, by either an inversion or 
duplication intercalating some DNA sequences within the regulatory landscape, has 
been shown to result in a partial loss of expression. Thus suggesting, it is critical for 
the proper transcriptional control of genes as an integral regulatory block to be 
preserved (Montavon et al. 2011). Within both mice and humans rearrangements at 
the Shh locus have also been identified. One such human case was shown to result in 
a phenotype including a solitary maxillary central incisor (SMCI); a facial feature 
associated with HPE spectrum disorder as well as complete syndactyly of the hands 
and feet. This was expected to have occurred as a result of both gain- and loss-of-
function cis-regulatory mechanisms. The HPE spectrum disorder in the child was 
attributed to the loss of SHH enhancers as a result of the inversion with a gain of 
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function “enhancer adoption” effect speculated as a cause of the preaxial 
synpolydactyly (Lettice et al. 2011). The removal of the boundary elements 
surrounding Shh would therefore be a way to examine how enhancers behave when 
they have the possibility of activating new genes and what happens when the 
genomic context of these enhancers is disturbed.  Unfortunately as yet it has not been 
possible to produce mice with either deletions or inversions within this region. While 
the SBLac3-119 has resulted in only runted offspring as yet and it has not been 
possible to generate either deletions or inversions in this region, this could suggest a 
dominant phenotype which requires further analysis. However it is also possible that 
genetic issues are occurring within these mice unrelated to the various modifications 
generated within them. All three lines generated for examination of this region came 
from the L35 ES cell line (carrying the Lmbr1_LHED insertion vector), whereas the 
three lines used to generate the deletions between Shh and the Zrs came from the S32 
line (Carrying the Shh2_LHED insertion vector). These cells underwent several 
rounds of targeting and selection and although no obvious chromosomal defects were 
identified it is possible subtle mutations have been acquired. Each of the lines is 
therefore currently going through several rounds of backcrossing before attempting 












Location of LHED reinsertions  
Table 8.1: Reinsertion sites of the LHED transposon after SB100X mobilzation 
Clones labelled with single numbers e.g. 120 represent those in which came from the original 
transfection within the S32 line, whereas the prefix ‘2’ e.g. 2-25 is used to denote second transfection 
on S32 cells. Finally the prefix‘3’ e.g. 3-119 represents clones harvested following the single 
transfection within the L35 cells. 
Clone Numbers Chromosome Start site 
3-63 1 10132129 
2-28 1 13035536 
28 1 64817966 
2-56 1 115299424 
30 1 151412958 
152 2 9776384 
2-19 2 52678558 
2-159 2 133268860 
2-132 2 166876113 
3-10 3 3794132 
3-26 3 4866073 
3-55 3 4866073 
124 3 19862883 
3-31 3 92016171 
3-123 4 14797281 
2-30 4 61875857 
2-149 4 85868154 
2-190 4 85868195 
2-17 4 116259347 
3-56 4 135914822 
3-91 4 139320332 
3-113 5 9168148 
175 5 9233859 
183 5 9235918 
191 5 9235918 
2-84  5 11836765 
35 5 12226155 
2-79 5 12469518 
3-104 5 12781420 
2-33 5 13565636 
119 5 14780967 
71 5 14952294 
3-124 5 15136713 
169 5 15196170 
3-69 5 15201982 
3-102  5 16581331 
194 5 16826233 
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5 5 19554861 
181 5 19554861 
6 5 20477133 
2 5 21271005 
2-107 5 21740196 
2-101 5 23262039 
197 5 23882414 
2-83 5 24419635 
31 5 26381308 
3-19 5 26425225 
2-76 5 26425323 
11 5 26427887 
75 5 26617860 
114 5 27059363 
3-134 5 27193105 
97 5 27351309 
2-130 5 27541737 
2-139 5 28141761 
3-2 5 28483004 
138 5 28500403 
66 5 28505362 
3-24 5 28684811 
2-110 5 28687701 
3-99 5 28777670 
3-41 5 28777672 
7 5 28787130 
3-70 5 28790598 
2-51 5 28796870 
98 5 28797890 
2-4 5 28889281 
120 5 28889622 
2-39 5 28889761 
115 5 28978743 
109 5 28993824 
110 5 28993824 
3-93 5 28996311 
3-96 5 29002839 
2-88 5 29011233 
148 5 29066757 
46 5 29116092 
2-77 5 29266136 
131 5 29278627 
2-67 5 29319991 
3-76 5 29403698 
2-73 5 29405968 
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2-148 5 29443264 
83 5 29444355 
92 5 29444355 
13 5 29445046 
2-191 5 29468681 
2-112 5 29471537 
2-161 5 29471538 
2-179 5 29475308 
2-120 5 29489431 
3-5 5 29498108 
2-134  5 29515622 
2-25  5 29535419 
130 5 29583183 
2-200 5 29589741 
2-157 5 29591086 
104 5 29622149 
2-153 5 29622343 
3-35 5 29626632 
3-137 5 29626757 
102 5 29630052 
118 5 29634908 
135 5 29635417 
68 5 29639709 
198 5 29647904 
2-95 5 29648626 
2-21  5 29648996 
3-109 5 29649217 
3-139 5 29653746 
3-92 5 29653752 
3-97 5 29654566 
3-83 5 29660909 
2-75 5 29722396 
3 -21 5 29729576 
3-60 5 29794631 
2-32 5 29797324 
3-119 5 29809901 
156 5 29870513 
26 5 30084989 
3-133 5 30252588 
100 5 30412905 
3-47 5 30417140 
3-20 5 30564372 
44 5 31017172 
2-187 5 31032905 
99 5 31754503 
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17 5 32175629 
132 5 32491259 
3-38 5 33985251 
43 5 35312641 
3-65 5 36904719 
128 5 38227932 
189 5 41093593 
112 5 42993672 
2-121 5 43026925 
111 5 44076759 
2-150 5 45800705 
2-127 5 47579156 
3-40 5 48010706 
3-53 5 48015632 
133 5 48229228 
3-15 5 48446271 
78 5 49299399 
157 5 49972984 
3 42 5 50348005 
3-7 5 50348122 
2-7 5 50644953 
9 5 51550601 
2-89 5 51797701 
3-95 5 52538277 
3-36 5 52538747 
2-111 5 53976070 
3-18 5 55701651 
2-146 5 57116619 
36 5 57140720 
150 5 58426076 
2-100 5 63964545 
199 5 64758091 
2-64 5 65066713 
2-98 5 65398770 
58 5 66700503 
2-155 5 69418387 
34 5 69934611 
3-85 5 71399112 
3-121 5 73217101 
3-48 5 76672996 
3-51 5 76672996 
108 5 78241139 
2-16 5 91598106 
2-59  5 91868398 
171 5 93230434 
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3-80 5 96192364 
2-3 5 98836299 
168 5 114367950 
3-94 5 120161311 
136 5 128326269 
3-115 5 135019134 
3-30 5 29798342 
188 6 9790272 
2-105 6 33574026 
96 6 113059174 
89 7 7644373 
3-22 7 13376563 
3 7 19820575 
2-128 7 20472003 
2-24 7 62375427 
2-129 7 62375431 
3-78 7 83068342 
2-90 7 120715376 
3-111 8 72271096 
122 8 73217921 
2-22 8 131461255 
3-117 9 752036 
2-69 9 7224628 
3-57 9 9418548 
3-28 9 105239133 
86 10 5365227 
177 10 7113602 
3-114 10 57165077 
2-117 10 77538788 
2-182 10 93653604 
3-77 10 119604549 
3-39 11 4334449 
16 11 62594873 
3-32 11 77999344 
3-138 11 77999344 
2-14 11 81915010 
2-163 11 90377302 
3-88 11 93579103 
3-59 11 93579185 
2-74 11 93924030 
2-118 11 97868120 
29 12 17088375 
2-172 12 20891160 
3-13 12 37708714 
64 12 77343914 
204 
 
3-87 13 29361265 
3-106 13 32005058 
170 13 38285963 
3 54 13 59837459 
2-1 13 529797324 
2-174 14 7452161 
159 14 9609204 
3-25 14 44752082 
2-70 14 74864534 
2-192 14 79903521 
33 14 120203248 
3-73 15 34130752 
2-5 15 39536956 
3-6 15 49690384 
22 15 80653664 
101 16 31121059 
3-27 17 3181968 
2-109 17 43957168 
3-50 17 74968608 
3-127 18 15181506 
3-44 18 68612645 
134 18 88798068 
178 19 32105143 
2-145 19 49106541 
76 19 57183357 
2-18 X 65899132 
2-50 X 101579793 
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